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Abstract
ACTH is the principal factor stimulating the formation and release of Cortisol from
the adrenal cortex and is controlled, in part, by the negative feedback inhibition of
Cortisol. Investigation into the kinetics ofCortisol production by cultured bovine
adrenocortical cells in response to ACTH-treatment and the relationship between the
Cortisol secretion and the expression of the steroidogenic acute regulatory (StAR)
mRNA was undertaken. ACTH (lOnM) treatment ofBAC cells on day 3 of culture
displayed an increase in the rate ofCortisol output over the initial 6 hours, P<0.05 at
each time point compared with untreated cells, followed by a marked decline in the
secretion rate thereafter. The decline in the Cortisol secretion rate was not due to a
decrease in the number of cells as the protein content of the culture wells did not vary
by more than 10% over the 12 hour period. Nor was the decrease in Cortisol secretion
a result of serum-deprived culture as a comparable response was seen in serum-
replete conditions. HPLC analysis of the culture medium revealed the secretion of
four main steroids; Cortisol, corticosterone, cortisone and 1 ip-
hydroxyandrostenedione. Cortisol was found to account for >50% of the total steroid
output by BAC cells at each of the time points studied. The total steroid output
increased over the initial 6 hours (6.1nmol/106 cells at 6 hours) followed by a decline
in levels to 4.4nmol/106 cells at 12 hours. Thus, the decline in Cortisol secretion was
not due to the production of another steroid in preference to Cortisol. Various
concentrations ofACTH also invoked a similar pattern of Cortisol secretion as did
treatment of BAC cells with angiotensin II. Interestingly, no decline in Cortisol
secretion was found when BAC cells were treated with forskolin or 8Br-cAMP.
Receptor desensitisation was ruled out as the cells responded to a second ACTH-
treatment. The response to the second ACTH-treatment produced a significant
increase in Cortisol output compared with the original response at the 8 and 12 hour
time points, P<0.05. In addition the cells responded to a series of 12 hour ACTH
treatments through 72 hours, with a constant level of Cortisol being maintained. The
protein levels over the 72 hour time course remained constant.
xni
The immunoactivity ofACTH was found to be reduced after an overnight
incubation at 37°C. ACTH, 0.01 and InM, showed a significant reduction (P<0.05)
in activity when placed on BAC cells after an overnight incubation compared with
ACTH prepared freshly on the day. ACTH at 10 and lOOnM showed no significant
reduction in activity. The concentration of lOnM ACTH in the culture medium was
reduced by 77% after a 12 hour incubation at 37°C, P<0.01, in the absence ofBAC
cells. A 17% reduction in concentration was found in the presence ofBAC cells,
though this was not significant compared with the original concentration.
The expression of StAR mRNA was used as a marker for the acute regulation of
steroidogenesis. Northern hybridisation revealed the presence of two StAR
transcripts, 3.0 and 1.8kb. The expression of the StAR transcripts was found to be
highest in freshly isolated cells, with both untreated and ACTH-treated cells
producing similar amounts. By day 3 of culture the levels of StAR mRNA had
decreased and day 3 was found to be the optimum time for the study of StAR mRNA
expression. Upon ACTH-treatment ofBAC cells the two transcripts show a biphasic
response with a peak at 6 hours (10-fold increase over untreated) followed by a
decline to almost untreated levels thereafter (P>0.05). A similar biphasic response
was found with various ACTH concentrations and Angll-treatment. Forskolin-
treatment showed a peak in StAR expression around 4 hour with a decline in levels,
although these were still significantly raised over untreated cells at 8 hours. 8Br-
cAMP showed no peak in expression with the levels of StAR mRNA remaining
constant over the 12 hour period.
The use of conditioned medium on BAC cells suggested the presence of an
inhibitory substance secreted into the medium. To ascertain ifCortisol was exerting a
local negative feedback effect, Cortisol itselfwas added to the culture medium. A
significant increase in the Cortisol output over and above that present in the medium
was found at 4 and 8 hours ofACTH-treatment. Cortisone was also found to have no
inhibitory effect on the secretion of Cortisol by BAC cells. Inhibition of the steroid
pathway at various points prevented the production of any steroids; however an
increase in the expression of the StAR transcripts was found. The reason for this
increase in StAR expression is unknown at present.
XII
In conclusion, ACTH-treatment ofBAC cells produced a decrease in the secretion
rate ofCortisol, paralleled by a decline in StAR mRNA expression at around 6 hours.
A series of experiments were conducted to investigate this observation. A decline in
the immunoactivity ofACTH may contribute to this, but probably only at lower
concentrations. More interestingly, evidence was found for the possible presence of a
local negative feedback mechanism in cultured BAC cells. The identity of the
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1.1 The Adrenal Gland
The anatomy of the adrenal gland was first described by Bartholomeo Eustachius in
1563 although little was known about its function (Thorn, 1968). The necessity of
functional adrenal glands for survival was discovered in the 1850s based on
observations by Addison of patients with destructive disease of the adrenal and
Brown-Sequard provided experimental evidence using adrenalectomised animals
(Orth, 1992). By the 1930s it was recognised that that the effects of adrenal
insufficiency could be divided into two categories: those due to electrolyte imbalance
and those arising from altered carbohydrate metabolism. In 1932 Cushing
documented the presence of small pituitary adenomas in patients with adrenocortical
hyperfunction (Orth 1992). We now know of its various functions affecting numerous
body systems.
1.1.1 Gross anatomy of the adrenal gland
In mammals the adrenal glands are situated one on each side of the vertebral column,
on the superior pole of each kidney. The shape and size of the adrenals varies
between species from almost spherical in rats to more flattened and triangular in
humans and cattle. In the human and bovine species, the left gland is crescent shaped
and the right is more pyramidal. The size of the gland varies with the size of the
animal, the human gland measures about 20-30mm in width, 40-60mm in length,
2-5mm in thickness and weighs about 4 grams. The gland is enclosed by several
layers of connective cells surrounded by collagen fibers, which form the capsule.
Relative to its size it has a larger vascular and autonomic nerve supply compared to
most other organs. The adrenal has a unique structure comprising of two functionally
and embryologically distinct tissues, the inner medulla composed ofneurectoderm-
derived chromaffin cells surrounded by an outer cortex ofmesodermic origin
(figure 1.1). The utility, if any, of having them together in one discrete organ is not
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known. In some species, e.g. amphibians and certain fish, two separate organs are
found (Orth, 1992).
1.1.1.1 The adrenal medulla
The adrenal medulla consists almost entirely of chromaffin cells. These are irregular
shaped polyhedral cells organised in cords or small clumps and surrounded by nerves,
connective tissue and blood vessels. Within the chromaffin cells are numerous
chromaffin granules containing the catecholamines, noradrenaline and adrenaline. In
addition, chromaffin vesicles contain numerous transmitters, neuropeptides and
proteins which may be released with the catecholamines (Ehrhart-Bomstein, 1998).
1.1.1.2 The adrenal cortex
The adrenal cortex is divided into three concentric zones (figure 1.2). The outermost
region is the zona glomerulosa (zg) which lies directly underneath the capsule and
secretes predominantly the mineralocorticoids. The secretory cells of the zg are
arranged in irregular ovoid clumps. The cytoplasm of the secretory cells contains
much smooth endoplasmic reticulum, numerous mitochondria and triglyceride
droplets, all essential for steroid production.
The zona fasciculata (zf) is the intermediate and broadest of the three zones,
comprising approximately 75% of the cortex, and secretes predominantly the
glucocorticoids. It consists of parallel cords of secretory cells disposed at right angles
to the capsule and separated by fine strands of supporting tissue containing
capillaries. The cytoplasm is even more rich in smooth endoplasmic reticulum and
lipid droplets than the zg.
The zona reticularis (zr)is the innermost zone responsible for secretion of small
quantities adrenal androgens and glucocorticoids. The zr consists of an irregular
network ofbranching cords and clumps of granular cells separated by numerous wide
1.2
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diameter capillaries. The cells are much smaller than those found in the -zf and contain
fewer lipid droplets (Burkitt, 1993).
The degree of demarcation of the three zones varies between species, the zf and zr of
the bovine adrenal cortex merge to form a single layer, whilst the bovine zg is clearly
defined from the inner zones. In contrast, the human zg is poorly demarcated and
cells from the zf can be observed directly under the capsule.
Several hypotheses exist to explain the formation and maintenance of the
adrenocortical zones. The zonal hypothesis proposes that each zone contains
differentiated cells with its fixed complement of steroidogenic enzymes and functions
as a self-contained unit. Each zone is responsible for replenishment of cells following
local cell death (Chester-Jones, 1957). Other theories are less rigid and suggest
migration of the cells through the cortex during their life span. The cell migration
theory proposes that a stem cell layer exists beneath the capsule which contributes
cells to the zg. These cells migrate through each of the zones, changing steroidogenic
function as the zone requires, and then dying within the zr (Zajicek, 1986). Hornsby
proposed the steroid gradient hypothesis which argues that the centripetal vascular
system created a gradient of a particular substance across the cortex (possibly
corticosterone) which regulates the expression of the steroidogenic enzymes. This
theory is dependent on the concept that the cells of each zone arise from the same
basic cell type, having temporary and morphological differences. This concept is
supported by a study showing that cultured adrenocortical cells from each zone
quickly reverted to the same steroidogenic phenotype (Hornsby, 1983).
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Figure 11: Human Adrenal gland. (xl2). The outer cortex (C) and a pale stained
inner medulla (M) can be seen. A dense fibrous tissue capsule (TC), stained blue,
surrounds the gland and provides external support. A prominent vein (V) is
characteristically located in the center of the medulla (Burkitt, 1993).
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Figure 1.2 : The morphological zonation of the human adrenal cortex. (x20)The
zona glomerulosa (G) lies beneath the capsule and consists of secretary cells
arranged in rounded clumps. The intermediate zona fasciculata (F) consists of
parallel cords of secretary cells disposed at right angles to the capsule. The zona
reticularis (R) lying adjacent to the medulla (M) consists of small closely-packed
cells arranged in irregular cords (Burkitt, 1993).
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1.1.2 Blood supply and innervation
Blood is supplied to the mammalian adrenal by numerous small arteries branching
from the aorta, inferior phrenic and renal arteries. Cortical arteries and arterioles
branch into capillary beds within the cortex. These vessels arise directly from the
capsule, initially forming an anastomotic network around the cells of the zona
glomerulosa, then continuing as longitudinal capillary sinusoids between the cells of
the zona fasciculata. Then vessels finally open into a plexus of large bore sinusoids
that surround the cells of the zona reticularis and, hence coalesce into veins at the
corticomedullary junction. The organisational pattern of the cortical vasculature
ensures that every steroidogenic cell is closely associated with at least one cortical
sinusoid. This is believed to be necessitated by the need to support the oxygen
demand made by the cytochrome P450 mediated hydroxylations of the stimulated
adrenal cortex (Bassett, 1997). Medullary arteries and arterioles penetrate the cortex
without branching then form capillary beds in the medulla. Blood from both the
cortical and medullary veins empties through a large central vein, leaving the adrenal
via the renal vein (left gland) or the vena cava (right gland) (Orth, 1992).
Early descriptions of the microanatomy of the adrenal cortex concluded that the
cortex was not directly innervated, with the nerve supply to the medulla passing
directly through the cortex without branching or synapsing with any adrenocortical
cells. However it is now generally accepted that the mammalian adrenal cortex
receives a rich nerve supply, with nerve terminals in direct contact with cortical cells
(Ehrhart-Bornstein, 1998).
1.2 Hypothalamic-pituitary-adrenal (HPA) axis
Adrenal glucocorticoid release is regulated by hormonal interactions between the
hypothalamus, pituitary and the adrenal. The hypothalamus produces corticotrophin-
releasing hormone (CRH) a 41 amino acid peptide synthesised in the parvocellular
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portion of the paraventricular nucleus. CRH enters the hypophysial portal blood
system and is transported to the anterior pituitary where it stimulates receptors on
pituitary corticotrophs to synthesis and secrete adrenocorticotrophin (ACTH). ACTH
in turn stimulates the adrenal cortex to produce glucocorticoids (figure 1.3) (Orth,
1992). Cortisol secretion is closely regulated by ACTH and there are three
mechanisms of neuroendocrine control: 1) episodic secretion and the circadian
rhythm ofACTH, 2) stress responsiveness of the HPA-axis and 3) feedback
inhibition by Cortisol ofACTH secretion (Aron, 2000a). The circadian rhythm is
superimposed on episodic secretion; it is the result of central nervous system events
that regulate both the number and magnitude of CRH and ACTH secretory episodes.
In humans the release ofACTH and glucocorticoids throughout the day follows a
circadian rhythm. The highest levels are found in the morning and the lowest levels in
the late evening. Circadian rhythms in plasma glucocorticoids has also been shown in
monkey (Holaday, 1977), sheep (Fulkerson, 1979) and cow (Thun, 1981). The
circadian rhythm can be altered by changes in sleep pattern, light-dark exposure and
physical or physiological stress such as surgery or depression. ACTH and Cortisol
secretion are also responsive to physical stresses. Stress responses originate in the
central nervous system and increase CRH. CRH release occurs in response to
physical stress (pain, hypoxia, surgery, exercise) or psychological stress (fear,
anticipation). Other factors such as arginine vasopressin and catecholamines can
indirectly regulate steroidogenesis through the HPA in a pulsatile, diurnal rhythmic
manner. The third major regulator ofACTH and Cortisol secretion is that of feedback
inhibition. Glucocorticoid feedback inhibition occurs at both the pituitary and
hypothalamus and involves two distinct mechanisms: fast and delayed feedback
inhibition (Aron, 2000b). Fast feedback inhibition ofACTH secretion is rate
dependent, i.e. it depends on the rate of increase of the glucocorticoids. This phase is
rapid, and ACTH secretion diminishes within minutes following an increase in
glucocorticoid levels. This fast feedback phase is transient and is though to occur via
actions on the cell membrane rather than via glucocorticoid receptors (Aron, 2000b).
Delayed feedback inhibition further suppresses CRH and ACTH secretion, thus with
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continued glucocorticoid administration ACTH levels continue to decrease and
become unresponsive to stimulation. The ultimate effect of continued glucocorticoid
administration is suppression of CRH and ACTH release and atrophy of the zonae
fasciculata and reticularis as a result of ACTH deficiency (Aron, 2000b). Delayed
feedback appears to act via the glucocorticoid receptor (see below), reducing the
synthesis of the messenger RNA for pro-opiomelanocortin, the precursor for ACTH
















Figure 1.3 Hypothalamic-pituitary-adrenal axis Diagrammatic representation of
the HPA axis. Corticotrophin releasing hormone (CRH) and ACTH stimulate ( +ve )
and Cortisol inhibits ( -ve) the appropriate gland.
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1.2.1 The intra-adrenal CRH-ACTH axis
A complete CRH-ACTH system exists within the adrenal, with the adrenal medulla
and/or intraadrenal nerves as the source of CRH and adrenal medullary chromaffin
cells as target for this local releasing hormone and the source ofACTH (Ehrhart-
Bornstein, 1998). Data from different studies have demonstrated that the CRH
influences adrenocortical steroidogenesis independently from the HPA-axis, CRH
exerts an effect on hypophysectomised rats (Bornstein, 1990) and calves (Jones,
1992). CRH immunoreactivety has been observed in human and bovine adrenal
medulla (Suda, 1986).
A direct effect of CRH on adrenocortical function seems unlikely, as CRH was shown
to have no effect on isolated adrenocortical cells (van Oers, 1992). ACTH
immunoreactivity was found in extracts of rat (Mazzocchi, 1993) and human (Suda,
1986) adrenal medulla and in the adrenal venous effluent ofhypophysectomised
calves in response to splanchnic stimulation (Jones, 1992). In addition, adrenal
fragments composed mainly of chromaffin cells released ACTH in response to high
concentrations of CRH (Andreis, 1992). In patients receiving ACTH replacement
therapy for proven pituitary ACTH deficiency, subsequent CRH administration
induced a significant increase in Cortisol levels that was preceded by a rise in ACTH
levels (Fehm, 1988). Thus suggesting that the adrenal medulla is a source of
extrapituitary ACTH that maybe stimulated by CRH.
1.2.2 Mechanism of steroidogenic action of ACTH in the adrenal
The actions ofACTH can conveniently be divided on temporal grounds; into acute
actions which take place over a few minutes/hours and the long-term effects which
require a period of hours or even days to become manifest. Both the acute and the
chronic responses are hormonally controlled via activation of adenylate cyclase
resulting in an increase in intracellular levels of cAMP and activation of the protein
kinase A pathway (Simpson, 1988), (Sala, 1979).
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1.2.2.1 Acute action of ACTH
This effect generally involves an increase in cholesterol supply to the inner
mitochondrial enzyme CYP11A, which catalyses the first step in adrenal steroid
biosynthesis. In addition, ACTH increases the rate of transport of cholesterol across
the inner mitochondrial membrane, this process is discussed in detail later (section
1.6)
1.2.2.2 Chronic action of ACTH
The longer term requirement for ACTH in maintaining steroid levels in
adrenocortical cells was first established from studies in hypophysectomised rats.
Purvis et al showed that the levels of both mitochondrial and microsomal P450
enzymes fall dramatically after hypophysectomy, but were restored following ACTH
administration. (Purvis, 1973). It therefore appears that ACTH acts chronically on the
adrenal cortex to regulate the levels of several if not all of the components of the
steroidogenic pathway (Simpson, 1983). It was subsequently shown that ACTH acts
to maintain the level of steroid output by inducing steroidogenic enzyme mRNA
synthesis and translation via a cAMP-dependent mechanism (Simpson, 1988). ACTH
is known to increase the expression of CYP11A (DuBois, 1981), CYP17 (Zuber,
1985), (Zuber, 1986), (McCarthy, 1983), 3p-HSD (Le Roy, 2000), CYP21
(Funkenstein, 1983) and CPY11B1 (Kramer, 1983). Each steroid hydroxylase gene
requires its own unique biochemical system for cAMP-dependent transcription
(Waterman, 1997). Discrete regulatory DNA elements and specific DNA-binding
proteins that participate in this highly regulated, cAMP-dependent gene expression
have been identified (Waterman, 1997). Investigation of the biochemical basis of the
ACTH-dependent transcription regulation of the steroid hydroxylase genes in the
adrenal has uncovered both traditional (CREB) and nontraditional (SF-1, NGFI-B,
Spl, ASP, PBX) cAMP-dependent transcription factors. For the nontraditional factors
it remains necessary to elucidate the coupling of PKA activity to the functions of
these proteins (Waterman, 1997).
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1.3 Second messenger pathways
Steroidogenic tissue can respond almost immediately to a stimulatory hormone. It is
well established that the interaction of a steroidogenic hormone, such as ACTH, with
its specific receptor at the cell surface can trigger the cAMP messenger system. The
activation of other second messenger systems, such as the phosphoinositol or
arachidonic acid systems, may occur depending on the stimulus and intensity of
stimulation.
1.3.1 Adenylate cyclase
The earliest signalling mechanism identified in adrenocortical cells was the adenylate
cyclase system (Sutherland, 1958). In mammals, adenylate cyclase is a single
polypeptide that resides in the plasma membrane of cells. Its role is to catalyse the
production of the intracellular second messenger molecule, 3',5'-cyclic
monophosphate (cAMP) from adenosine triphosphate (ATP). When a hormone e.g.
ACTH, binds to the relevant cell surface receptor, activation of adenylate cyclase is
not a direct process (figure 1.4). Activation of the receptor in turns causes the
activation of a guanyl nucleotide-binding proteins (G-protein), which regulates the
activity of adenylate cyclase (Gilman, 1995). The action of G-protein on adenylate
cyclase activity is either stimulatory or inhibitory depending on the G-protein
involved (Gs or G; respectively). In the inactive state G-protein exists as a complex of
three polypeptides, a, p and y, and has guanosine diphosphate (GDP) bound to a
single GDP-binding site. On activation of the receptor, the GDP is released in
exchange for guanosine triphosphate (GTP), causing the breakdown of the G-protein
into a free a subunit bound to GTP and a p/y complex that does not dissociate further.
The free a subunit-GTP diffuses to adenylate cyclase, where it binds and causes
activation, resulting in the subsequent release of cAMP. The process ends when
intrinsic GTPase of the a subunit hydrolyses the bound GTP to GDP and the a
subunit reforms with the p/y complex. (Gilman, 1995).
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cAMP further transmits the intracellular signal by activating a cAMP-dependent
protein kinase, protein kinase A (PKA), leading to subsequent phosphorylation
events. The inactive form ofPKA is a tetramer consisting of two catalytic and two
regulatory subunits. cAMP binds to the regulatory subunits, leading to their
dissociation from the catalytic subunits. The free catalytic subunits are then
enzymatically active and able to phosphorylate their target proteins (Doskeland,
1993). Intracellular cAMP is inactivated by conversion to 5'-AMP, a reaction
catalysed by the enzyme phosphodiesterase (Hancock, 1997).
The effects of increased intracellular cAMP levels in response to ACTH include
phosphorylation of cholesterol esterase and cholesterol ester synthetase, leading to the
respective activation and inactivation of these enzymes and a consequent increase in
the availability of free cholesterol from cholesterol esters, enhancement of cholesterol
transport into the mitochondria and facilitation of cholesterol binding to CYP11A
(Orth, 1992).
Increases in cAMP activates the transcription of specific target genes. The regulatory
region of the gene activated by cAMP contains a short DNA sequence called the
cAMP response element (CRE) (Hancock, 1997). CREs were originally identified as
cis-acting elements that confer transcriptional activation in response to elevated
cAMP levels. The CRE sequence is recognised by a specific gene regulatory protein
called CRE-binding (CREB) protein (Dooley, 1999). CREB is phosphorylated, by
PKA on a single serine residue, in response to elevated cAMP. Phosphorylation
allows the CREB to interact efficiently with the transcriptional co-activator called
























Figure 1.4 Hormonal activation of adenylate cyclase. Binding ofACTH promotes
the interaction of the receptor (R) with a G-protein. The activated G-protein a
subunit then dissociates from the receptor and stimulates adenylate cyclase (AC),
which catalyses the conversion ofATP to cAMP. The rise in cAMP activates PKA




1.3.2 Signalling through membrane phosphoinositides
Between 2 and 8 % of the lipids in eukaryotic membranes are inositol containing
lipids. One of the most widespread pathways of intracellular signaling is based on the
use of second messengers derived from the hydrolysis of the membrane bound
phospholipid, phosphatidylinositol 4,5-bisphosphate (InsP2). These messengers are
generated by a membrane transduction process comprising three components: a
receptor, a coupling G protein and phospholipase C (PLC). Stimulation of cell surface
receptors initiates the hydrolysis of InsP2 producing two important metabolites;
inositol 1,4,5-trisphosphate (InsP3) and diacylglycerol (DAG) which serve as second
messenger signals (figure 1.5). DAG acts by stimulating protein kinase C (PKC) and
InsP3 releases calcium from internal stores (Berridge, 1989). InsP3 is recycled by
sequential phosphorylation/dephosphorylation back to inositol and DAG is recycled
through conversion to phosphatidic acid and cytidine diphospodiacylglycerol, which
combines with free inositol to reform phosphatidylinositol. Thus, although the
stimulation of PLC results in the increased breakdown of InsP2 the net effect is to
increase phosphoinositide turnover, rather than to decrease phosphoinositide mass
(Berridge, 1989).
The activation of the phosphoinositol/PLC system in bovine and rat zona glomerulosa
(Kojima, 1985a), (Farese, 1984) as well as bovine zona fasciculata/reticularis cells
(Clyne, 1992), (Bird, 1989), (Walker, 1991b) in response to angiotensin II (Angll)
has been demonstrated. Using BAC cells as a model it has been demonstrated that
Angll works through an inhibitory guanine nucleotide-binding regulator of adenylate
cyclase (Gj)-and a stimulatory G protein regulator of phospholipase C (Gq)-coupled
Angll-type 1 receptor. This leads to inhibition of adenylate cyclase and stimulation of



















Figure 1.5 Activation of phospholipase C. Binding of an extracellular signal, such
as Angll, promotes the interaction of the receptor (R) with a G-protein (G). The
activated G-protein stimulates phospholipase C which hydrolyses InsP2 to produce




Growing evidence has suggested a role for arachidonic acid in steroid production in
the adrenal gland. Arachidonic acid can be released from the 2-position on the
glycerol backbone ofphospholipids by calcium mediated activation of phospholipase
A2 (PLA2) or alternatively by activation of phospholipase C. It can function itself as
an intracellular mediator or be further metabolised through one of three pathways,
lipoxygenase, cyclooxygenase or cytochrome P450-dependent epoxygenase, to
produce various metabolites (Cooke, 1999).
An adrenocorticotrophic hormone-induced 43-kDa protein has been purified and
cloned in rat adrenal cells, named arachidonic acid-related thioesterase involved in
steroidogenesis (ARTISt) (Finkielstein, 1998). ARTISt has been shown to act as an
intermediary in the regulation ofPLA, activity by cAMP and therefore plays a role in
the activation of steroidogenesis by helping to mediate the release of arachidonic acid
(Maloberti, 2000).
Lipoxygenase metabolites of arachidonic acid have been shown to stimulate
steroidogenesis in bovine adrenal cells. The 15-lipoxygenase pathway was found to
be activated by low concentrations ofACTH, at which no increase in cellular cAMP
was observed (Yamazaki, 1996), (Wang, 2000). It has been postulated, therefore, that
at low concentrations of ACTH-stimulation of adrenal cells, arachidonic acid
metabolites are the principal second messengers, whereas at high concentrations of
ACTH stimulation cAMP is the principal messenger (Mele, 1996).
In rat and bovine glomerulosa cells it was observed that Angll stimulated the release
of arachidonic acid and that inhibition of this release prevented aldosterone
production (Natarajan, 1990), (Kojima, 1985b). It has therefore been suggested that
the mechanism for ACTH and Angll stimulated steroidogenesis may involve an
increase of intracellular arachidonic acid release.
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The mechanism by which arachidonic acid and its metabolites regulate hormone-
induced steroidogenesis is unclear (figure 1.6). It has been postulated that arachidonic
acid and its metabolites regulate the transfer of cholesterol from the outer to the inner
mitochondrial membranes. Therefore several studies have investigated the role of
arachidonic acid in StAR protein regulation. Using inhibitors of arachidonic acid an
essential role for arachidonic acid in steroid biosynthesis and StAR protein and gene




















Figure 1.6 Proposed hormonal activation of arachidonic acid. Trophic hormone
stimulation induces arachidonic acid release from phospholipids, either dependency
or independently of cAMP. The nature of this pathway remains to be elucidated.
Adapted from (Wang, 1999b).
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1.4 The Adrenal Steroids
1.4.1 Structure of steroids
The adrenal cortex secretes the steroid hormones, essential regulators ofmany
physiological processes within the body. Endogenous steroids are produced from
cholesterol, which is a complex molecule containing 27 carbon atoms and possesses a
ring structure common to the steroid hormones, the cyclopentanophenanthrene
nucleus. This nucleus consists of three cyclohexane rings and one cyclopentane ring
joined to each other by common sides (Figure 1.7) (Orth, 1992).
Figure 1.7 : Basic steroid ring structure. The four rings are identified by letters.
Each carbon atom is numbered as shown. Adapted from (Brooks, 1979)
The adrenocortical steroids are of two structural types: those that have a 2-carbon side
chain attached at position 17 of the D ring and contain 21 carbon atoms (C-21
steroids), and those that have a keto or hydroxyl group at position 17 and contain 19
carbon atoms (C-19 steroids) (Schulster, 1976). The C-19 steroids have androgenic




The main adrenal steroids are those with mineralocorticoid or glucocorticoid activity,
although some sex steroids, (androgens and estrogens) are also secreted. The
secretion rates and biological activity of the major steroid secreted by the human





Cortisol 100 100 100 -
corticosterone 5 30 160 -
aldosterone 0.75 - 30000-50000 -
DOC 1.2 - 1000 -
androstenedione 3 - - 20
DHEA 125 - - 10
DHEA.S 8 - - 20
testosterone 0.06 - - 100
Table 1.1 Secretion rates and biological activities of the major steroids secreted
by the human adrenal cortex. Secretion rates are given relative to Cortisol (around
15-30mg/day in humans). The biological activities expressed relative to Cortisol* or
testosterone**. (Brooks 1979)
1.4.2 The mineralocorticoid
Mineralocorticoids play a critical role in regulating the concentrations of minerals,
particularly sodium and potassium, in extracellular fluids. The principal steroid with
mineralocorticoid activity is aldosterone. The major target of aldosterone is the distal
tubule of the kidney where it's principal function is to regulate water and electrolyte
balance. Aldosterone acts by facilitating the reabsorption of sodium and the excretion
of potassium and hydrogen ions in the distal renal tubule. Aldosterone also has
similar effects on sweat glands, salivary glands and the colon. The major net effect is
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to conserve body sodium by stimulating its resorption (or absorption in the case of the
colon), conservation ofwater following conservation of sodium. Aldosterone output
is controlled by the renin-angiotensin system. Renin, a protein made in the kidney,
converts angiotensinogen to angiotensin I, which is subsequently converted to an
active peptide, angiotensin II (Angll). Angll interacts with cell surface receptors in
the zona glomerulosa stimulating aldosterone synthesis (Brooks, 1979).
1.4.3 Adrenal androgens
Androstenedione, dehydroepiandrosterone (DHEA) and its sulfate (DHAS) analog are
the main C19 steroids secreted by the adrenal cortex. They have minimal intrinsic
adrenrogenic activity, and they contribute to androgenicity by their peripheral
conversion to the more potent androgens, testosterone and dihyrotestestosterone.
Although DHEA and DHAS are secreted in greater quantities, androstenedione is
qualitatively more important as it is more readily converted peripherally to
testosterone (Aron, 2000b).
1.4.4 The Glucocorticoids
In most mammals the principal glucocorticoid secreted is Cortisol, whereas, due to a
lack of the CYP17 enzyme, rodent adrenals secrete corticosterone as the major
glucocorticoid. Glucocorticoids have a diverse array of actions with effects on
intermediary metabolism, the nervous system and some process related to
reproduction (Orth, 1992).
1.4.4.1 Effects on intermediary metabolism
As the name suggests glucocorticoids regulate glucose metabolism. In the fed state
the effects of glucocorticoids are minimal. However, during fasting, glucocorticoids
stimulates several processes that collectively serve to increase and maintain blood
glucose concentrations. In the liver glucocorticoids increase hepatic glucose
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production by increasing substrate availability and stimulating release of glucogenic
amino acids from peripheral tissue, such as skeletal muscle. Glucocorticoids also
directly activate key hepatic gluconeogenic enzymes, such as glucose-6-phosphate
and phosphoenolpyruvate carboxylinase (Orth, 1992). Glucocorticoids also alter
carbohydrate metabolism by inhibiting peripheral glucose uptake in muscle and
adipose tissue. Glucocorticoids acutely activate lipolysis in adipose tissue with the
release of glycerol and free fatty acids. This is partially due to direct stimulation of
lipolysis by glucocorticoids, but is also contributed to by decreased glucose uptake
and enhancement of the lipolytic hormones by glucocorticoids (Aron, 2000b).
1.4.4.2 Effects on other tissues and functions
Glucocorticoids have potent anti-inflammatory and immunosuppressive properties
(Orth, 1992). One of the principal glucocorticoid effects is on immune cells
trafficking to and from the peripheral circulation (Fauci, 1974), causing a
redistribution of lymphocytes from the intravascular compartment to the spleen,
lymph nodes, thoracic duct and bone marrow. Glucocorticoids also prevent local
inflammatory responses by inhibiting the movement of cells and fluid from the
intravascular space (Aron, 2000b). As a consequence glucocorticoids have been used
to treat inflammatory conditions such as rheumatoid arthritis, and as adjunction
therapy for conditions such as autoimmune diseases (Orth, 1992).
Glucocorticoids accelerate the development of a number of systems and organs in
fetal and differentiating tissues (Aron, 2000b). Examples of these development-
promoting effects include increased surfactant production in the fetal lungs (Odum,
1988) and accelerated development of hepatic and gastrointestinal enzyme systems
(Aron, 2000b).
Glucocorticoids also have an effect on numerous other tissues. For example, in
connective tissue, excess glucocorticoids inhibit fibroblasts, leading to loss of
collagen and connective tissue, thus resulting in thinning of the skin. Glucocorticoids
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readily enter the brain, and although their function in the central nervous system is
unknown, their excess or deficiency may have profound effects on behavior and
cognitive function (Orth, 1992).
1.4.5 The glucocorticoid receptor
Glucocorticoids travel via the blood stream to their target cells, enter the cells by
simple or facilitated diffusion, and then bind to specific glucocorticoid receptor. Most
tissues in the body appear to possess glucocorticoid receptors, including the adrenal
cortex (Loose, 1980). The glucocorticoids receptor is a ligand-induced transcription
factor that belongs to the steroid/thyroid receptor superfamily (Beato, 1995). The
steroid hormone receptor superfamily represents the largest known family of
transcription factors described for eukaryotes (Tsai, 1994). Amino acid sequences
show that the receptors can be divided into several domains (figure 1.8). At the N-
terminal end is a variable region known as the A/B domain, which is involved in gene
activation. The C domain contains two zinc fingers and is responsible for DNA
recognition and for dimerisation. Downstream of the C region, a variable hinge
region, the D domain. This domain may contain sequences responsible for
localisation of the receptor to the nucleus. Ligand binding is to a large E domain. This
region is approximately 250 amino acids in length and is also responsible for
association with heat shock proteins, hsp90, hsp70 and hsp56 (Pratt, 1993) and
dimerisation. At the C-terminal end is the last region called the F domain, but no
function has been assigned to this area of the protein (Tsai, 1994).
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Figure 1.8 Functional domains of steroid receptors. The structure of steroid
receptors can be divided into six domains, A, B, C, D, E and F. the function of each
domain is indicated by the solid lines.
Glucocorticoid receptors (GRs) are mainly localised within the cytoplasm (Wikstrom,
1987), (Fltun, 1996). The cytoplasmic receptor, when bound by glucocorticoid,
undergoes an activation or 'transformational' change, dissociates from the hsp
complex and exposes the DNA binding domain (DBD) region which allows
translocation from the cytoplasm to the nucleus (reviewed in (Reichardt, 1998). Once
GRs arrive within the nucleus, the activated receptor influences gene transcription
either by binding to glucocorticoid response elements (GREs) or by interacting with
other transcription factors (Reichardt, 1998). The resulting proteins elicit the
glucocorticoids response, which may be inhibitory or stimulatory depending on the
specific gene and tissue affected. Intermediary steroids such as progesterone, 11 -
deoxycortisol and deoxycorticosterone may function as partial antagonists, in the
presence ofmore active glucocorticoids. However the physiologic role of these
hormones in glucocorticoid action is probably negligible as they circulate in low
concentrations.
The syndrome of familiar glucocorticoid resistance, first described in 1976, is a
disorder characterised by hypercortisolism without Cushingoid features
(Vingerhoeds, 1976). Abnormalities of the GR number, affinity for glucocorticoids,
stability and translocation into the nucleus have been described (Hurley, 1991), (Karl,




Figure 1.9 A simplified model of glucocorticoid action. Glucocorticoids (S) enter
the cell by diffusion and bind to specific receptors, with associated hsp (i). The
binding of the glucocorticoid causes the receptor to undergo a transformation step (*).
The activated receptor is directed into the nucleus, where it binds to a specific
glucocorticoid-response element (GRE). This initiates transcription of the
corresponding mRNAs and the translation of these mRNAs are proteins that alter cell
function. See text for more detail.
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1.4.5 Disorders of adrenal steroids
The main disorders of adrenocortical function are hyperfunction or hypofunction.
Hyperfunction occurs when there is excessive secretion of Cortisol (Cushing's
syndrome), or aldosterone (primary aldosteronism). Androgens may also be secreted
in excess (Brooks, 1979).
Deficient adrenal production of glucocorticoids or mineralocorticoids results in
adrenocortical insufficiency, which is either the consequence of destruction or
dysfunction of the cortex (primary adrenocortical insufficiency or Addison's disease)
or secondary to deficient pituitary ACTH secretion (secondary adrenocortical
insufficiency) (Orth, 1992). The etiology ofprimary adrenocortical insufficiency has
changed over time. Prior to 1920, tuberculosis was the major cause of adrenocortical
insufficiency. Since 1950, autoimmune adrenalitis with adrenal atrophy has
accounted for about 80% of cases. It is associated with a high incidence of other
immunologic and autoimmune endocrine disorders, such as HIV (Aron, 2000b).
Primary adrenocortical insufficiency, or Addison's disease, is rare, with a reported
prevalence of 110 per million population in the United Kingdom, and is more
common in females (Aron, 2000b). Clinical signs and symptoms do not become
manifest until at least 90% of the adrenal tissue is destroyed. Hyperpigmentation is
the classic physical finding and is due to the high circulating levels ofACTH
resulting from the lack of Cortisol suppression of the feedback inhibition. Cortisol
deficiency causes weakness, fatigue, anorexia, nausea and vomiting, hypotension,
hyponatremia and hypoglycemia. Mineralocorticoid deficiency produces renal
sodium wasting and potassium retention and can lead to severe dehydration,
hyperkalameia, hyponatremia and acidosis (Aron, 2000b).
Secondary adrenocortical insufficiency due to ACTH deficiency is most commonly a
result of exogenous glucocorticoid therapy. Pituitary or hypothalamic tumors are the
most common causes of naturally occurring pituitary ACTH hyopsecretion. ACTH
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deficiency is the primary event and leads to decreased Cortisol and adrenal androgen
secretion. Aldosterone secretion remains normal in the majority of cases (Aron,
2000b). The manifestations of glucocorticoid deficiency are similar to those for
primary adrenocortical insufficiency; however, since aldosterone secretion is usually
normal the manifestations ofmineralocorticoid deficiency are absent (Orth, 1992).
Glucocorticoid excess or Cushing's syndrome is caused by an excess of circulating
Cortisol, which is high at all times i.e. no diurnal rhythm. It is most commonly
iatrogenic, resulting from chronic glucocorticoid therapy. Spontaneous Cushing's
syndrome is caused by abnormalities of the pituitary or adrenal or may occur as a
consequence ofACTH secretion by nonpituitary tumors (ectopic ACTH syndrome)
(Tsigos, 1995). Cushing's syndrome is classified as either ACTH-dependent or
ACTH-independent. The ACTH-dependent types, Cushing's disease or ectopic
ACTH syndrome, are characterised by chronic ACTH hypersecretion, which results
in hyperplasia of the adrenal zonae fasciculata and reticularis. Resulting in increased
secretion ofCortisol, androgens and deoxycorticosterone. Cushing's disease is the
most frequent type of Cushing's syndrome accounting for 70% of reported cases
(Orth, 1995). ACTH-independent Cushing's syndrome may be caused by a primary
adrenal neoplasm (adenoma or carcinoma) or nodular adrenal hyperplasia. In these
cases the excess Cortisol suppresses pituitary ACTH secretion (Orth, 1995). Mild to
moderate obesity, typically involving the face and trunk, is the most common
presenting feature ofCushing's syndrome.
The most prominent metabolic abnormalities reflect the glucocorticoid action. About
75% of patients have glucose intolerance and many of these have hyperglycemia
(Tsigos, 1995). Protein breakdown is accelerated and the carbon chains of the
liberated amino acids may be converted to glucose, the nitrogen is also lost in the
urine leading to a negative nitrogen balance. This catabolic effect not only causes
osteoporosis and muscle wasting but also thinning of the skin. The tendency to
bruising and purple striae, most obvious on the abdominal wall, are probably due to
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this thinning (Orth, 1995). The mineralocorticoid effects ofCortisol leads to urinary
retention of sodium, with hypertension occurring in about 75% of cases. High
circulating levels of androgens may account for the common findings of greasy skin
with acne vulgaris, and for the hirsutism and menstrual problems in women (Tsigos,
1995).
1.5 Biosynthesis of steroid hormones
Two major types of enzymes are involved in steroid biosynthesis: 1) the cytochrome
P450s and 2) steroid dehydrogenases. The main enzymes involved in human and
bovine adrenal steroid biosynthesis are listed below (table 1.2).
Enzyme Gene symbol Location Protein
length (aa)
P450ssc CYP11A mitochondrial 482
(481)
3P-hydroxysteroid HSD3B1 microsomal 371
dehydrogenase HSD3B2 (371)
P450cl7 CYP17 microsomal 508
(509)
P450c21 CYP21 microsomal 494-495
(496)
P450clip CYP11B1 mitochondrial 479
(479)
Table 1.2 Genes encoding the major steroidogenic enzymes of the adrenal cortex.
Numbers in brackets represent the protein length in the bovine species.
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Steroidogenic P450s catalyse either a single hydroxylation at a specific position on
the steroid or a series of consecutive hydroxylations which result in C-C bond
cleavage (Hanukoglu, 1992). Each P450-catalysed hydroxylation has the following
stoichiometry:
Steroid-H + NADPH + H+ + 02 ► Steroid-OH + NADP+ + H20
The first enzymatic step in the production of all steroids is the side chain cleavage of
cholesterol to pregnenolone by CYP11A (figure 1.10). The reaction consists of three
successive monooxygenations, hydroxylations at C-22, followed by C-20, and finally
cleavage of the C-20,22 bond. This reaction takes place in the mitochondria.
Reducing equivalents from mitochondrial NADPH are transferred by a flavoprotein
(adrenodoxin reductase ) to a ferredoxin protein containing an iron sulphur cluster
(adrenodoxin), which then transfers the electrons to CYP11A. (Stocco, 1996).
CYP11A is expressed in all three zones ofbovine and human adrenal cortex.
(Ishimura, 1997). The other components involved in the side chain cleavage of
cholesterol, adrenodoxin and adrenodoxin reductase have also been localised in the















Pregnenolone produced by this reaction leaves the mitochondria and is transported to
the endoplasmic reticulum, where it undergoes further transformation. In the adrenal
cortex of human, bovine, ovine and pigs pregnenolone is converted by CYP17 to
17a-hydroxypregnenelone (figure 1.11). This enzyme catalyses two distinct
reactions: the 17a-hydroxylation of C21 steroids, a step required for Cortisol
production, and the cleavage of the C17-C20 bond of C21 steroids essential for
androgen biosynthesis. Rodents such as rat, mouse hamsters and guinea pig
synthesise corticosterone as the principal glucocorticoid due to the lack ofCYP17
expression in the adrenal (Le Goascogne, 1991). CYP17 is present in the zona
fasciculata and reticularis but not in the zona glomerulosa of bovine, and human
adrenals (Ishimura, 1997).
Pregnenolone and 17-hydroxypregnenolone are converted to progesterone and 17-
hydroxyprogesterone respectively by a two step reaction: dehydrogenation of 3p-
hydroxy-5-ene-steroid and isomerization of 3-oxo-5-ene-steroid. This two step
process is catalysed by 3 p-hydroxysteroid dehydrogenase (3P-HSD). 3P-HSD
appears to be situated in the membrane of the smooth endoplasmic reticulum and is
present in all three zones of the cortex (Ishimura, 1997). At least two types of 3P-
HSD (types I and II) have been cloned in the human, although only the type II
enzyme has been detected in the adrenal cortex (Labrie, 1994), whereas in the bovine
types I, II, III and IV have been found (Morel, 1997).
CYP21, a microsomal enzyme, catalyses the conversion ofprogesterone and 17-
hydroxyprogesterone to deoxycorticosterone and deoxycortisol respectively (figure
1.11). Immunohistochemical staining has found CYP21 expression in all three zones
of the adrenal cortex (Ishimura, 1997). Congenital adrenal hyperplasia is the result of
an inborn deficiency in CYP21 and results in steroid biosynthesis being channeled in
the direction of androgen synthesis, resulting in the excessive production of the C19
steroids, DHEA and androstenedione. Androstenedione may be converted
peripherally to testosterone causing virilisation (Aron, 2000b). In this condition the
cortex is broadened and consists mainly of zr-type cells (Hanukoglu, 1992).
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Deoxycortisol and deoxycorticosterone then leave the endoplasmic reticulum and
enter the mitochondria for the final step in glucocorticoid production (figure 1.11).
Here they are converted to Cortisol and corticosterone respectively by CYP11B1.
CYP11B1 is also located on the matrix side of the inner mitochondrial membrane and
utilises reducing equivalents provided by adrenodoxin and adrenodoxin reductase, as
described for CYP11A. (Ishimura, 1997).
In the cells of the zona glomerulosa a parallel series of events takes place.
Aldosterone is synthesised from deoxycorticosterone by a two-step reaction : 11(3-
hydroxylation and aldehyde formation at the CI8 position catalysed by CYP11B2
(Ishimura, 1997). CYP11B2 has many properties similar to CYP11B1 but the two
enzymes are distinct molecular species encoded by different genes. The gene for
CYP11B2 has been isolated from the adrenal cortex human (Kawamoto, 1992) and
cow (Hashimoto, 1989). In the case of the bovine adrenal cortex, both aldosterone
and Cortisol are synthesised by CYP1 IB 1, although the precise regulatory mechanism
of this enzyme is not known (Ishimura, 1997).
Cortisol and corticosterone are converted to their corresponding inactive forms,
cortisone and 11 -dehydrocorticosterone respectively, by 11 P-hydroxysteroid
dehydrogenase (1 lp-HSD) (Mazzocchi, 1998).There are two isoenzymes of 1 ip-
HSD, type 1 and type 2 (1 lp-HSD 1 and llp-HSD2) (Mazzocchi, 1998). 1 lp-HSD 1
is a bi-directional enzyme with low affinity for glucocorticoids and is found in the
liver, testis, lung and kidney (Funder, 1996). 11P-HSD2 is a unidirectional enzyme
with high affinity for glucocorticoids and is expressed in high concentrations in the
kidney, adrenal and colon (Romero, 2000). 1 lp-HSD plays a key role in controlling
the access of glucocorticoids to their receptors and protecting the nonselective













































Figure 1.11 Diagrammatic representation of the steroid pathway in the human
adrenal. Showing the steroids produced by the zona glomerulosa (zg);
fasciculata (zf) and reticularis (zr).
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1.6 Acute regulation of steroidogenesis
Trophic hormones activate a chain of reactions that lead to free cholesterol being
transported to the mitochondria where it is converted to pregnenolone and then by
further enzymatic steps to glucocorticoids or mineralocorticoids. This process is
dependent on the supply and intracellular transfer of cholesterol.
1.6.1 Sources of cholesterol
Cholesterol is an essential component of cell membranes, the cholesterol within the
membranes is not static and a constant cycling of cholesterol between the plasma
membrane and other intracellular compartments such as the Golgi, lysosomes and
endoplasmic reticulum exists. Steroidogenic cells convert cholesterol into steroid
hormones in response to hormonal stimulation. This process is unrelated to
cholesterol homeostasis within the cells. Therefore the steroidogenic cells require a
supply of cholesterol that exceeds the constitutive cellular requirements. There are
two principal sources of cell cholesterol.
1.6.1.1 Endogenous cholesterol biosynthesis.
Cholesterol biosynthesis from acetate or other cholesterol precursors produces free
cholesterol or cholesterol esters if esterified by acetyhcholesterol acyltransferase.
Cholesterol synthesis begins with the synthesis of acetoacetyl CoA from two acetyl
CoA molecules. A third acetyl CoA molecule is added by the enzyme hydroxy-3-
methylglutaryl-CoA synthase to form hydroxy-3-methylglutaryl-CoA (HMG-CoA).
HMG-CoA is then converted to cholesterol through various intermediaries including
mevalonate, squalene and lanosterol. Cholesterol acts as a feedback inhibitor of
HMG-CoA reductase to regulate the intra- and intercellular levels of cholesterol
(figure 1.12) (Schulster, 1976). The genes encoding HMG-CoA reductase were found
to contain a sterol-regulatory element in the proximal promoter region (Brown,
1997). A family of transcription factors called sterol regulatory element binding
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protein (SREPB) was found to bind to this element and promote the expression of the
HMG-CoA and other genes, such as the LDL-receptor, involved in cholesterol
biosynthesis (Brown, 1997). Cholesterol interacts with a protein on the endoplasmic
reticulum and Golgi named SREBP activating protein (SCAP) that in turn controls
the activity of a protease that cleaves the precursor of SREBP (Brown, 1997),
(Brown, 2000). When cholesterol levels are adequate, the protease is not activated
and therefore SREBP is not released and does not migrate to the nucleus. As a result,
expression of the genes for HMG-CoA reductase is not induced. When the cholesterol
levels are low, the SREBP precursor is cleaved, SREBP migrates to the nucleus and
the expression of the HMG-CoA reductase gene is promoted (Brown, 2000). Thus,
cholesterol levels in a cell are sensed by the SCAP-SREBP pathway to feedback













Figure 1.12 Biosynthesis of cholesterol. The adrenal cortex can synthesize
cholesterol from acetate. In this synthesis the key enzyme is HMG-CoA reductase,
which converts hydroxy-3-methylglutaryl-CoA (HMG-CoA) to mevalonate. The
dashed arrow indicates feedback inhibition ofmevalonate formation by cholesterol
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1.6.1.2. Uptake of cholesterol from plasma lipoproteins
Exogenous lipoproteins such as high density lipoproteins (HDL) or low density
lipoproteins (LDL), carry and deliver both free and cholesterol esters to the cells
(Sviridov, 1999). Cholesterol is taken up from plasma lipoproteins and subsequently
stored in intracellular lipid droplets. Lipid droplets appear to be a morphological
characteristic of steroidogenic cells, since they have been observed in all species
studied to date (Nussdorfer, 1986).
In humans, the primary pathway for cellular cholesterol uptake involves the low
density lipoprotein (LDL) receptor. These receptors function via endocytic uptake
and lysosomal degradation of lipoprotein particles to release cholesterol and other
lipids into the cell (Krieger, 1999). An alternative process, occurring with HDL, is the
selective uptake pathway in which HDL cholesteryl ester is taken into the cell without
the uptake and degradation of the HDL particle. The selective uptake pathway is
active in a variety of mammalian cell types including human and bovine adrenal cells
(Yaguchi, 1998), (Cherradi, 2001), but is particularity active in steroidogenic tissue of
rats and mice (Pittman, 1987), (Acton, 1996). The biochemical mechanism of
selective uptake is unclear.
1.6.2 Cholesterol transport
Once within the steroidogenic cell, cholesterol transport in response to hormone
stimulation can be thought of as occurring in two stages. The first part of the process
is the mobilization of cholesterol from cellular stores to the outer mitochondrial
membrane, while the second part consists of the transfer of cholesterol from the outer
to the inner mitochondrial membrane.
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1.6.2.1 Cholesterol transport to the mitochondria
The factors and processes involved in the mobilisation of cholesterol to the outer
mitochondrial membrane are thought to involve changes in cellular architecture and
transport proteins. Studies have demonstrated that cholesterol transport to the
mitochondria is dependent on an intact cytoskeleton (Feuilloley, 1996). The
cytoskeleton is formed by three types of polymers, microtubules, microfilaments and
intermediate filaments. Cytochalasin B and other inhibitors ofmicrofilament and
microtubule function have been found to block cholesterol transfer to the
mitochondria in adrenal cells (reviewed in (Hall, 1997). Microtubules are required by
adrenocortical cells for the transduction of the corticotrophic message ofACTH and
cholesterol transport, whereas microfilaments control the metabolism of
polyphosphoinositides as well as the transport of cholesterol and intermediate steroids
from cytoplasm to the mitochondria. The intermediate filaments are involved in the
stimulus-response coupling of certain corticotrophic factors such as Angll
(Feuilloley, 1996).
A role for cellular cholesterol carrier or transport proteins was postulated in order to
facilitate the movement of the hydrophobic cholesterol through the aqueous spaces
and deliver them to specific organelles, such as the mitochondria. Several proteins,
protein complexes and subcellular structures have been suggested to play a role in
cholesterol trafficking (reviewed (Sviridov, 1999). These include clathrin-coated pits
which are involved in trafficking cholesterol from the plasma membrane to the
lysosomes and trans-Golgi network. Clathrin-coated pits are involved in LDL-
receptor mediated endocytosis. After LDL binds to the LDL receptor, the ligand-
receptor complex is sequestered into clathrin-coated pits (Krieger, 1999). The
scavenger receptor class B, type 1 (SR-B1) mediates the selective uptake ofHDL
cholesteryl ester in transfected cells, thus suggesting that SR-B1 may be responsible
for this activity in steroidogenic cells (Acton, 1996), (Temel, 1997). SR-B1 is most
abundant in steroidogenic tissues utilising HDL-derived cholesterol for the synthesis
of steroid hormones (Acton, 1996).
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1.6.2.2 Cholesterol transport within the mitochondria
As mentioned above the first step in steroidogenesis is the conversion of cholesterol
to pregnenolone, a reaction catalysed by CYP11A which resides on the matrix side of
the inner mitochondrial membrane. Studies have shown that the true rate-limiting step
effected by hormone treatment was the delivery of cholesterol from the outer to the
inner mitochondrial membrane (Jefcoate, 1987), (Privalle, 1983), (Karaboyas, 1965).
In accordance with this proposal was the finding that the hydroxylated analogs of
cholesterol, which can readily diffuse across the mitochondrial membranes, were able
to reach the inner mitochondrial membrane thus promoting steroidogenesis in the
absence of trophic hormone stimulation (Lambeth, 1982), (Tuckey, 1989). These
observations indicate that CYP11A was fully active and that the lack of cholesterol
for steroid biosynthesis was the limiting factor. The two mitochondrial membranes
are separated by an aqueous space through which the hydrophobic cholesterol must
pass (figure 1.13). The aqueous diffusion of cholesterol is very slow and cannot
account for the rapid increase in hormone-stimulated steroid production, necessitating










Figure 1.13 Graphic illustration of the mitochondrial compartments and
components of the SCC complex. This diagram shows the aqueous space through
which the relatively hydrophobic cholesterol has to pass to reach the side chain
cleavage (SCC) complex.
Early studies demonstrated that ACTH-stimulated steroidogenesis was blocked by
protein synthesis inhibitors such as puromycin and cycloheximide (Ferguson, 1962),
(Garren, 1965). These studies also demonstrated that the step blocked by the
inhibitors was distal to cholesterol ester hydolysis but proximal to side chain
cleavage of cholesterol i.e. at the delivery of cholesterol to CYP11A (Davis, 1968)
and had a rapid turnover time (Garren, 1965). It has been shown that the
cycloheximide-sensitive step is located in the mitochondria (Simpson, 1966) and that
the protein synthesis inhibitors had no effect on CYP11A (Arthur, 1976). It was later
demonstrated that the delivery of cholesterol from the outer to the inner
mitochondrial membrane was the step inhibited by cycloheximide (Privalle, 1983).
Cholesterol may be delivered to a pre-steroidogenic pool in the presence of
cycloheximide; however, pregnenolone production does not occur until the inhibitor
is removed and the cells stimulated with trophic hormone (Stevens, 1993). As a
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result of these observations, a search began for a hormone-sensitive, rapidly
synthesised, highly-labile, cycloheximide-sensitive protein whose function was the
transfer of cholesterol from the outer mitochondrial membrane to the inner
mitochondrial membrane.
1.7 Candidates for the transfer protein
A variety of candidates have been put forward as the protein involved in the acute
regulation of steroidogenesis. These have included sterol carrier protein 2 (SCP2),
steroidogenesis activator peptide (SAP), the peripheral benzodiazepine receptors
(PBR) and the steroidogenic acute regulatory (StAR) protein.
1.7.1 Sterol carrier protein 2
SCP2 is a small, 13kDa protein, postulated to play a role in intracellular transport and
metabolism of lipids such as cholesterol. SCP2, also known as non-specific lipid
transfer protein, is found to be abundant in the liver and various steroidogenic tissues.
SCP2 has been demonstrated to transfer cholesterol from lipid- containing vesicles to
mitochondria and can increase pregnenolone production in isolated adrenal
mitochondria (Chanderbhan, 1986). Chanderbhan also demonstrated that treatment of
adrenal cells with anti-SCP2 antibody resulted in an inhibition of steroid production
(Chanderbhan, 1986). The synthesis of SCP2 has been shown to be under the
regulation of ACTH in the adrenal; however, this regulation only occurred after many
hours of treatment and was not cycloheximide sensitive (Trzeciak, 1987). The exact
mechanism of SCP2 action is not fully understood. One hypothesis is that SCP2 acts
to transport cholesterol through the cytoplasm (reviewed in (Seedorf, 2000).
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1.7.2 Steroidogenesis activator peptide.
SAP is a 3 kDa protein that was first purified from rat adrenals (Pedersen, 1983). SAP
is found only in steroidogenic tissue. Its levels can be acutely increased by trophic
hormone stimulation and these changes are blocked by cycloheximide. A role for
SAP in cholesterol transfer within the mitochondria was demonstrated by addition of
SAP to isolated mitochondria resulting in a 4- to 5-fold increase in steroid production
(Pedersen, 1983). SAP shows a striking homology to a heat-shock protein called
glucose-related protein (GRP 78). Heat shock proteins can act as molecular
chaperones and allow proteins to unfold so they can be imported through contact
points in mitochondria (Lill, 1996). However, a mechanism whereby SAP can
transport cholesterol to the inner mitochondrial membrane has not yet been
elucidated.
1.7.3 Peripheral benzodiazepine receptor
Benzodiazepines are widely used for their anxiolytic, anticonvulsant and hypnotic
actions. These effects are mediated by the y-aminobutyric acid (GABA) receptor
located in the central nervous system (Pritchett, 1989). However, a second class of
receptor has been identified in peripheral tissues, the peripheral benzodiazepine
receptor (PBR) (Verma, 1989). PBR is a 18kDa membrane-spanning receptor found
primarily on the outer mitochondrial membrane in peripheral tissue such as lung, liver
and kidney. The greatest expression ofPBR was shown to be in steroid-producing
cells such as the adrenal, ovary and testis (Papadopoulos, 1993). Radioligand binding
studies indicated that PBR was primarily associated with mitochondria (Basile,
1986), (Hirsch, 1989). PBR expression was found to be induced by ACTH in BAC
cells (Besman, 1989). Disruption of the PBR gene in R2C rat Leydig tumor cells
resulted in the reduction of steroid secretion, whereas introduction of the receptor
back into cells resulted in a return to normal steroid production. This study also
demonstrated that PBR-depleted cells failed to produce pregnenolone when treated
with exogenous cholesterol (Papadopoulos, 1997a). A role for PBR in the acute
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stimulation of adrenocortical steroidogenesis has been implicated, possibly by
mediating the entry, distribution and/or availability of cholesterol within the
mitochondria (Papadopoulos, 1997b).
1.7.4.Steroidogenic acute regulatory protein
1.7.4.1 Introduction
The steroidogenic acute regulatory (StAR) protein was first described by Orme-
Johnson and colleagues as an ACTH-induced, cycloheximide-sensitive, 30kDa
phosphoprotein in hormone-treated rat adrenal (Krueger, 1983) and a luteinising
hormone-induced protein in rat corpus luteum (Pon, 1986) and mouse Leydig cells
(Epstein, 1991a). This protein, and an unphosphorylated form found mainly in
quiescent cells, were found to be localised to the mitochondria (Epstein, 1991b).
Similar mitochondrial proteins were reported by Elliot et al in bovine adrenal
glomerulosa cells in response to ACTH and Angll (Elliott, 1993). Proteins similar to
these were described in the MA-10 mouse Leydig tumor cell line and in addition to
the 30kDa protein, a 37kDa precursor protein was also found (Stocco, 1988). The
30kDa protein, named StAR protein, was purified and the cDNA cloned and
sequenced in MA-10 cells. A full length 1456-bp cDNA clone containing an open
reading frame of 852 nucleotides encoding a protein of 284 amino acids (Clark,
1994). Full length cDNA clones for StAR have now been isolated for human
(Sugawara, 1995a), bovine (Hartung, 1995), hamster (Fleury, 1996), rat (Lee, 1997)
and pig (Pilon, 1997) and all have at least 84% homology. The StAR gene consists of
seven exons split by eight introns (figure 1.14)
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Exon I II III IV V VI VII
I II II I ■
Intron size 2kb 0.3kb 1.8kb 0.14kb 0.65kb 0.85kb
lkb
Figure 1.14 Schematic organization of the functional human/bovine StAR gene.
Transient transfection experiments demonstrated that that the expression of the
cDNA-derived protein in MA-10 cells resulted in increased steroidogenesis in the
absence of hormone stimulation (Clark, 1994). Similarly, when the non-steroidogenic
COS-1 cell line was co-transfected with CYP11A, adrenodoxin, and StAR protein an
increase in the conversion of cholesterol to pregnenolone was observed (Sugawara,
1995a). These results point to a role for StAR protein in hormone-regulated steroid
production.
1.7.4.2 Lipoid congenital adrenal hyperplasia
Further evidence for a key function for StAR protein in steroidogenesis are the results
from studies on congenital lipoid adrenal hyperplasia (lipoid CAH) (reviewed in
(Miller, 1997). Lipoid CAH is a lethal condition that results from a complete inability
of the infant to synthesis steroids. Affected infants die within days to weeks, due to
the lack ofmineralocorticoids and glucocorticoids unless treated with steroid
hormone replacement therapy (Lin, 1995). As the mitochondria of affected adrenals
and gonads fail to convert cholesterol to pregnenolone, the disease was thought to be
the result of a defect in the CPY11A gene (Camacho, 1968), (Hauffa , 1985). The
gene for CYP11A (Lin, 1991) and its protein levels (Sakai, 1994) were found to be
normal in these patients. Other elements of the side-chain cleavage system,
1.44
Introduction Chapter 1
adrenodoxin and adrenodoxin reductase, have also been shown to be normal (Lin,
1991). In addition, the genes and/or protein levels of the other proteins purported to
play a role in the acute regulation of steroidogenesis, SAP, SCP2 and PBR were
found to be normal in these patients (Lin, 1993).
Lin et al investigated the StAR gene for possible mutations and found nonsense
mutations which resulted in the premature insertion of stop codons, thus producing
truncated StAR protein. A number of other mutations have since been identified.
Most patients are of Japanese or Korean ancestry, among whom the Q258X (mutation
of glutamine to a stop codon at the 285th amino acid residue) mutation accounts for
approximately 70% of cases (Yoo, 1998), [Katsumata, 1999), (Korsch, 1999),
(Katsumata, 1998), (Bose, 1997), (Bose, 1998).
1.7.4.3 Expression of StAR
Studies using techniques such as western and northern analysis, in situ hydridisation,
immunocytochemistry, RNAse protection assays and RT-PCR have shown that StAR
expression is confined to steroidogenic tissues and the steroidogenic cells within
these tissues (Clark, 1995b). StAR protein is not expressed in human placenta which
implies that that this tissue has an alternative mechanism for the transfer of
cholesterol to the side-chain cleavage system. This mechanism to date has not been
elucidated (Clark, 1995b). However StAR protein has been found in the placenta of
cow (Pescador, 1996), pig (Pilon, 1997), and rodent (Arensburg, 1999). StAR is
expressed in both glomerulosa and fasciculata/reticularis cells of the adrenal cortex
(Nicol, 1998), (Nishikawa, 1996), (Pollack, 1997), (Peters, 1998), (Cherradi, 1998a),
(Hartung, 1995).
1.7.4.4 Transcriptional control of StAR
StAR expression is subject to both positive and negative regulation by various agents
which presumably act on its promoter. In early studies it was shown that hormone-
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stimulated steroid production was accompanied by a rapid rise in StAR mRNA
(Clark, 1995b). Trophic hormone-stimulation usually results in an increase in
intracellular cAMP. cAMP was found to have a positive effect in regulating StAR
gene expression. Most studies have shown that the cAMP-responsive site was found
within the first 254 nucleotides relative to the transcription start site. The StAR
promoter however, lacks a full consensus cAMP response element. Therefore the
cAMP response element binding protein may not act directly on sequences found in
the StAR promoter (Sugawara, 1995b), (Caron, 1997), (Sugawara, 1997).
A transcription factor that maybe important in the regulation of the StAR gene is
steroidogenic factor 1 (SF-1). SF-1 is a novel member of the orphan nucleotide
receptor family of transcription factors that bind as a monomer to specific consensus
response elements to induce the expression of the steroid hydoxylases (Morohashi,
1995). Several SF-1 consensus binding sites have been identified in the StAR
promoter, with two of these sites (at positions -97 and -42) highly conserved in
several species. Using transient transfection protocols, SF-1 has been shown to
transactivate the StAR promoter in several cell types (Caron, 1997), (Sugawara,
1997), (Sandhoff, 1998), (Rust, 1998).
Additional factors are also involved in StAR's temporal and tissue-specific
expression. The CCAAT/enhancer binding proteins (C/EBPs) are a family of basic
region/leucine zipper transcription factors implicated as regulators of differentiation
and function in multiple cell types (Johnson, 1993). Thus far six members of the
C/EBP family have been identified. Two of these, C/EBPa and C/EBPp, have been
found in steroidogenic tissue and two putative C/EBP binding sites in the StAR
promoter have been identified (Christenson, 1999), (Nalbant, 1998), (Reinhart, 1999),
(Silverman, 1999). These studies have shown that the StAR promoter is
transactivated by C/EBPp during transient transfection assays. It has also been
demonstrated that SF-1 and C/EBPp interact as SF-1 transactivation of the StAR
promoter has been shown to be dependent on the presence ofC/EBP-binding sites
1.46
Introduction Chapter 1
(Silverman, 1999). Sterol regulatory element binding protein 1 a (SREBP-la) may
also be involved in the regulation of the StAR gene. Studies have shown the presence
of potential SREBP sites in both the rat (Shea-Eaton, 2001) and human (Christenson,
2001) StAR promoters.
1.7.4.5 Models of StAR action
StAR was originally identified as a phosphoprotein, with the earlier work by Orme-
Johnson demonstrating a strong correlation between the phosphorylated forms of
StAR and steroidogenesis. The subsequent cloning of StAR cDNA from a number of
species revealed that all of the known sequences contain two conserved consensus
sequences for phosphorylation catalysed by protein kinase A, at two serine residues
(S57 and S195) in humans and bovine (Arakane, 1997). Indeed, human StAR was
shown to be rapidly phosphorylated on both these serine residues in response to 8-
bromo-cAMP but only phosphorylation of SI 95 appeared to be functionally
significant (Arakane, 1997). StAR protein has consensus sequences for
phosphorylation catalysed by other kinases, including calcium/calmodulin protein
kinase II and protein kinase C (Sugawara, 1995a).
The first model proposed that in response to stimulation by trophic hormones, StAR
was rapidly synthesised in the cytosol as a 37kDa precursor and quickly targeted to
the mitochondria via its signal sequence. As the transfer of StAR to the inner
mitochondrial compartment begins, "contact sites" between the outer and inner
membranes are formed. The formation of "contact sites" collapsed the
intermitochondrial membrane aqueous space that served as a barrier to keep the
hydrophobic cholesterol from crossing to the inner membrane, thus allowing
cholesterol transfer via the newly formed lipid bridge. During mitochondrial import
the signal and targeting sequences are sequentially removed by a matrix processing
protease resulting in the 30kDa mature form of the protein. After processing of the
37kDa protein to the 30kDa, the membranes would separate and no further transport
of cholesterol would occur. Therefore the continued synthesis and processing of StAR
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precursor protein was required for the continued transport of cholesterol to the inner
mitochondrial membrane (Stocco, 1996).
Several observations made this a viable model, firstly the fact that StAR was found to
be localised to the mitochondria. Secondly the observation that the transport of
mitochondrial proteins across the membranes occurs via "contact sites" (Pfanner,
1990). Finally it was demonstrated that mitochondrial "contact sites" in bovine
adrenocortical cells contained the first two enzymes in the steroidogenic pathway,
CYP11A and 3P-HSD (Cherradi, 1995).
It soon became clear that a revision of this model was required when it was shown
that mitochondrial import was not essential to the function of StAR (Arakane, 1996).
It was found that COS-1 cells transfected to express StAR proteins lacking the N-
terminal 62 amino acids, and thus all of the signal sequence, supported
steroidogenesis to the same extent as wild-type StAR, yet never entered the
mitochondria (Arakane, 1996). Similarly, recombinant StAR lacking the N-terminal
62 amino acids could fully support steroidogenesis in isolated mitochondria without
being imported into the mitochondria (Arakane, 1998). It seems therefore, that import
of StAR is not required for cholesterol transfer to the inner mitochondrial membrane.
Truncations of the C-terminus, by 28 amino acids, resulted in the complete loss of
steroid production (Arakane, 1996), indicating that the cholesterol transferring
capability of the StAR protein resides in the C-terminal region (Lin, 1995), (Arakane,
1996), (Wang, 1998). This conclusion was reinforced by the finding that all mutations
in LCAH are in the C-terminal region of the protein (Lin, 1995).
A study by Kallen et al demonstrated that StAR can also act as a sterol transfer
protein and that the function of StAR may be to enhance desorption from one sterol-
containing membrane to another (Kallen, 1998b). In this model, newly synthesised
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StAR preprotein is selectively directed to the mitochondria by its N-terminal domain.
On arrival at the outer mitochondrial membrane, the C-terminus acts on the outer
membranes to produce alterations that favor cholesterol desorption to the inner
membrane. Thus StAR's steroidogenic activity may be attributed to its ability to
promote cholesterol movement from the relatively sterol-rich outer membrane to the
sterol-poor inner membrane. The nature of the interaction between StAR and the
outer mitochondrial membrane remains unclear (Kallen, 1998a).
Based on physico-chemical studies on recombinant StAR, Miller et al suggested that
StAR acts on the outer mitochondrial membrane as a molten globule (Bose, 1999),
(Bose, 2000), (Christensen, 2001). Most proteins are folded into unique
conformations determined by energetic information specified by their sequences.
Folding can proceed through a variety of intermediate states, comprising partially
folded forms of individual domains or of the entire protein. Intermediates which have
lost at least some of their tertiary structure but which have retained virtually all of
their secondary structure are termed molten globules. Proteins may go through molten
globule intermediate states during membrane insertion (Pilon, 1997). Subjecting
StAR to limited proteolysis at different pH values it was demonstrated that StAR
behaves differently as the pH decreases. StAR was shown to form a molten globule
structure at pH 3.5-4.0, thus suggesting that StAR is biologically active at local acidic
pH (Bose, 1999). Bose et al speculated that the acidic state of the outer mitochondrial
membrane is caused by a transfer ofprotons across the two mitochondrial
membranes. A proton pump produces an electrochemical gradient leading to a
reduction in pH outside the mitochondria. StAR undergoes conformational changes
that result in a partial unfolding of the protein and a transition to a molten globule
state. Transition to a molten globule may lower the energy required to open the StAR
structure further, possibly exposing a cholesterol channel or it may prolong the
interval with which StAR can reside on the outer membrane, thus providing more




Elucidation of the crystal structure of StAR protein has proven difficult. StAR protein
is difficult to crystallise because it is not soluble to the extent required to form
crystals. Therefore, information on the tertiary structure of StAR was not available
until Tsujishita & Hurley crystallised and solved the structure of START domain of
the MLN64 protein (Tsujishita, 2001). MLN64 is a 50 kDa protein of unknown
function that is specifically expressed in the malignant cells of breast carcinomas. The
C-terminus ofMLN64 shares significant homology with StAR protein (Watari,
1997). The StAR related transfer (START) domains are 200-210 amino acid motifs
that occur in a wide range of proteins, including the phosphatidylcholine transfer
protein and acyl-CoA thioesterase, suggesting it has a role in lipid metabolism. The
crystal structure ofMLN64-START revealed an a+(3 fold built around a U-shaped
incomplete P-barrel. The interior of the protein encompasses a hydrophobic tunnel
that is large enough to bind a single cholesterol molecule. The START domain of
MLN64 shows high homology (35%) with StAR-START domain and both can bind
cholesterol in a ratio of 1:1. Based on the START domain structure and cholesterol
binding stoichiometry, it was proposed that StAR functions in transferring cholesterol
to the inner mitochondrial membrane via its ability to bind cholesterol and act as a
cholesterol-shuttling protein (Tsujishita, 2001).
Mutations in the StAR gene have been shown to cause LCAH. When three of the
most common mutations were mapped onto the MLN64-START domain model they
were found to reside quite close to each other. Two of the of these mutations were
found to reside within the cholesterol binding hydrophobic tunnel. Tsujishita and
Hurley predicted that the LCAH-causing mutations would destabilise the tunnel
resulting in a decrease in cholesterol binding (Tsujishita, 2001).
The role of StAR protein in cholesterol transfer remains a mystery. The fact that
StAR does not need to be imported into the mitochondria to be fully active in
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steroidogenesis does not agree with the proposal that StAR acts as a cholesterol-
shuttling protein. Also at odds with this concept is the fact that once StAR is imported
and processed from the 37 kDa precursor to the 30 kDa mature protein it is no longer
active in cholesterol transfer, implying that StAR would not be able to act as a carrier
protein on a continuous basis.
It has been postulated that StAR protein interacts with other mitochondrial outer
membrane proteins and/or phospholipids to produce its effect. However attempts to
identify such binding partners have produced no positive results. A study using
fluorescence energy transfer demonstrated that StAR and PBR are closely associated
on the outer mitochondrial membrane (West, 2001). Based on this close association
West et al proposed that cytoplasmic StAR targets cholesterol to the mitochondrial
membrane and that StAR then transfers cholesterol to PBR for import across the
membrane space (West, 2001). This would be in keeping with work by
Papadopoulous et al, who found that in the absence of PBR, StAR is incapable of
stimulating steroidogenesis (Papadopoulos, 1997a).
Although PBR may play a role in cholesterol transfer, little is known about the
mechanism of its action in this process. Moreover, the fact that StAR protein works in
a non-steroidogenic host (COS-1 cells) indicates that StAR protein can transfer
cholesterol into the mitochondria in the absence of outer mitochondrial membrane
proteins, either as a sterol transfer protein, a molten globule or as cholesterol-





to shuttle cholesterol to inner membrane
Figure 1.15 Putative mechanisms for StAR action. Shown are several ways in
which StAR has been hypothesised to deliver cholesterol to the inner mitochondrial
membrane. Upon trophic hormone stimulation, the 37-kDa protein precursor is
synthesised and transported to the mitochondrial membrane. The 37-kDa protein
interacts with a specific receptor protein on the outer mitochondrial membrane, at this
time the insertion process begins. StAR itselfmay function as a cholesterol-shuttling
protein. The hydrophobic regions in the START domain may alter the mitochondrial
membrane and StAR structure to allow for the passage of cholesterol.
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1.8 Adrenal cells in culture as a model for study
Many of the pioneering studies on adrenocortical function were performed using
intact animals in vivo (Orth, 1992). The study of the adrenal cortex in its natural
environment has certain advantages; however, the concentration of adrenal hormones
in the plasma are very low and require sensitive assays. The measurement of steroid
hormones in body fluids gives little information about the source of the hormones or
to what extent they have been metabolised. The advent of in situ methods, where the
adrenal vein is catheterised, allowed the measurement of adrenal hormones in the
effluent blood (at a higher concentration than plasma), while maintaining the organ in
its natural environment.
In vivo methods do not allow the researcher to distinguish between the cell types of
the adrenal, nor can the effects of cortico-medullary interactions be analysed. They
are also unsuitable preparations with which to study the cellular mechanisms of
agonist stimulated steroidogenesis. Examination of the steroid capacity of
adrenocortical cells began when the glands themselves or slices or parts were
incubated at 37°C in buffered solutions (Vinson, 1978). Added substances,
particularly potential precursors, gave valuable information about the steroidogenic
pathway. The use of slices of adrenal tissue suffered from poor oxygenation and
impaired delivery of agonist to the inner cell layers. Thus reducing the steroidogenic
response when compared to in vivo or in situ studies cells (Kloppenborg, 1968). Such
preparations also contained a variety of cell types and methods were sought for
separation. The simplest of these was to remove the outer tissue capsule of the gland,
thus stripping off the zona glomerulosa and the cells adhered to it (Vinson, 1978).
This was refereed to as the capsular portion of the gland and the remaining zona
fasciculata/reticularis was called the decapsulated gland.
The next advance was to groups or suspensions of one cell type. Adrenal tissues
slices were digested using collagenase or trypsin (Kloppenborg, 1968), (O'Hare,
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1973). The early studies using cultured rat adrenocortical cells were carried out on
mixed populations of zona glomerulosa and fasciculata cells (Tait, 1974). Also early
studies using bovine adrenocortical cells were either unpurified freshly isolated cells
prepared from adrenocortical slices (Hepp, 1977) or unpurified cultured cells
prepared from crudely dissected inner zone adrenal cortical cells (Gospodarowicz,
1977). Therefore interpretation of in vitro results with stimuli which affected both
zones has been difficult. The need to use purified cell preparations was noted and
several methods are now available for the purification of dispersed cells, these
include gradient density centrifugation or column filtration (Tait, 1974), (McDougall,
1979). The cells of choice can then be maintained in a chemically defined media.
Isolated cells offer clear advantages in that there is free access of the test substances
to the receptor on the cell membrane and the steroids accumulate in the medium
overlying the cells at a high concentration (Vinson, 1978). Also they allow a large
number of incubations to be carried out with identical amounts of tissue from a small
number of animals.
Various researchers have shown that ACTH stimulates glucocorticoid synthesis in
adrenocortical cells at physiological doses which are lower than those required when
tissue slices are used (Kloppenborg, 1968). Further, ACTH log-dose response curves
for glucocorticoid output have been constructed and this output has been correlated
with cAMP production (Harming, 1970), (Lowry, 1973), (Beall, 1972). Gill et al
postulated that raised cytosolic levels of cAMP activated a protein kinase as the next
step in the mechanism ofACTH action (Gill, 1970). Cultured cell preparations have
been increasingly used to investigate the acute second messenger and steroid
secretory responses to steroidogenic agonists and the longer term effects on
steroidogenic enzyme activity. The ability to maintain homogeneously dispersed cells
from rat or bovine adrenal cortex in primary culture has provided a valuable in vitro
model system for the study of the mechanisms which maintain adrenocortical
structure and regulate its function. (Williams, 1989).
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1.9 Aims of the thesis
1) To investigate the mechanisms responsible for the kinetics of Cortisol production
ofprimary cultured BAC cells whereby the rate of Cortisol secretion declines
markedly between 6 and 12 hours of ACTH-treatment.
2) To investigate whether there is any relationship between the kinetics of Cortisol
secretion and the expression of StAR mRNA in BAC cells.
3) To investigate whether local feedback mechanisms for Cortisol secretion are
exhibited by primary cultures ofBAC cells.
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CHAPTER 2: MATERIALS & METHODS
2.1 MATERIALS
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Dulbecco's modified Eagle medium/F 12 (DMEM/F12) Life Technologies
Duralon nylon membrane Stratagene







Ham's F-10 Life Technologies
Hydrogen peroxide (30% v/v) Sigma
Hydrocortisone Sigma
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Nylon gauzes (30, 100, 250 pm)
Penicillin/streptomycin
Plastic containers, 30, 50, 250ml sterile
Polypropylene RIA tubes
Phenol.




Restriction enzymes (Pst I, EcoRl, Hindlll)
Salmon sperm DNA
Sephadex G-10 and G-50
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Tissue culture plates MacKay & Lynn
Whatman 3MM filter paper
Whatman grade 1 filter paper
MacKay & Lynn
MacKay & Lynn
Yeast extract Life Technologies
All chemicals were AnalaR grade and obtained from Sigma or Merck, unless stated
otherwise,
2.1.2 Company Addresses
Amersham International PLC, Little Chalfont Buckinghamshire, UK
BDH Merck, Lutterworth, Leicestershire, UK
Biddy Sterilin, Stone, Staffordshire, UK.
Boehringer Mannheim UK, Lewes, East Sussex, UK
Ciba Laboratories, Horsham, West Sussex, UK
Diagnostic Products Corporation (EURO/DPC), Gwynedd, UK
Euroso Ltd, Whitestone Business Park, Whitestone , Hereford, UK
ICN Phannaceuticals Ltd, Basingstoke, Hampshire, UK
Life Technologies, Inchinnan Business Park, Renfrewshire, UK
Lockertex, Warrington, UK
MacKay & Lynn, Edinburgh, UK
NIBSC, Potter's Bar, Hertfordshire, UK
Pharmacia Biotech Ltd Milton Keynes, UK
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Qiagen Ltd, Dorking, Surrey, UK
Sarstedt, Leicester, UK
Scottish Antibody Production Unit (SAPU), Carluke, Lanarkshire, UK
Sigma, Poole, Dorset, UK
Stratagene Ltd, Cambridge, UK
Waters, Milford, UK
Worthington, Lome Laboratories Ltd, Twyford, Berkshire, UK
Non-commercial source :
The StAR plasmid was a generous gift from Dr. Richard Ivell, Institute for Hormone
and Fertility Research, Hamburg, Germany.
Etomidate, trilostane and ketoconazole were kindly supplied by Professor Ian Mason.
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2.2 METHODS
2.2.1 Bovine adrenocortical cell preparation
Bovine adrenal glands were obtained from the local abattoir. The glands were
trimmed of fat and 100pm slices were obtained using a Stadie-Riggs microtome. The
first slice, consisting of the capsule and the zona glomerulosa, was discarded and the
second slice, the zonae fasiculata/reticularis (zff), was placed into a pre-weighed pot
containing Earle's balanced salt solution (EBSS)/0.2% (w/v) bovine serum albumin
(BSA). Slices showing visible medullary tissue were discarded.
Digestion method 1
5g of tissue was collected, chopped with scissors into l-2mm fragments, washed with
EBSS/BSA and digested with 50ml of collagenase (type 1) 2mg/ml at 37°C for 2
hours, with shaking every 30 minutes. The resultant cell suspension was then filtered,
by gravity, using 250 and 100pm mesh nylon gauzes to remove undigested tissue and
then centrifuged for 20 minutes at 450g to pellet the cells. The supernatant was
discarded and the cell pellet resuspended in EBSS/BSA and filtered through a 30pm
gauze to give a single cell suspension. The cell suspension was then purified using a
column filtration method [McDougall, 1979) which involves the cells being drawn,
by gentle suction, through a sintered glass Allihn funnel (100mm x 20mm disc: 16-
40pM pore size) containing 1ml Sephadex G-50 layered on top of 3ml of Sephadex
G-10, previously equilibrated with EBSS/BSA. The G-50 serves as a course filter to
remove any remaining larger debris whilst the G-10 selectively allows passage of red
blood cells, zona glomerulosa cells and finer cell debris through the column,
retaining the larger zfr cells in the interstites of the Sephadex G-10 gel.
The cells were recovered by resuspending the Sephadex gel in 50ml of EBSS/BSA
and filtering through another 30pm gauze trapping, the beads but allowing the zfr
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cells to pass through. The resultant cell suspension was centrifuged for 30 minutes at
45Og (Williams, 1989).
Digestion method 2
3g of tissue was collected and the slices rinsed with warmed (37°C) DMEM/F12
containing 1% penicillin/streptomycin (P/S) and amphotericin B. The slices were
placed into a glass digestion pot with fresh DMEM/F12. The digestion pot was
placed on a stirrer and incubated at 37°C for 20 minutes. The DMEM/F12 was
removed and replaced with 20ml DMEM/F12 containing 0.25% trypsin. The slices
were stirred at 37°C and the solution decanted after 15 minutes, this was repeated
once more to ensure removal of any serum proteins which may inhibit the action of
trypsin. Another 20mls was added to the slices and placed on the stirrer at 37°C for
20-30 minutes. The solution begins to appear cloudy with cells and debris. The
solution is decanted into a 250ml pot and retained. The remaining tissue was broken
down by up and down action of a 5/10ml pipette, fresh digestion mixture was added
and incubated for a further 20 minutes on the stirrer at 37°C. This process was
repeated until only the connective tissue was left. The cell suspension was filtered
with a lOOpM filter and centrifuged for 30 minutes at 450g.
For both digestion methods the pelleted cells were resuspended in 50ml of growth
medium (10% serum in the form of controlled processed serum replacement-1
(CPSR-1) in Ham's F-10 supplemented with 100 IU/ml penicillin/streptomycin (P/S)
and 25p.g/ml amphotericin B (Amp B). The cell yield was determined by counting on
a haemocytometer, plated into culture dishes and maintained in an incubator at 37°C
with a humidified atmosphere of 95% air, 5% CO2
The trypsin digestion method was a less labour intensify alternative to the
collagenase digestion. The two digestion methods produced comparable results when
the isolated cells were treated with ACTH.
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2.2.2. Treatment of cells with agonist and inhibitors
Cells were plated out in 25cm2 tissue culture flasks at a density of 5xl06 cells/flask,
12-well (0.33xl06 cells/well) or 6-well (1.5xl06 cells/well) culture plates. Unless
stated otherwise the experiments were carried out on day 3 of culture. The cells were
serum-deprived overnight in Ham's F-10 supplemented with 0.2% BSA plus P/S and
Amp B and maintained in an incubator at 37°C with a humidified atmosphere of
95% air: 5% C02. The following morning the cells were washed twice with EBSS,
then incubated with the appropriate agent, diluted in Ham's F-10 plus 0.2% BSA, P/S
and Amp B, for the required period of time. The overlying medium was removed and
stored at -20°C prior to steroid analysis. The cells were washed twice with EBSS and
used for RNA or protein analysis. RNA extraction was carried out immediately. If
this was not possible the cells were snap frozen with liquid nitrogen and stored at -
80°C.
For the cells treated on various days in culture, the cells on day 0 were incubated in
sterile 25cm universals, the cultured cells in 25cm2 flasks. Before treatment with
ACTH the cells were washed twice with Earle's balanced salts solution (EBSS). The
medium changes on day 0 cells were carried out by centrifugation (45Og for 30
minutes) to pellet the cells before resuspending in fresh medium. For cells in culture
the medium overlying the cells was removed by aspiration prior to replacement by
fresh medium. At the appointed time, termination of the experiment for day 0 cells
was by centrifugation prior to removing the medium, and for the cells in culture the
medium was simply removed from the flask.
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2.2.3 Radioimmunoassay for Cortisol
The assay consists of a double antibody preprecipitate to separate the bound and free
phases. Using sheep anti-cortisol-3-carboxy-methyloxime (anti-cortisol-3CMO)
antisera and a cortisol-3-CMO -125I-iodohistamine [Gray, 1983 #2], The
preprecipitate was prepared from 650pl reconstituted sheep Cortisol anti-serum,
530pl normal sheep serum, 15ml donkey anti-sheep and 10ml 0.1M citrate buffer
(0.02% (w/v) gelatin, 0.013% (w/v) sodium azide), which was mixed and left
overnight at 4°C. The solution was then centrifuged, at 230g for 15 minutes, the
supernatant carefully decanted and the pellet resuspended in 500ml 0.1M citrate
buffer.
Standards were prepared using Cortisol (lOmM dissolved in ethanol) in Ham's F-
10/0.2% BSA, giving values of 0, 1, 2, 5, 10, 20, 50, 100, 200, 500, 1000,
2000nmol/L Cortisol (Figure 2.1). Quality control samples representing 8, 80, 800
nmol/L Cortisol were also prepared, to check for intra-assay drift and inter-assay
precision. Inter- and Intra-assay variations were routinely found to be < 10%. The
minimum detection limit was 7.1nmol/l. The sheep anti-cortisol-3-carboxy-
methyloxime (anti-cortisol-3CMO) antisera is highly specific for Cortisol, with the
following cross-reactivity for other steroids: corticosterone 1.25%; progesterone
0.035%; 11-deoxycortisol 4.6%; deoxycorticosterone 1.92%.
Sample/standard/QC (100pl), 700pl of I25I-cortisol ( cortisol-3-CMO-(2-l25I)
iodohistamine diluted in assay buffer (0.1M citrate; pH 4.0) to give ~ 10,000 cpm,
and 250pl of the preprecipitate were added to polypropylene tubes, vortexed, and
incubated for 70 minutes at 37°C. The samples were then centrifuged at 3000rpm for
30 minutes, the supernatant decanted by tipping the tubes onto cellulose wadding.
The samples are then counted on a gamma-counter (LKB 1621 Multigamma), and
the data analysed using RIA-calc software.
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Figure 2.1 Representative standard curve for the 12SI radioimmunoassay for
Cortisol. Standard solutions for Cortisol (l-2000nM, in Ham's F10 + 0.1% BSA)
were assayed in duplicate and the standard curve fitted to a four parameter logistic
equation. Tracer binding in the absence of Cortisol was typically 70 - 80% of the total
tracer.
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2.2.3 High Performance-Liquid-Chromatography (HPLC) for
steroids
The profile ofUV-absorbing 4-en-3-ketosteroids secreted by BAC cells in culture
was determine by reversed-phase high performance liquid chromatography (HPLC)
on a Hewlett Packard LCI 100.
2.2.3.1 Optimisation
Optimisation of the HPLC was carried out (with the assistance ofDuncan Campbell,
as part of a student project), to determine the best volume of dichloromethane for
extraction, to ensure that the amount of steroid extracted was proportional to the
original concentration and to ascertain the retention times for each of the steroids for
identification.
A known Cortisol concentration added to Ham's F10 and extracted using various
volumes of dichloromethane. The results shown in the table below are the mean of
three independent samples. In parenthesis percentage of value obtained by RIA.
RIA HPLC
Cortisol Volume ofDichloromethane
(nmol/1) LI L6 L9 L12_
5 3.2(61%) 3.1(58%) 4.6(87%) 4.9(94%)
38 17.1 (45%) 24.6 (65%) 35 (94%) 34(91%)
443 256 (58%) 204(46%) 335 (76%) 378 (85%)
In order to be able to calculate how integrated peak area related to the amount of
steroid injected, a mixture of seven steroids were injected (cortisone, Cortisol 110-
hydroxyandrostenedione, deoxycortisol, deoxycorticosterone, testosterone and 17a-
hydroxyprogesterone). The stock mixture (lmg/ml of each steroid) was diluted
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(figure 2.2), to confirm that the peak area, adjusted formolecular weight, was
directly proportional to the concentration of steroid in the sample injected.
Routine identification of steroids was based on their retention times. To determine
the retention time for each of the steroids of interest, a solution, O.lmg/ml in ethanol,
of each steroid was injected on to the HPLC and the time of elution was noted. The
retention times are shown in table 2.1.
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Figure 2.2 Integrated peak area relative to steroid concentration. Samples of
known concentrations were injected onto the HPLC. The peak area was then
calculated to be directly proportional to the concentration of steroid in the original
sample.
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Cortisone 360.4 C21H3o05 5.81




Corticosterone 346.5 c2Ih30o4 11.41
Deoxycortisol 346.5 c21h30o4 12.94
Androstenedione 286.4 c,9h2602 16.77
Deoxycorticosterone 330.5 c2,h30o3 21.83
Testosterone 287.4 c19h27o2 24.55
Table 2.1 Retention times of steroids separated by HPLC. Retention times were
determined by injecting each steroid, O.lmg/ml steroid dissolved in ethanol, on to
HPLC.
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2.2.3.2 Method
Steroids, in the medium overlying the cells, were extracted using 1ml ofmedium to
9ml dichloromethane. Testosterone was added to the medium prior to extraction as
an internal standard, used to determine the amount of recovery. The mixture was
vortex and then centrifuged for 15 minutes at 1 OOOrpm, the upper aqueous layer was
removed and the solvent layer dried under air. The extracted steroids were then
dissolved in methanol prior to injection.
The steroids were separated on a CI SpBondapak reverse phase column in an
isocratic system using 1:1 methanol : distilled water at a flow rate of 1.3ml/min,
giving a column run time of 37 minutes. The absorptivity at 245nm was used to
monitor the elution of the steroids. The eluted steroids were identified by their
retention time and quantified by integrated absorption peak areas which are directly
proportional to the quantity of steroid injected. A standard mixture (O.lmg/ml) of the
steroids of interest was injected ahead of any samples, a trace is shown in figure 2.3.
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TIME (minutes)
Figure 2.3. High performance liquid chromatograph of standard mix. Standard
mix ofUV absorbing steroids (O.lmg/ml). 1, cortisone; 2, Cortisol; 3, 11 (3-
hydroxyandrostenedione; 4, corticosterone; 5, deoxycortisol; 6, androstenedione; 7,
deoxycorticosterone; 8, testosterone; 9, 17a-hydroxyprogesterone.
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2.2.4 ACTH immunometric assay
ACTH was measured using a IMMULITE automated analyser (DPC), employing a
solid-phase, two-site chemiluminescent enzyme immunometric assay. Polystyrene
beads coated with a monoclonal, murine anti-ACTH antibody directed against the
18-39 C-terminal fragment and an alkaline phosphatase-labelled polyclonal rabbit
anti-ACTH antibody directed against the 1-24 N-terminal fragment ensure that only
the intact ACTH molecule is detected.
The sample and a buffer/serum matrix were simultaneously introduced into the test
unit containing the labelled polystyrene beads and incubated for approximately 30
minutes at 37°C with intermittent agitation. ACTH in the sample binds to the
antibody-coated bead, any unbound sample was removed by a centrifugal wash. The
alkaline phosphatase-labelled antibody was introduced and the test unit was
incubated for a further 30 minutes. The unbound enzyme conjugate was removed by
a centrifugal wash.
The chemiluminescent substrate, a phosphate ester of adamantyl dioxetane, was
added, and the test unit incubated for a further 10 minutes. The substrate undergoes
hydrolysis in the presence of alkaline phosphatase to yield an unstable intermediate.
The continuous production of this intermediate results in the sustained emission of
light. The bound complex was therefore proportional to the concentration ofACTH
in the sample.
The IMMULITE system automatically calculates test results from the observed
signal using a stored master curve. Calibration range is 9-1250pg/ml, intra- and inter-
assay precision over the assay ranges was <10%. The ACTH antiserum was highly
specific for ACTH, with low cross-reactivity to other ACTH fragments that maybe
present in the sample.
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2.2.5 Protein assay
The cells were washed twice with 1ml EBSS, 500pl of 1% Triton -X100 was added
to each well and scrapped with the rubber end of a 1ml syringe plunger. The contents
of the wells were then placed into a microfuge tube. The samples were diluted 1:10
with distilled water prior to analysis by the dye-binding assay ofBradford (1976).
The assay was adapted for use on a Cobas Fara (Roche Diagnostics) centrifugal
analyser. The dye, coomassie brilliant blue G-250 was prepared as described by
Bradford [Bradford, 1976) and filtered through Whatman grade 1 filter paper before
use. A standard curve was constructed using a range of BSA concentrations (0-
lOOpg/ml) which were prepared in 0.1% Triton -X100.
2.2.6 Measurement of glucose
Glucose is measured using the hexokinase method [Bondar, 1974). Glucose is
phosphorylated in the presence of hexokinase and ATP, producing glucose-6-
phosphate. The glucose-6-phosphate reacts with NAD+ in the presence of glucose-6-
phosphate dehydrogenase to form gluconate-6-phosphate and NADH. The increase in
absorbency, at 340nm, is proportional to the glucose concentration.
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2.2.7 Preparation of StAR cDNA probe
The 400 bp segment ofbovine StAR cDNA (figure 2.4) corresponding to bp 210-608
(Hartung, 1995), contained within a pMOSBlue vector, was mixed with competent
DH5 (E.coli strain) cells.
2.2.1A Preparation of competent DH5 cells
The DH5 cells were made competent by inoculating 1ml of bacteria culture into
100ml L-broth supplemented with lOmM MgS04 and 0.2% (w/v) glucose. This was
incubated at 37°C, 225rpm for 2 hours to give an A600 of 0.2-0.3 OD. The cells
were then cooled to 4°C on ice and centrifuged for 5 minutes at lOOOg at 4°C. The
cell pellet was resuspended in 10ml of ice cold Miller transformation solution (L-
broth containing 10% (w/v) PEG 8000, 5% (w/v) DMSO, 50 mM MgCl2, pH 6.5),
and either used directly for transformation or frozen in 200ql aliquots on ethanohdry
ice and stored at -70°C (Chung, 1989).
2.2.7.2 Transformation of bacteria with cloning vector
The tubes containing the pMOSBlue vector/competent cells mix were incubated for
30 minutes at 4°C. Pre-warmed SOC medium (2% (w/v) bactotryptone, 0.5% (w/v)
yeast extract, lOmM NaCl, 2.5 mM KC1, lOmM MgCL, lOmM MgS04, 20mM
glucose) was added (0.9ml) and the tubes incubated for 1 hour at 37°C, 225rpm, to
allow expression of ampicillin resistance. The transformation mix was then plated, at
various dilutions, onto agar plates, containing 100p,g/ml ampicillin. The plates were
incubated overnight at 37°C. Ampicillin-resistance colonies on the plate were then
picked off and grown up overnight in either 100 or 400ml L-broth and ampicillin.
Prior to using or storing the bacteria an aliquot of the L-broth culture was subjected
to alkaline lysis miniprep to ascertain whether the plasmid inserted into the
competent cells contained the required insert. The bacteria was then pelleted and
frozen prior to further processing.
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gaaccggagg gccctagggg gcccggcccc agctgcgtgg attaaccagg ttcggcgtcg
cggctctctc ctaggttctc agctggaaga ccctctctac agcgaccaag agctggccca
tatccagcag ggagaggagg ccatgcagtg ggccctgggc atcctcaaag accaggaggg
ctggaagaag gagagccggc aggccaatgg ggacgaggtg ctgagtaaag tgatccctga
cgtgggcaag gtgttccggt tggaggtggt ggtggaccag cccatggaga ggctttatga





































































































































































































































































Figure 2.4 Complete nucleotide sequence of the bovine StAR gene transcript.
Underlined is the 400 bp segment ofbovine StAR cDNA corresponding to bp 210-
608 used as a probe for the northern hybridisation performed in this thesis. (Hartung,
1995).
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2.2.7.3 Alkaline lysis minipreps of DNA
The transformed culture (1.5ml) was added to an microfuge tube and centrifuged in a
microfuge at 12000rpm for 20 seconds to pellet the cells. Cell pellets were
resuspended in lOOpl of lysis buffer (25mM Tris.HCl pH 8.0, lOmM EDTA, 10%
(w/v) glucose, 2mg/ml lysozyme) and left at room temperature for 10 minutes .
200pl 0.2M NaOH/1% SDS solution was then added and the mixture vortexed
gently, and then placed on ice for 5 minutes. 150pl 3M potassium acetate (pH 4.8)
was added and the solution vortexed for 10 seconds to ensure complete mixing. The
tube was placed on ice for a further 5 minutes, and centrifuged for 1 minute in a
microfuge at 12000rpm to pellet the cell debris and chromosomal DNA. The
supernatant was then transferred to a clean microfuge tube, plasmid DNA
precipitated by the addition of 0.9ml isopropanol and stored at -20°C for 15 minutes.
The solution was centrifuged for 2 minutes at room temperature to pellet the plasmid
DNA, which was then resolubilised in 40pl TE (lOmM Tris pH 8.0, ImM EDTA)
[Birnboin, 1979 #8],
2.2.7.4 Purification of DNA
Qiagen kits were used for these procedures and the company's protocols followed.
The plasmid purification protocol was based on a modified alkaline lysis procedure
followed by binding of plasmid DNA to an anion-exchange resin under appropriate
low salt and pH conditions. RNA, proteins and other cellular impurities are removed
by a medium salt wash. Plasmid DNA is then eluted in a high salt buffer and
concentrated and desalted by isopropanol precipitation.
The bacterial pellet was resuspended in buffer PI (50 mM Tris, lOmM EDTA,
1 OOpg/ml RNase A), ensuring that no cell clumps form. The lysis buffer (200mM
NaOH, 1% SDS) was added, the suspension mixed by inversion and incubated at
room temperature for 5 minutes. Chilled neutralisation buffer (3M potassium acetate
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(pH 5.5) was added and mixed by inversion. The lysate was then poured into the
QIAfilter cartridge and incubated for 10 minutes at room temperature. The plunger
was inserted and the cell lysate filtered into a QIAGEN-tip which was equilibrated
with buffer QBT (750mM NaCl, 50mM MOPS, (pH 7.0), 15% isopropanol, 0.15%
Triton X-100).The QIAGEN-tip was then washed with buffer QC (1.0M NaCl,
50mM MOPS (pH 7.0), 15% isopropanol), and the DNA eluted with buffer QF
(1.25M NaCl, 50mM Tris, Tris-Cl, (pH 8.5) 15% isopropanol).
The DNA was then precipitated with 0.7 volumes isopropanol and centrifuged at >
15,000g for 30 minutes. The supernatant was removed and the DNA pellet washed in
70% ethanol. The resulting pellet was air dried for 5-10 minutes and dissolved in a
suitable volume ofTE buffer (lOmM Tris/HCl; pH 8.0, 0.4M EDTA). The yield was
then determined by UV spectrophotometry.
2.2.7.5 Restriction enzyme digestion
DNA was generally digested at a concentration of 0.1-0.5pg/ml, the enzyme
concentration was never more than 10% of the final volume to avoid problems with
excess glycerol interfering with digestion. The digests were always carried out in the
buffer recommended by the manufacturer of the enzymes. At the end of the digestion
0.5pg DNA was checked on an agarose gel to monitor the progress of the digestion.
When digestion was complete the reaction was stopped by the addition of2.5pl 0.4M
EDTA/50 pi of reaction and heat inactivated at 65°C for 10 minutes. The DNA was
then precipitated with 125pl 6M ammonium acetate and 750pl isopropanol and
centrifuged for 5 minutes at 12000rpm. The pellet was washed with 180ml of 70%
ethanol, centrifuged as before and briefly air dried before reconstituting in TE buffer.
2.2.7.6 Isolation of DNA probe
This procedure was carried out using a Qiagen kit, following the company's
protocols. The DNA was separated on a gel and the DNA fragment of interest,
visualised by ethdium bromide and UV, was excised from the gel with a clean sharp
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scalpel, placed into a pre-weighed microfuge tube, and the tube re-weighed. 3
volumes of buffer QX1 (composition unknown) was added to 1 volume of gel (100
mg ~100pl) and the mixture incubated for 10 minutes at 50°C. To help dissolve the
gel the tube was mixed by gently flicking every 2-3 minutes during the incubation.
Isopropanol (1 volume) was added, the solution mixed and placed into a QIAquick
spin column in a collection tube and centrifuged for 1 minute. The flow through was
discarded and the QIAquick column washed with buffer PE (composition unknown),
and centrifuged for 1 minute. The DNA was then eluted with 50pl of lOmM Tris-
HCL, pH 8.5 or with water, depending on the future use of the probe, by placing the
elution buffer onto the centre of the column and centrifuging for 1 minute. The DNA
was then stored at -20°C.
2.2.8 RNA isolation from cells in culture
Cells in tissue culture dishes were washed twice with EBSS to remove any traces of
growth medium. If the RNA was not extracted immediately the cells were snap
frozen, by adding liquid nitrogen to the flask, and stored at -80°C. The cells were
then lysed by the addition of ofRNAzol, 0.2ml/million cells in accordance with the
manufacturers instructions. The RNAzol was gently pipetted over the cells five times
to ensure solubilisation of the RNA and then transferred to a clean, RNAse-free
microfuge tube and kept on ice. 100pi of chloroform was added and the tubes shaken
vigorously for 15 seconds, then left on ice for 5 minutes. After centrifugation at
12000rpm for 15 minutes to separate the phases, the upper aqueous phase, containing
the RNA, was transferred to a clean microfuge tube.
The RNA was then recovered by precipitating with an equal volume of isopropanol
for 30 minutes at 4°C, centrifuging at 12000rpm for 15 minutes, followed by
washing the pellet with 180pl of 70% ethanol, centrifuging as before and air drying
on ice for 10 minutes. The RNA pellet was resuspended in lOOpl ofRNAse-free
water. Quantification of the RNA was by UV spectrophotometery and confirmation
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of the RNA quality was carried out by gel electrophoresis (figure 2.5). The samples
were then analysed by northern hybridisation. The RNA samples can be stored at
-70°C prior to analyses.
2.2.9 Northern hybridisation
Northern blotting analysis involves separating RNA by electrophoresis followed by
permanent transfer to a nylon membrane and hybridisation with the specific probe of
interest. Prior to sample preparation the gel equipment was washed with 7X-PF
detergent, soaked in 3% (v/v) hydrogen peroxide for 15 minutes, then rinsed in
RNAse-free water and drained.
The RNA samples (25pg), 18 and 28S markers (5pg of a sample), molecular weight
RNA markers, and a negative control (RNA containing no detectable StAR mRNA)
were precipitated by the addition ofO.lx volume 3M sodium acetate (pH 5.5) and 3x
volumes absolute ethanol to the RNA, and incubated overnight at -20°C. The
following morning the samples were centrifuged for 15 minutes at 12000rpm to
pellet the RNA. The pellets were washed with 180pl of 70% ethanol, vortexed,
centrifuged and air dried for 5 minutes. The pellet was then resuspended in 3.7pl of
RNAse-free water and 12.3pl of glyoxal/phosphate buffer/DMSO mix was added,
the samples were denatured at 50°C for 1 hour. The samples were then cooled on ice
and 4pi ofRNA loading buffer (lOmM Na Phosphate; pH 7.0, 50% (v/v glycerol,
0.4% (w/v) bromophenol blue) was added. The samples were loaded onto a 1.2%
agarose gel (agarose/1OmM phosphate buffer/RNAse-free water) with a running
buffer of 1 OmM phosphate buffer at 100V for approximately 4 hours. The buffer was
circulated to avoid ionisation of the phosphate buffer which raises the pH causing the
glyoxal to dissociate from the RNA.
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The RNA was then transferred to the nylon membrane by capillary transfer.
Using a suitable receptacle (a pyrex dish) a capillary bridge was formed by placing
three pieces ofWhatman 3MM filter paper (cut to the same width as the gel and
approximately three times as long) onto a glass plate with some 20xSSC (3.0M
NaCl, 0.3M Na citrate) removing any air bubbles between the layers by carefully
rolling a glass pipette over the filter paper. The pyrex dish was filled with a litre of
20xSSC. The gel was then placed on top of the filter paper and air bubbles removed
as before (the top left hand corner of the gel was cut off to aid orientation). A piece
ofnylon membrane, cut to the same size as the gel and wetted in 2xSSC, was then
placed on top of the gel, removing any air bubbles. Nine pieces ofWhatman 3MM
paper (cut to the same size as the gel) were placed on top of the membrane; the first
six were wetted in 2xSSC and the air bubbles removed as described and the
remaining three placed on the top dry. The sides of the wick were covered with
parafilm to ensure that the transfer only took place through the gel and glass pipettes
were placed on two opposite sides of the set-up to support the transfer. Absorbent
tissues was placed on top of the Whatman paper (approximately 9cm) and a smaller
glass plate placed on top of these with a 0.5kg weight. The transfer was left
overnight.
The following morning the set-up was disassembled and the site of origin marked on
the nylon membrane and the top left hand corner cut off for orientation purposes. The
membrane was baked at 80°C for 30 minutes to de-glycoxylate the RNA. The RNA
was then covalently bound to the membrane by exposing it to 240mJ UV light at
312nm in a Bio-rad crosslinker.
The first two lanes on the membrane, containing the molecular weight markers and
18S/28S markers, were cut off and stained for 5 minutes in methylene blue (0.04%
(w/v) in 0.5M Na acetate; pH 5.5). Destaining in distilled water revealed nucleic
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acids stained blue. If the correct pattern of staining was observed the blot was then
ready to be hybridised (figure 2.5).
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A. RNA quality gel









Figure 2.5 RNA integrity check gel and molecular weight markers . A: Gel run
prior northern hybridisation to test quality ofRNA. If gel shows clear bands with no
smearing, as shown above, this indicates good quality RNA which is not degraded.
B: RNA markers. Strip cut from northern hybridisation showing the molecular
weight makers and 18 &28S RNA markers.
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2.2.10 Hybridisation with Vogelstein random primer probe
To prepare the radiolabeled probe, 50ng of template DNA and 250ng of random
primer were mixed with TE buffer (10pl volume), denatured for 5 minutes at 100°C
followed by quenching on ice to avoid renaturation. The following were then added;
5pi of labelling buffer (0.5M Tris HC1; pH 6.9, 0.1M MgS04, ImM DTT, ImM
dATP, ImM dGTP and ImM dTTP), 5pl [32P]-dCTP (lOpCi/pl), 26.5pl sterile
water, lpl nuclease free BSA (10 mg/ml) and 2.5ul Klenow enzyme (2 U/ml). The
reagents were incubated for 1 hour at room temperature to allow incorporation of the
[32P]-dCTP into the template DNA (labelling).
After this time lpl samples was removed to calculate the amount of radioactivity
incorporated into the DNA probe. 0.5pl was spotted onto duplicate DE81 filter discs,
dried and the radioactivity determined. The filters were washed in 0.5M NariTPCh
rinsed with distilled water followed by ethanol and the radioactivity determined. The
amount of radioactivity incorporated (% incorporation) and specific activity are then
calculated.
The procedure was stopped by the addition of 2.5pl 0.4M EDTA pEI 8.0 and the
'labelled' probe was then purified, removing 'unlabelled' nucleotides, by passing it
through a NAP-5 column equilibrated with 6xSSC and eluting with 1ml 6xSSC.
Probes used have a specific activity of 1-2x109cpm and were used at a concentration
of~lxl06cpm/ml hybridisation solution.
QuikHyb was used as the hybridisation solution, according to the manufacture's
instructions. The blot was soaked in. 6xSSC for 5 minutes. The wetted blot was then
placed into a Techne hybridisation bottle and hybridised with 10ml ofQuickhyb
solution for 10-20 minutes at 68°C. The Vogelstein random primer DNA probe was
added to lOOpl of salmon sperm DNA (lOOpg/ml) and both were denatured by
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heating at 100°C for 10 minutes followed by cooling on ice. This solution was then
added to the hybridisation solution and incubated for 3 hour at 68°C. The membrane
was then washed twice for 15 minutes at room temperature with 2xSSC/0.1% SDS
wash solution, followed by a 30 min wash at 60°C with 0.2xSSC/0.1% SDS wash
solution. The membrane was briefly air dried, wrapped in saran-wrap and laid down
on Kodak XAR-5 film with an intensifying screen at -70°C for 24-72 hours. For
quantification analysis the membrane was laid on the BioRad phosphoimaging
system and the hybridising bands and quantified using the BioRad imaging software.
The membranes were stripped by washing twice for 15 minutes in 0.1xSSC/0.1%
SDS at 100°C and re-probed for the housekeeping gene, P-actin. This was to ensure
equal loading ofRNA in each well.
2.2.11 Statistical analysis
On the advice ofMrWilliam Adams, Department ofMedical Statistics, University of
Edinburgh, the following statistical tests were used to analysis the data presented in
this thesis. All data were analysed using Instat or Instatprism software.
Results are expressed as means ±SD. Comparison ofmeans were assessed using
Student's t-test and considered significant when P<0.05.
To assess the plateau in Cortisol output an non-linear curve equation was fitted:
Y=Ymax*(l-exp(-K*X)), where Y= Cortisol value.
The peak in StAR transcript expression was extrapolated using a 2nd order
polynomial quadratic equation: Y=A+B*X+C*X2 where Y= StAR value.
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CHAPTER 3 : CHARACTERISATION OF THE
STEROIDOGENIC PROFILE TO ACTH BY BOVINE
ADRENOCORTICAL (BAC) CELLS.
3.1 Introduction :
Adrenocorticotropin (ACTH) is a 39 amino acid polypeptide (MW 4500kDa)
produced by the anterior pituitary from a precursor molecule called
preopiomelanocortin (POMC), MW 28,500kDa (figure 3.1). Within the pituitary
POMC is synthesised and proteolytically cleaved into several fragments including
ACTH, P-lipotropin and p-endorphin (Orth, 1992). The primary action ofACTH is
on the adrenal cortex where it increases glucocorticoid synthesis and secretion. The
principal glucocorticoid secreted in humans and bovine species is Cortisol. ACTH
has much less effect on adrenal androgen production and, at physiological levels,
virtually no effect on aldosterone production.
The biological function ofACTH is dependent upon the NH2-terminal 24 amino
acids, which are the same in all species studied. Any species variation occurs with
the remaining 7 amino acids of the COOH-terminus. This part of the peptide forms
a 'tail' that apparently stabilises the molecule within the body (the half-life of
ACTH in circulation of humans is about 10 minutes) (Schwyzer, 1977).
Replacement of glutamate, in the human sequence, at amino acid 33 by glutamine is
the only difference in the ACTH sequence between human and bovine species
(figure 3.1) (Schwyzer, 1977).
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Ser Tyr Ser Met Glu His Phe Arg Trp Gly
11 15 20
Lys Pro Val Gly Lys Lys Arg Arg Pro Val
21 25 30






Ala Phe Pro Leu Glu Phe -COOH
Figure 3.1 Amino acid sequence of ACTH. Modified from ACTH and related
peptides: structure, regulation and action. (Schwyzer, 1977).
ACTH acts by binding to specific G-protein coupled receptors on the cell surface
and activating intracellular signal transduction systems. The actions ofACTH are
mediated via the cAMP second messenger system, as discussed in chapter 1.
It was once thought that ACTH was the sole stimulus of steroid hormones from the
adrenal zona fasciculata/reticularis cells; however, it has now been shown that these
cells respond to a wide variety ofhormones and neurotransmitters, such as
vasopressin (Walker, 1991b), Angll (Canny, 1998), acetylcholine [Walker, 1991a),
(Clyne, 1993b), phorbol ester (Kenyon, 1988) and interferons (Tachikawa, 1999).
ACTH acts via the adenylate cyclase second messenger pathway system to promote
steroidogenesis in the adrenal cortex. This pathway can also be stimulated by the
diterpene compound forskolin and 8-bromo-cAMP (8-Br-cAMP), a cAMP
analogue. Forskolin activates adenylate cyclase in mammalian cells. However its
actions are not mediated through interactions with any of the major classes of
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receptors. In most, but not all, situations the actions of forskolin appear to be
consistent with a direct action on the catalytic unit of adenylate cyclase (Seamon,
1983). Adenylate cyclase has been shown to have two forskolin-binding sites, a low
affinity site being associated with the catalyst and a high affinity site being
attributed to the activated complex of the catalyst (Seamon, 1984), (Nelson, 1986).
Forskolin has been reported to stimulate cAMP and steroid hormone production in
bovine adrenocortical cells (Langlois, 1987), (Yanagibashi, 1989), (Juska, 1995).
Other agonists, such as angiotensin II (Angll), do not have any effect on cAMP
levels but exert their effects through the activation of phosphoinositidase C (PLC)
(Bird, 1989). Much work has been done on the effect ofAngll on aldosterone
synthesis in the adrenal zona glomerulosa (Kojima, 1985a), (Farese, 1984),
(Kojima, 1985b). Nevertheless the hydrolysis of phosphoinositides and the
production ofCortisol in BAC cells in response to Angll has been demonstrated
(Bird, 1992b), (Clyne, 1992).
Bovine adrenocortical (BAC) cells have been used to study the mechanism of action
of a variety of steroidogenic agents on different aspects of the steroidogenic
response. BAC cells have be used individually (Kenyon, 1988), after immediate
isolation (Walker, 1991b), (Nishikawa, 1996), (Yaguchi, 1998) or following culture
(Le Roy, 2000), (Tachikawa, 1999), (Clyne, 1993b). The use of cells in culture is
the more widely used approach but the length of time in culture before
experimentation varies from 24 hours to 6 days after isolation.
The aims of this chapter were firstly, to try and determine the ideal culture
conditions with which to study the steroidogenic response ofBAC cells. The
response ofBAC cells on various days in culture, and the use of serum in the
experimental culture medium were investigated. Secondly the steroidogenic
response ofBAC cells to ACTH over a 12 hour period was studied. This included
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an identification of the various steroids produced by the BAC cells in response to
ACTH-treatment, the response to various ACTH concentrations and the response to
both synacthen (ACTH,_24) and the native ACTH,.39 peptide. Finally a comparison
between the BAC cell response produced to ACTH and that produced by other
agonists was studied.
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3.2 Results
3.2.1 The responsiveness of BAC cells to ACTH1.24 treatment at
various stages in culture.
BAC cells were exposed (6 & 24 hour treatments) to ACTH,_24 on the day of
isolation (day 0) and on days 1, 2, 3, and 4 of culture. The cells on day 0 were
placed in sterile 25 ml universals (5xl06 cells/universal) and those on days 1, 2, 3
and 4 were cultured in 25 cm2 tissue culture flasks (5x106 cells/flask). The cells
were maintained in Ham's F10 medium containing 10% CPSR1 (a controlled
processed bovine serum replacement used in place of serum) throughout these
experiments.
Figure 3.2 demonstrates that, on each of the days studied, the amount of Cortisol
secreted into the medium overlying the ACTH,.24-treated BAC cells was
significantly increased compared with equivalent untreated cells at 6 hours (P<0.05)
and at 24 hours (P<0.05).
There was a significant difference in the amount of Cortisol production by BAC
cells at 6 hours compared with 24 hour on each of the days apart from day 1. On day
0 there was a significant decrease in the Cortisol output at 24 hours compared with 6
hour ACTH-treatment, P<0.05. On days 2, 3 and 4 the Cortisol output in response to
ACTH-treatment increased between 6 and 24 hours, P<0.05.
The Cortisol output from the ACTH,_24-treated cells at 6 hours was increased slightly
over the different days in culture. A significant increase in the amount ofCortisol
produced by the cells was found on day 2 when compared with day 0 (P<0.05) and
day 1 (P<0.05). No difference was found between the cells which had been cultured
for 2, 3 or 4 days. ACTH1_24-treatment for 24 hours also produced an increase in
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Cortisol output with time in culture. No significant difference was found in the
Cortisol output between days 0 and 1 at 24 hour ACTH-treatment. However there
was a significant increase in the amount of Cortisol secreted into the overlying
medium after 24 hours ACTH-treatment on days 2, 3 and 4 when compared with the
Cortisol produced by BAC cells on day 0 (P<0.001). There was also a significant
increase in the amount ofCortisol secreted by BAC cells in response to 24 hour
ACTH-treatment on day 4 compared with day 1 of culture (P<0.05). There was no
significant difference (P>0.05) between the Cortisol output at 24 hour ACTH,.24
treatment on days 2, 3 and 4 of culture.
Based on these observations subsequent experiments were carried out on day 3, after
an initial culture period of 2 days.
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Untreated cells 6h □ Untreated cells 24h
ACTH 1 OnM 6h ■ ACTH 1 OnM 24h
Figure 3.2 : Cortisol output by BAC cells in response to ACTH^ treatment on
separate days of culture. BAC cells were maintained in Ham's F10 + 10% serum
throughout the experiment. The cells were treated with or without lOnM ACTH,.24
as indicated. Results shown are mean ± SD of three independent cell isolations.
* P< 0.05, ** P<0.01, ***P<0.001 comparing untreated cells with treated cells at
each of the time points, on each day e.g. 6h untreated on day 0 v 6h ACTH treated
on day 0 etc. x P<0.05 comparing 6h treated with 24 h treated on same day of
culture
The comparisons between the 6h ACTHi„24 treated cells and 24 hours ACTHi_24
treated cells on separate days are discussed in the text.
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3.2.2 Effects of serum on the Cortisol response of BAC cells
treated with ACTH.,^
BAC cells were cultured for 2 days in 25cm2 flasks. One group of cells was
maintained in Ham's F10 containing 10 % serum and a second group of cells was
serum-deprived overnight prior to the experiment, i.e. the medium was removed and
replaced with Ham's F10 + 0.2% bovine serum albumin (BSA). The following
morning both sets of cells were washed twice with EBSS prior to ACTH! 24-
treatment in either Ham's F10 containing 10 % serum or Ham's F10 containing
0.2% bovine serum albumin (BSA). At the designated times the medium was
removed and assayed for Cortisol. Untreated cells were studied at 6 and 48 hours
only.
The effect of serum on the pattern ofCortisol production over a 48 hour period is
illustrated in figure 3.3. In both the presence and absence of serum there was a
significant increase in the amount ofCortisol produced by ACTH,.24-treated cells
compared with untreated cells at 6 and 48 hours (P<0.05).
No significant difference was found in the amount ofCortisol secreted into the
medium overlying the ACTH1_24-treated cells when maintained in either the presence
or absence of serum.
From these results it is clear that lOnM ACTH,_24 was adequate to stimulate BAC
cells in the presence or absence of serum. Based on these findings all subsequent
work with BAC cells was conducted in the absence of serum, unless stated
otherwise.
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I:3h B6h : : 12h
□ 24h □ 36h D48h
Figure 3.3 : Effect of serum on the Cortisol output by BAC cells in response to
ACTHi_24 treatment. BAC cells were cultured in 25cm flasks for 2 days, then
either A, maintained in the presence of serum or B, serum-deprived overnight. The
cells were treated with ACTHi_24 (lOnM) as indicated, untreated cells only at 6 and
48 hours. The medium overlying the cells was then removed and assayed for
Cortisol. Results shown are mean ± SD of three independent cell isolations.
**P<0.05, **P<0.01 comparing 6 and 48 h untreated with 6 and 48h ACTH-treated
cells.
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3.2.3 Treatment of BAC celis with ACTH.^ over a 12 hour period
Exposure ofBAC cells to ACTH,.24 (lOnM) resulted in a significant secretion of
Cortisol into the medium overlying the cells. Figure 3.4A displays means ± SD for
four experiments each from independent cell isolations and figure 3.4B the
combined means ± SD of the four experiments.
The results from each of the four independent experiments shown in figure 3.4A
conform to a reproducible pattern of Cortisol output. At each of the time points
studied (1-12h) there was a significant increase in the Cortisol concentration in the
medium overlying the ACTH1.24-treated cells compared with untreated cells at the
same time point. Over the time course there was an increase in the rate of Cortisol
production by BAC cells over the initial four hours with a fall in the rate of
production thereafter. Fitting a nonlinear curve equation the plateau in Cortisol
production was found to vary between 4 and 8 hours for the four experiments.
This pattern is reflected in the graph combining the four experiments (figure 3.4B).
ACTH,.24-treated cells displayed a significant increase in the amount of Cortisol
secreted into the medium overlying the BAC cells compared to untreated cells at
each of the time points studied, P<0.00 at 1 and 2 hours, P<0.001 at 4, 6, 8 and 12
hours. Using a nonlinear curve fit equation it was found that the plateau occurred at
a concentration of 3.2 ± O.lnmol cortisol/106 cells, corresponding to the amount of
Cortisol secreted into the medium after 6 hours ofACTH1.24-treatment.
Figure 3.5 displays the protein content ofBAC cells over the course of the
experiment. This did not vary by more than 10% over the 12 hour time period, thus
indicating no significant decrease in the number of cells in the culture wells.
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Figure 3.4A Cortisol production by BAC cells in response to ACTH1.24
treatment. BAC cells were treated with or without ACTH^24 (lOnM) for the times
indicated. The results presented are from four independent cell isolations, means ±
SD from triplicate wells. **P<0.01, ***P<0.001 comparing untreated with ACTH-
treated cells at each time point. Inserts show untreated cell data in more detail.
3.11
Characterisation of the steroidogenic profile
to ACTH by BAC cells
Chapter 3
5 T
1 2 4 6 8 12
TIME (h)
□ untreated ■ ACTH
Figure 3.4 (B): Cortisol production by BAC cells in response to ACTH^.24
treatment. BAC cells were treated with or without ACTH1.24 (lOnM) for the times
indicated, medium overlying the cells was then removed and assayed for Cortisol.
Results shown are the combined mean ± SD of the four experiments in figure 3.4A.
Insert shows the untreated cell data in more detail.
**P<0.01, ***P<0.001 comparing untreated with ACTH-treated cells at each time
point.
3.12
Characterisation of the steroidogenic profile
to ACTH by BAC cells
Chapter 3
120
1 2 4 6 8 12
TIME (h)
Figure 3.5 : Protein concentration of BAC cells incubated with ACTH1.24.
BAC cells were cultured for 2 days, serum-deprived overnight and incubated with
ACTH1.24 for the times indicated. The medium was removed and the cells
solubilized in Triton XI00 prior to assay for protein by the Bradford method (see
section 2.2.5). Results shown are mean ± SD of three independent cell isolations.
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3.2.4 Production of other steroids over the 12 h time course
HPLC data illustrated that over the 12 hour time period, ACTH1.24-treated BAC cells
produce four UV-absorbing, 4-en-3-ketosteroids: Cortisol, corticosterone, cortisone
and 11P-hydroxyandrostenedione. No steroids were detected in the untreated cells at
any of the time points studied. Figure 3.6 shows representative traces from HPLC
data at each of the time points.
Cortisol and corticosterone were detectable in the medium overlying BAC cells
treated with lOnM ACTH(.24 after 1 hour (figure 3.7). Over the first six hours of
ACTH1.24-treatment the amount of Cortisol and corticosterone produced by BAC
cells was similar, with no significant difference found. A significant difference was
seen at 8 and 12 hours ofACTH,_24 treatment as the amount of corticosterone
produced by the cells decreased (P<0.05). Both Cortisol and corticosterone output by
BAC cells display the familiar pattern, i.e. an increase in Cortisol production over
the first 6 hours ofACTH treatment followed by a drop in output thereafter.
Cortisone and 1 ip-hydroxyandrostenedione were not detectable in the medium
overlying BAC cells until 6 hours ofACTH,_24 treatment. The cortisone output
remained constant over the 6-12 hour period with no significant difference found at
any time point, whereas 11 P-hydroxyandrostenedione appears to peak at 8 hours;
however, no significant difference was found. Cortisol production was found to be
significantly increased over the production of cortisone after 6 (P<0.01), 8 (P<0.05)
and 12 (PO.Ol) hours ACTH|.24-treatment. The levels ofCortisol in the medium
overlying ACTH^-treated BAC cells were increased over those of
11 p-hydroxyandrostenedione after 6 (PO.Ol) and 12 (PO.05) hours.
For the first 2 hours ofACTH-treatment, Cortisol and corticosterone are produced in
similar amounts (Table 4.1). Thereafter, the percentage of corticosterone found in
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the medium decreases. The amount of Cortisol secreted into the medium remains at
around 50% of the total steroids detected, thus making it the principal steroid
secreted by ACTH1.24-treated BAC cells
The total amount of steroids in the medium overlying the BAC cells was also found
to be increased over the initial 6 hours, followed by a decline in levels thereafter
(figure 3.7E and table 3.1)
3.15
Characterisation of the steroidogenic profile





1 , 1 1 1 1—
5 15 30








Figure 3.6 Representative HPLC traces of steroids secreted by BAC cells.
Separation of adrenal steroids on C18p Bondapak reverse phase column,
absorptivity at 245nm. Peak 1 : cortisone, 2 : Cortisol, 3:1ip-
hydroxyandrostenedione, 4 : corticosterone and 5 : testosterone (internal standard).
The differences in peak height of the internal standard, testosterone, on the
individual traces are due to the various amounts of testosterone added to the
samples, ranging from 1 to O.Olnmole/ml, prior to extraction.
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Figure 3.7 Distribution ofUV-absorbing steroids produced by BAC cells in
response to ACTH^. Steroids produced by BAC cells, as measured by HPLC, are
A, Cortisol; B, Corticosterone; C, 1 ip-hydroxyandrostenedione; D, Cortisone and
E, Total steroid output. Results shown are means ± SD of three independent
experiments. *P<0.05, **P<0.01, comparing all Cortisol time points with thel hour
Cortisol time point, x P<0.05 comparing all corticosterone time points with the 1
hour corticosterone time point. ♦ P<0.05, ♦ ♦ P<0.01 comparing total steroids at
time points with lhour time point.
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STEROIDS
(nmol/106 cells) Oh lh 2h 4h 6h 8h 12h







0 0.3 1.3 2.2 3.4 2.2 2.4
Cortisol (±0.08) (±0.2) (±0.7) (±0.6) (±0.3) (±0.2)
(50%) (52%) (58%) (56%) (46%) (55%)







0 0.3 1.2 1.6 1.7 0.7 0.8
Corticosterone (±0.1) (±0.2) (±0.3) (±0.7) (±0.1) (±0.6)
(50%) (48%) (42%) (28%) (15%) (18%)
TOTAL 0 0.6 2.5 3.8 6.1 4.8 4.4
Table 3.1 Distribution of steroids produced by BAC cells. Total amount of
steroids produced by BAC cells (in parenthesis percentage of total steroid
production). Results are mean ± SD from three independent cell isolations.
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3.2.5 Pattern of Cortisol production in response to various doses
of ACTH,.24
To investigate if the dose ofACTH,_24 had any effect on the pattern ofCortisol
output by BAC cells, three further doses ofACTH,.24 (0.01, 1 and lOOnM) were
used to treat the cells (figures 3.8-3.10).
Figure 3.8 displays the response ofBAC cells to O.OlnM ACTH,_24 treatment, where
figure 3.8A displays three independent experiments and figure 3.8B the three
experiments combined. The individual experiments, which were performed with
triplicate wells for each time point, demonstrate that ACTH,.24-treatment at all of the
time points studied gave rise to a significant increase in the Cortisol output in
ACTH124-treated cells compared with untreated cells. This was reflected in the
combined results of figure 3.8B, where at each time point studied there was a
significant increase in the Cortisol secreted into the overlying ofACTHI.24-treated
cells compared with untreated cells (P<0.05).
Figure 3.9A & B displays the response by BAC cells to lnM ACTH,^. For each of
the three individual experiments (figure 3.9A) and the combined data (figure 3.9B),
there was a significant increase in the amount of Cortisol produced by ACTH,.24-
treated cells compared with untreated cells (see figures for details). Likewise, in
response to lOOnM ACTH,.24 there was a significant increase in the Cortisol content
of the overlying medium compared with the untreated cells (P<0.05) (figure 3.1 OA
& B)
The plateau in the Cortisol output, when the experiments were combined, was found
to be at 4 hours for O.OlnM, 6 hours for lnM and between 8 and 12 hours for the
highest dose, lOOnM.
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Figure 3.8A Cortisol production by BAC cells in response to 0.01 nM ACTH^-
treatment. BAC cells were treated with or without ACTH^ for times indicated.
Results from three independent cell isolations (1,2 &3) means ± SD from triplicate
wells. *P<0.05, **P<0.01, ***P<0.001 comparing untreated with ACTH^-treated
cells at each time point. Inserts show untreated cell data in more detail.
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Figure 3.8 B : Response, by BAC cells, to 0.01nM ACTH^24
BAC were treated with ACTH^ (0.0 InM) for the times indicated. The graph on
this page shows the combined mean ± SD of the three experiments shown in figure
3.8A. Inserts displays the untreated cells in more detail. *P<0.05 comparing
untreated and ACTH^-treated cells at each time point.
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Figure 3.9A Cortisol production by BAC cells in response to InM ACTH1.24-
treatment. BAC cells were treated with ACTH1.24 (InM) for the times indicated Results
from three independent cell isolations (1, 2 & 3), means ± SD from triplicate wells.
*P<0.05, **P<0.01, ***P<0.001 comparing untreated with ACTH1.24-treated cells at each
time point. Insert shows untreated cell data in more detail.
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Figure 3.9B : Cortisol production by BAC cells in response to InM ACTH^-
treatment. BAC cells were treated with or without ACTHi_24 (InM) for the times
indicated, the medium was removed and assayed for Cortisol. Results shown are
mean ± SD of the three independent experiments shown in figure 3.9A. Insert
shows untreated cell data in more detail. *P<0.05, **P<0.01 comparing untreated
with treated at each time point.
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Figure 3.10A Cortisol output by BAC cells in response to lOOnM ACTHi_24-
treatment. Results from three independent cell isolations (1,2 &3), means ± SD
from triplicate wells. *P<0.05, **P<0.01, ***P<0.001 comparing untreated with
ACTH^-treated cells at each time point. Inserts show untreated cell data in more
detail.
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Figure 3.10B: Cortisol response, by BAC cells, to lOOnM ACTH^ treatment.
BAC were cells were treated with or without ACTH^ (lOOnM) for the times
indicated, the medium was removed and assayed for Cortisol. Results shown are
mean ± SD of the three independent experiments shown in figure 3.10A. Insert
shows untreated cell data in more detail. *P<0.05, **P<0.01 comparing untreated
with treated at each time point.
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3.2.6 Treatment of BAC ceils with ACTH-^g
The native ACTH peptide (ACTH,_39) gave rise to a significant increase in the
amount ofCortisol secreted into the medium overlying BAC cells compared with
untreated cells, at all of the time points studied (P<0.001) (figure 3.6). Treatment
with ACTH,.39 (lOnM) produced a response comparable with that found for
ACTH,_24-treated (lOnM) cells, for example at 6 hours of treatment values of
3.2 ± 0.6 and 3.3 ± l.Onmol cortisol/106 cells were found with ACTH,.24 and
ACTH,_39 respectively.
As with ACTHj.24 the Cortisol output by BAC cells in response to ACTH,_39-
treatment diminished over the time period studied. However the plateau began at a
concentration of 3.8 ± 0.3nmol cortisol/106 cells, a level of Cortisol found between 6
and 8 hours of treatment (3.3 ± 1.0 and 3.9 ± l.lnmol cortisol/106 cells
respectively).
These results establish that there was little difference in the response ofBAC cells
treated with ACTH,.39or ACTH,_24. Consequently the use of the more economical
and widely used synthetic ACTHj.^ was valid, and this was used in subsequent
experiments, unless stated otherwise.
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Figure 3.11 : Cortisol response in BAC cells treated with ACTHi_39
BAC cells were treated with or without ACTH^ (lOnM) for the times indicated,
the medium overlying the cells was then removed and assayed for Cortisol. Results
are mean ± SD of 5 independent cell isolations. Insert shows untreated levels in
more detail. ***P<0.001 comparing untreated with ACTH^-treated at each time
point.
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3.2.7 Response by BAC cells to Forskolin, 8 Br-cAMP and Angll
Forskolin-treatment gave rise to a significant increase in the amount of Cortisol
secreted into the medium overlying BAC cells, compared with untreated cells, at
each of the time points studied; P<0.01 at 1 and 2 hours and P<0.001 at 4, 6, 8 and
12 hours (figure 4.3). When the data were analysed using a nonlinear curve fit
equation no plateau in Cortisol production was found. The maximal response in
Cortisol output was at 12 hours, when expressed as a percentage of this maximal
response the other time points show a gradual increase in the amount of Cortisol
produced; 8% ± 5; 22% ± 7; 52% ±11; 60% ± 5; 72% ± 13 at 1, 2, 4, 6 and 8 hours
respectively.
Treatment ofBAC cells with 8 Br-cAMP also produced a significant increase in
Cortisol secretion compared with untreated cells at each time point studied (P<0.05).
Once more, no plateau in Cortisol output was found when analysed by the nonlinear
curve fit equation. As with forskolin the maximal response in Cortisol output was at
12 hours and when expressed as a percentage of this maximal response the other
time points show a gradual increase in the amount of Cortisol produced; 4% ± 2;
15% ± 9; 47% ± 22; 60% ± 10 and 66% (± 15) at 1, 2, 4, 6 and 8 hours respectively.
Angll-treatment ofBAC cells gave rise to a significant increase in Cortisol output
over untreated cells at all the time points studied (P<0.05). However, unlike
forskolin and 8Br-cAMP, Angll-treatment ofBAC cells produced a plateau in the
Cortisol output. Akin to that of ACTH,_24, the plateau occurred around 6 hours of
Angll treatment.
Figure 4.6 illustrates the different steroids produced by BAC cells in response to
forskolin, 8 Br-cAMP and Angll. All four UV-absorbing steroids were found in
response to forskolin-treatment. The profile of steroid output was similar to that
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found with ACTH, in that Cortisol and corticosterone are produced in similar
amounts over the initial 4 hours, thereafter the Cortisol levels increase and the levels
of corticosterone fall. Cortisone was produced at 4 hours of treatment and appears to
increase over the following 8 hours of treatment. The levels of
11 (3-hydroxyandrostenedione appeared to be less that those found with ACTH-
treatment. Cortisol, corticosterone and cortisone were detected in the medium of
8Br-cAMP and Angll-treated cells. Levels of 11 (3-hydroxyandrostenedione were
undetectable with both these treatments.
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Figure 3.12 Cortisol output by BAC cells in response to forskolin (10 pM)
BAC cells were treated with or without forskolin for the times indicated, the
experimental medium was removed and assayed for Cortisol. Results shown are
mean ± SD of five independent cell isolations. Insert shows untreated cell data in
more detail.
**P<0.01, ***P<0.001 comparing untreated with treated at each time point.
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Figure 3.13 Cortisol output by BAC cells in response to 8-Br-cAMP (100 p,M)
BAC cells were stimulated with or without 8 Br-cAMP for the times indicated, the
experimental medium was removed and assayed for Cortisol. Results shown are
mean ± SD of five independent cell isolations. Insert shows untreated cells in more
detail. *P<0.05, **P<0.01, comparing untreated cells with treated cells at each time
point.
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Figure 3.14 Cortisol output by BAC cells in response to Angll (lOnM)
BAC cells were stimulated with or without Angll for the times indicated, the
experimental medium was removed and assayed for Cortisol. Results shown are
mean ± SD of three independent cell isolations. Insert shows untreated cell data in
more detail. *P<0.05, **P<0.01 comparing untreated cells with treated cells at each
time point.
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Figure 3.15 Distribution of UV-absorbing steroids produced by BAC cells.
Steroids produced by BAC cells, as measured by HPLC, in response to A,
Forskolin; B, 8 Br-cAMP and C, Angll. Total steroid output is shown in the insert
graphs. Results shown are from one experiment.
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3 3 Discussion :
Consistent with previous studies (Williams, 1989), (Bird, 1992a), the results
presented here show an enhanced responsiveness of BAC cells to ACTH, when
maintained in primary culture, compared to the response found with freshly isolated
cells. Although exposure to ACTH,_24 for 6 hours provokes a significant response
from BAC cells on each of the days studied, the cells were less able to sustain such
levels of output over 24 hour exposure to ACTH,.24 on days 0 and 1. The cells
improve with time in culture producing a significant Cortisol response at 24 hour on
days 2, 3 and 4 (figure 3.2). The increase in Cortisol secretion in response to ACTH
over the days of culture has been shown to be paralleled by increased formation of
cAMP (Bird, 1992a). The response by BAC cells to other agonists such as
angiotensin II, adrenaline and acetylcholine has also been shown to be enhanced
with time in culture (Bird, 1992a) (Walker, 1991a).
Compared with freshly isolated cells, BAC cells were reported to show a marked
increase in cellular lipid content following primary culture (Williams, 1989). Using
electron microscopy it was found that after 48 hours in culture BAC cells showed
improved integrity of ultrastructure with an increased density of lipid droplets. The
number of lipid droplets on day 3 of culture was found to be six times the number of
lipid droplets/per cell section of day 0 cells.
The increase in the number of lipid droplets within the BAC cell by day 3 of culture
may be one of the reasons why the cells respond so well in lipid-free medium. The
use of serum, whether as fetal calf serum or processed serum replacements, in cell
culture is essential in the initial stages for effective plating and maintenance of the
cells. However, to ensure that the response achieved was due to agonist treatment
rather than any potential effect ofhormones in serum, it is advantageous to use a
more defined medium. Figure 3.3 demonstrated that the response by BAC cells to
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ACTH in either serum-free or serum-containing medium was similar. An increase in
the amount of Cortisol secreted into the overlying medium was observed over the
initial 6 to 12 hours thereafter, the further synthesis ofCortisol was not detectable.
To investigate further this fall in the steroid response, BAC cells were treated with
ACIHj.24 over a time period of 12 hours, in lipid-free medium. Figure 3.4 shows
that the diminished Cortisol response occurs around 4-6 hours ofACTH,_24-
treatment. Similar results were found by Jefcoate et al, although in their study the
Cortisol output was found to be linear up to 12 hours after the addition ofACTH
(lOOnM) (DiBartolomeis, 1984), (Jefcoate, 1987). The reason for the discrepancy
could be the could be the presence of 10% fetal bovine serum in the medium and the
higher concentration ofACTH used in these two studies by Jefcoate et al. The
conclusion drawn by Jefcoate and colleagues for the decline in steroid output was a
decrease in the amount of cholesterol availability to the mitochondria. On
determining the cholesterol accumulation in BAC cell mitochondria, they found a
peak accumulation (60%) was reached by 2 hour, followed by a dramatic decline in
mitochondrial cholesterol, reaching untreated levels by 12 hours (DiBartolomeis,
1984). This was mirrored by an increase in cholesterol side-chain cleavage activity
at 2 hours, followed by a decline in activity (Jefcoate, 1987). However, a study by
Rainey et al showed BAC cells treated with ACTH for successive 12 hours could
produce Cortisol over a 72 hour period when maintained in lipoprotein-ffee medium.
The cholesterol necessary as substrate was found to arise from de novo synthesis
within the cell. ACTH was found to increase 3-hydroxy-3-methylglutaryl coenzyme
A (HMG-CoA) reductase activity within 12 hours of addition to the medium.
(Rainey, 1985). The cholesterol content of the BAC cells used in this thesis was not
measured. The lack of cholesterol availability is unlikely to be the reason for the
decline in Cortisol output as no decline in Cortisol secretion was seen with forskolin
or 8 Br-cAMP.
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To exclude cell detachment as a cause of the decline in Cortisol synthesis, the
protein content of the wells was measured over the time-course of the experiment.
The protein content was found to be constant over the 12 hour time course and
cannot explain the plateau in the Cortisol response (figure 3.5).
In an attempt to explain the plateau in Cortisol production, the hypothesis that
Cortisol was either being converted to its inert metabolite, cortisone, or the
accumulation of another steroid was investigated. Cortisol is converted to cortisone
by the action of 11 P-hydroxysteroid dehydrogenase (11 p-HSD) in humans
(Mazzocchi, 1998). 11 P-HSD type 2 (llpHSD2), is an NAD-dependant
unidirectional enzyme with high affinity for glucocorticoids (Funder, 1996).
Recently the 11 p-HSD2 cDNA was cloned in the bovine adrenal, showing a 67%
homology with the human cDNA (Romero, 2000). HPLC was used to study UV-
absorbing steroids secreted into the medium bathing the BAC cells. The data
obtained reveal that over the 12 hour time period ACTHj.^-treated BAC cells
produce four principal steroids, Cortisol, corticosterone, cortisone and
11 P-hydroxyandrostenedione. Cortisol and corticosterone were produced in equal
amounts for the first two hours after ACTH,_24 addition, thereafter the levels of
corticosterone decline and the levels of Cortisol continue to increase up to 6 hours
where a plateau of output is reached. The decline in corticosterone coincided with
the detection of 11 P-hydroxyandrostenedione in the medium overlying the BAC
cells, which may reflect an increase in CYP17 activity. The CYP17 mRNA has been
shown to increase in as little as 2 hours after ACTH treatment ofBAC cells, with
concentrations increasing 20-fold by 8 hours (Zuber, 1986). Cortisone was
detectable in the medium after 6 hours of ACTH,.24-treatment, around the time when
a fall in the levels of Cortisol output was observed. Nevertheless the levels of
cortisone remaining constant over the following 6 hours. This suggests that some
Cortisol is converted to cortisone but not in sufficient quantities to explain the
decline in the rate of Cortisol synthesis. Other studies have also shown that BAC
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(DiBartolomeis, 1984), (Rainey, 1985). The results presented in this thesis and those

























Figure 3.16 Pathway of steroid production in cultured BAC cells. The
metabolism of cholesterol to the four main steroids (bold) in BAC cell culture.
The next step was to determine if the decrease in ACTHi_24-treated BAC cells was
dose-dependent. BAC cells were treated with three concentrations of ACTH|_24,
0.01, 1, and lOOnM. The output in Cortisol with these doses of ACTH,.24 was found
to produce a similar pattern to that seen with lOnM ACTH]_24. The plateau in
Cortisol production being reached earlier with the lowest concentration (0.0 InM) of
ACTH1.24 and being less marked with the higher concentration (lOOnM). Thus
suggesting that the ability of BAC cells to maintain Cortisol output in response to
ACTH, -24 may be dose-dependent and that some factor is affecting the response at
the lower concentrations.
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ACTH,.24 (Synacthen) is a synthetic hormone derivative containing full corticotropic
activity used in place ofACTH for diagnosis and treatment. It is also used in the
majority of steroidogenesis studies utilising cell culture as a model. To ascertain if
the observed pattern in Cortisol response was due to some artefact ofACTH,_24, the
full length peptide, ACTH,_3g was used to treat BAC cells. ACTH1.39 produced a
comparable response to that found with ACTH,_24 with an increase in the Cortisol
output up to 4-6 hours followed by a plateau in the production ofCortisol thereafter.
This indicates that ACTH,.24 gives rise to a true representation of the steroidogenic
response, thus the use ofACTH^ was valid in these circumstances.
In order to determine if the plateau in Cortisol output was restricted to ACTH action,
the response ofBAC cells to other agonists, forskolin, 8-Br-cAMP and Angll, was
investigated. Both forskolin and 8 Br-cAMP utilise the cAMP second messenger
pathway and Angll works via the phospholipase C pathway. If the reason for the
plateau in Cortisol production was related to the second messenger system then a
corresponding decrease in the Cortisol produced in forskolin- and 8 Br-cAMP -
treated cells would be expected. Neither forskolin nor 8 Br-cAMP displayed a
plateau in Cortisol output over the 12 hour time period of the experiment. Angll on
the other hand, showed a similar pattern to that found with ACTH, with a plateau in
Cortisol output being reached by around 6 hours. Thus, it appears that the plateau in
Cortisol production is not unique to ACTH-treatment and is not restricted to agonists
acting via the cAMP second messenger pathway.
The results presented in this chapter have illustrated that the response ofBAC cells
to ACTH-treatment was maximal on day 3 of culture and this was in accordance
with other studies (Williams, 1989). BAC cells respond to ACTH-treatment by
secreting increasing amounts of Cortisol into the medium bathing the cells over the
initial 4-6 hours. Thereafter, the further synthesis ofCortisol was not detectable. This
decline in synthesis was not explained by the production of other steroids, as
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Cortisol remained the major steroids secreted over the 12 hour time course of the
experiment. Treatment by forskolin and 8 Br-cAMP did not have the same effect on
the production ofCortisol, whereas Angll did. The action of forskolin and
8Br-cAMP are not mediated through receptors on the cell membranes. Therefore
one possible explanation could be receptor desensitisation, as the actions ofboth
ACTH and Angll are mediated via cell surface receptors (Raikhinstein, 1994),
(Penhoat, 1995). As ACTH is the principal trophic hormone to stimulate the
adrenocortical cells, the study ofAngll was not taken further. Receptor
desensitisation may be a result of growing BAC cells in primary culture. Primary
culture is an artificial environment in which to grow cells and the responsiveness of
the cells may be modified as a result. Further investigation of some aspects of the
cell culture system would therefore be merited.
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CHAPTER 4 : INVESTIGATION OF ACTH RECEPTOR
DESENSITISATION AND SOME ASPECTS OF THE
CELL CULTURE SYSTEM WHICH MAY EFFECT THE
STEROIDOGENIC RESPONSE BY BAC CELLS
4.1 Introduction
The ACTH receptor was one of the earliest receptors to be recognised when Haynes
(1958) described the action of ACTH in generating cAMP in adrenal cells (Haynes,
1958). The cloning of the human ACTH receptor has allowed the definition of a new
subfamily ofG protein-coupled receptors, the melanocortin receptor family, of which
there are five members, MC1-5R (Mountjoy, 1992). The MC2-receptor (MC2-R)
preferentially binds ACTH and is expressed in the adrenal cortex. Thus it is
considered to be the ACTH receptor (Liakos, 1998). The deduced bovine ACTH
receptor sequence shows 81% homology to the human receptor (Raikhinstein, 1994).
Both the human and bovine sequences comprise 297 residues (MW 33258kDa) and
show seven hydrophobic transmembrane domains. Amino acids within the
membrane spanning domains are important for ligand recognition. ACTH binds
through amino acid residues 1-18, thereby initiating the chain of events that mediate
its function. Analysis of the bovine and human ACTH receptors revealed both
protein kinase A (PKA) and protein kinase C (PKC) phosphorylation motifs,
suggesting that the involvement ofPKA and PKC pathways in ACTH action may be
mediated in part by phosphorylation of the ACTH receptor (Raikhinstein, 1994).
The technique of cell culture allows cells to be maintained outside the body and
given the appropriate conditions cells will not only survive but multiply and even
express differentiated properties. However, cell culture systems do not provide the
complete three-dimensional structure, cell-cell interactions, blood supply,
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extracellular matrix and paracrine influences that the cells have in vivo. Primary cell
cultures comprise cells derived directly from a particular organ or tissue and as such
are generally considered to be more representative than cell lines in expressing
tissue-specific properties. However, the loss ofmorphological and biochemical
characteristics associated with the tissue of origin can occur during the process of
adaptation to tissue culture conditions. The extent of this dedifferentiation depends
on the cell type and its suitability to the culture conditions. An important factor is the
nutritional environment which will affect all physiological and metabolic events
occurring within the cells. Culture media contains various components present in
body fluids e.g. the correct balance of salts, vitamins, amino acids necessary for cell
functions and an energy source in the form of six carbon sugars, such as glucose, for
the growth of cells in primary culture. The requirement for an animal serum (fetal
calf, horse or a serum replacement mix) is necessary for growth factors, essential
hormones and attachment factors.
Primary cultures of adrenocortical cells have been invaluable in many studies of the
molecular biology, cell biology and physiology of steroidogenesis within the adrenal
cortex. In BAC cell culture care must be taken in order to minimise the degree of
contamination of cells from the zona glomerulosa and medulla which may affect the
outcome. Contamination with non-steroidogenic cells such as fibroblasts does not
usually occur in BAC cell culture. One advantage of using bovine adrenal glands
over human glands is the clear zonation found in the bovine, allowing the isolation of
the cortical cells at high purity. Careful dissection of the adrenal zones and
purification of the dispersed cells by density gradient centrifugation or column
filtration to remove debris (see 2.2.1) helps to minimise contamination (Hornsby,
1991).
A study by Hornsby et al illustrated that BAC cells could be maintained in culture
with a life span of about 60 generations (Hornsby, 1978). The morphology of the
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cells did not change greatly and the cells retained the ability to synthesise steroids in
response to ACTH-treatment over the time culture. BAC cells in continuous primary
culture have been shown to synthesise Cortisol initially as the major steroid. After 10
to 20 days of culture, Cortisol synthesis was no longer detected and could not be
stimulated by ACTH (Simonian, 1979). The levels of deoxycortisol and earlier
precursors increased, thus providing evidence that BAC cells lose the ability to 11 p-
hydroxylate steroids with time in culture.
The results presented in chapter 3 suggested that the plateau in Cortisol production
found in ACTH-treated BAC cells may be the result ofACTH receptor
desensitisation. A series of experiments were undertaken in this chapter to investigate
this possibility. Also investigated in this chapter was the stability of ACTH itself.
ACTH has a short plasma half-life (7-12 minutes) (Aron, 2000a), although the
synthetic ACTH (synacthen) is reported to be more stable.
Also investigated in this chapter was the effect of the cell culture medium on the
ability of the BAC cells to maintain a steroidogenic output.
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4.2 Results
4.2.1 Repeat ACTH.,.24 treatment of BAC cells.
An experiment was designed to verify that the cells were still responsive after 24
hours ACTH,^-treatment. One set ofBAC cells were incubated for 24 hours with
ACTH,_24 (lOnM), the other set were treated as normal, i.e. no ACTH,_24
pre-incubation. The following morning both sets of cells were washed twice with
EBSS and treated with ACTH,_24 (lOnM) for various times between 1 and 12 hours.
Figure 4.1 demonstrates that 24 hour ofACTH1.24-treatment had no effect on the
responsiveness of the cells to further ACTH treatment. The red bars represent the
primary response to ACTH,_24 (lOnM) treatment over the time period studied i.e.
cells which have had no ACTH pre-incubation. The green bars shows the secondary
response i.e. cells incubated overnight with ACTH,_24 (lOnM) and then subjected to
ACTH,_24 for the same times as the primary experiment. A significant increase in the
Cortisol response over untreated cells was seen under both conditions (P<0.05).
The amount of Cortisol secreted into the overlying medium was slightly higher in the
cells pre-treated with ACTHj_24 for 24 hours, though this was not found to be
significant at the early time points. However, BAC cells pre-incubated with
ACTH,_24for 24 hours displayed a significant increase in the amount of Cortisol
produced at both 8 and 12 hours ofACTHj.^-treatment compared with the cells that
were not pre-incubated with ACTH,_24 (P<0.05).
The timing of the Cortisol plateau was slightly later in the ACTH,_24 pre-incubated
cells. For the cells which where not pre-incubated with ACTH the plateau occured at
a Cortisol concentration of 1.5 ± 0.1nmol/106 cells, somewhere between 4 and 6 hrs
ACTH,.24 treatment. In contrast the cells pre-incubated with ACTHI.24 showed a
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plateau forming at 2.2 ± 0.1nmol/106 cells, which is between 6 and 8 hours of
ACTH,.24-treatment.
4.2.2 Effect of 12 hour ACTH1.24 treatments on BAC cells.
BAC cells were grown in 6-well plates as previously described and serum-deprived
overnight. The cells were washed twice with EBSS and the medium with or without
ACTH,_24 replaced. The medium was then changed every 12 hours, through 72 hours.
The medium sample at each time point was stored for Cortisol measurement, and the
cells removed from the culture plate with Triton X-100 for protein determination (see
methods, 2.2.5).
As can been seen from figure 4.2, BAC cells continued to respond to ACTH,.24 over
the 72 hour period of treatment. After each 12 hour replenishment there was a
significant amount of Cortisol generated by the BAC cells treated with ACTH,_24
compared with untreated cells, at each time point P<0.001. There was a significant
decrease in the amount of Cortisol produced between the 12 and 24 hour period,
3.9 ± 0.2 and 2.4 ± 0.3nmol/lxl06 cells at 12 and 24 hours respectively (PO.Ol).
Over the remaining 72 hours the Cortisol output increased again to roughly the 12
hour value, 3.4 ± 0.6nmol/lxl06 cells at 72 hours. This value was not significantly
different from that at 12 hours.
To verify that the cell number remained constant throughout the term of the
experiment the protein content of the tissue culture wells were measured at each time
point. Figure 4.2B confirms that there was no significant difference in the protein
content at any given time during the course of the experiment.
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Figure 4.1 Treatment and re-treatment with ACTH^ BAC cells were either
treated without ACTHi_24 (maroon bars) or with ACTH]^ (green bars) overnight
prior to treatment with ACTH^ for times indicated. Results are mean ± SD of three
independent experiments. *P<0.05, **P<0.01, ***P<0.001 comparing untreated with
treated for each condition at each time point. XP<0.05 comparing ACTH^
conditions at each time point studied. Insert shows untreated cell data in more detail.
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Figure 4.2 BAC cells treated with ACTH^ every 12 hours. BAC cells are
cultured for 2 days and serum-deprived overnight. The medium, with or without
ACTHj.24, overlying the cells was replenished every 12 hours. Results shown in
graph A are mean ± SD of four independent cell isolations. *** PO.OOl, comparing
untreated with treated conditions. Insert displays the untreated cells in more detail.
Graph B displays the attached cell protein concentration, of ACTHi_24-treated cells,
throughout the experiment.
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4.2.3 Medium Glucose concentration.
To ascertain whether Ham's F10 has an adequate glucose concentration (lg/1) to cope
with BAC cell steroidogenesis over the time period studied, DMEM/F12, a medium
containing a higher glucose concentration (3g/l) was used. One set ofBAC cells were
maintained in DMEM/F12 containing 10% CPSR1 for 2 days and serum-deprived
over-night in DMEM/F12 + 0.2% BSA, while the other set was maintained in Ham's
F10 as previously described. The following morning the cells were washed twice
with EBSS and then treated with ACTH,.24(10nM) in the appropriate medium, with
0.2% BSA added, for various times between 1 and 12 hours.
In response to ACTH^-treatment BAC cells grown in DMEM/F12 produced a
comparable response to that found in cells grown in Ham's F10 medium. The
ACTH,_24-treated cells produced a significant response when compared to the
untreated cells at each of the time points studied, P<0.05 at lhour and P<0.01 for the
remaining time points (figure 4.6). No significant difference was seen between the
two conditions at any of the time points. The untreated Cortisol values for cells
maintained in DMEM/F12 are shown as an insert, the Cortisol output by untreated
cells in both mediums was indistinguishable.
Cells grown in DMEM/F12 thus display the same pattern as cells grown in Ham's
F10 medium in that the Cortisol output increases over the initial 4 hours, reaching a
plateau around 6 hours of ACTH1_24-treatment. For cells maintained in both Ham's
F10 and DMEM/F12 the plateau in Cortisol output was found to occur at the same
time, around 8 hours.
The glucose content in Ham's F10 medium bathing BAC cells was monitored
throughout the time course. At 0 hours the glucose concentration in the Ham's F10
was 5.8mmol/l. The glucose concentrations at 6 hours in ACTH,.24-treated and
untreated cell medium was 5.6mmol/l (97% of amount at Oh), and again at 12 hours
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the glucose concentrations in the medium overlying both untreated and treated cells
was 5.55mmol/l (96 %) and 5.4mmol/l (93 %) respectively. This demonstrates that
the amount of glucose taken up into the cells as an energy source for steroidogenesis
was a small proportion of that present in the medium overlying the cells.
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Figure 4.3 ACTH1.24 (lOnM) treatment of BAC cells in DMEM/F12. BAC cells
were either maintained in DMEM/F12 (maroon bars) or Ham's F10 (yellow bars)
and treated with or without ACTH1.24 lOnM for the time indicated. The medium
overlying the cells was removed and assayed for Cortisol content. Results shown are
mean ± SD of three independent cell isolations. *P<0.05, **P<0.01 comparing
untreated with treated at each time point. Insert shows untreated cell data in more
detail.
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4.2.4 ACTH1_24 stability studies
To examine the stability of ACTHj.24 over the experimental time course, BAC cells
were cultured as previously described. The following morning the cells were treated
with various concentrations of ACTH,_24 which had either been prepared on the day
of the experiment or prepared the night before and incubated overnight at 37°C in
plastic 25ml universals.
A significant decrease in the levels of Cortisol secreted into the medium overlying the
cells was seen when 0.0InM ACTH,.24 was incubated overnight at 37°C compared
with ACTH,_24 prepared on the day of the experiment, (P<0.05). Likewise InM
ACTHj.24 produced a significant decrease in Cortisol output when incubated
overnight (P<0.05). Incubating the ACTH,_24 overnight at 37°C had no effect on 10
and lOOnM ACTH,_24, which produced a comparable response to that observed with
ACTHj.24 prepared on the day of the experiment (figure 4.4).
Figure 4.5 illustrates the effect an overnight incubation at 37°C had on forskolin
(lOpM) and its ability to stimulate Cortisol production in BAC cells. Like the higher
doses ofACTHj.,4, no difference was found between forskolin made fresh on the day
of the experiment and that incubated overnight.
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Figure 4.4 Effect of incubating ACTH^ overnight at 37°C on the Cortisol
response by BAC cells. BAC cells were treated with or without various
concentrations ofACTH1.24 prepared on the day of the experiment (red bars) or
incubated overnight at 37°C (green bars). Results are mean ± SD of three
independent cell isolations. *P<0.05 comparing the two ACTH,_24 conditions at each
time point. Inserts display untreated cell data in more detail.
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Figure 4.5 Effect of incubating forskolin (10p.M) overnight at 37°C on its ability
to invoke a Cortisol response by BAC cells. BAC cells were treated with forskolin
(lOjaM) prepared on the day of the experiment (maroon bars) or forskolin incubated
overnight at 37°C (green bars). Results are mean ± SD of three, independent cell
isolations.
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4.2.5 ACTh^.39 concentration in the culture medium
The next step was to measure the concentration ofACTH in the cell culture medium
to determine if the ACTH concentration remained constant over the time span of the
experiments. The measurement ofACTH was carried out by a two-site
immunometric assay, using antibodies directed against the 18-39 C-terminal
fragment and the 1-24 N-terminal fragment. Thus ensuring that only the intact
ACTHj^g molecule is detected (see section 2.2.4). Therefore ACTH,_39 was used in
these experiments. Three concentrations were incubated in tissue culture plates
overnight at 37°C. The ACTH,_39 concentrations in the medium before and after the
incubation were measured.
ACTH,.39 concentrations of 1, 10 and lOOnM were used and figure 4.6 shows that at
all the concentrations there was a decrease in the ACTH,_39 concentration measured.
After an overnight incubation at 37°C the concentration ofACTH^g in the medium
containing InM decreased by 90% to O.lnM, this value was obtained in both the
experiments. The lOnM ACTH,.39 sample decreased by 73% to 2.7nM (2.5/2.9nM in
the individual experiments), and the lOOnM sample decreased by 39% to 61nM
(54/68nM in the individual experiments).
To determine if the decrease in ACTH^ concentration was affected by the presence
ofBAC cells in the tissue culture plates, a second experiment was performed where
ACTH,.39 (lOnM) was incubated in tissue culture plates in the presence or absence of
BAC cells for 1,6, 12 and 24 hours (Figure 4.7). In the absence of BAC cells the
ACTHj.jg concentration in the medium was reduced by 60% within the first hour,
with a 77% reduction found at 6, 12 and 24 hours incubation. When compared with
the original concentration of lOnM at 0 h, these reductions were found to be
significant at each of the time points studied (P<0.05).
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The presence ofBAC cells in the culture plates impedes this dramatic decrease in the
ACTH,_39 concentration, with only a 3, 10, 17 and 27% reduction in concentration
observed after 1,6, 12 and 24 hours incubation respectively. No significant
difference was found between 0 hour and any of the time points studied.
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Figure 4.6 Concentration ofACTH^ in the medium overlying BAC cells.
Ham's F10 with 0.2% BSA containing ACTH^g was incubated overnight at 37°C in
tissue culture plates prior to ACTH^g measurement. Results are means of two
independent experiments, the yellow dots are the value for each of the experiments
(InM both values were 0.InM; lOnM values were 2.5 and 2.9; lOOnM values were
54 and 68).
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Figure 4.7. Concentration of ACTH^ in the medium with or without BAC cells
present. ACTHi.39(10nM) was incubated in tissue culture plates with or without
BAC cells present as indicated. The medium was removed and assayed for ACTH^g
content. Results are mean ± SD of three independent measurements. *P<0.05, **
P<0.01 comparing each time point with zero hour..
4.17
Investigation of ACTH receptor desensitisation and some Chapter 4
aspects of the cell culture system which may effect the
steroidogenic response by BAC cells.
4.2.6 Effects of conditioned medium
BAC cells were cultured as previously described. One set of cells (set A) were
treated with or without ACTH,_24 (lOnM) for 24 hours in Ham's F10 plus 0.2% BSA.
The second set of cells (set B) were serum-deprived overnight as previously
described. The following morning the medium from set A cells was removed and
transferred onto set B cells. Five experimental conditions were set up: 1) Normal
response 2) Control conditioned medium, 3) Control conditioned medium plus
ACTH,.24 (lOnM), 4) ACTH-conditioned medium, 5) ACTH,.24-conditioned medium
plus ACTH,_24 (lOnM) see below.
Set A cells Set B cells
medium transferred














to set B cells
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ACTH conditioned medium
medium transferred
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Figure 4.8 Set up for conditioned medium experiment.
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Figure 4.9A illustrates the normal response ofBAC cells treated with ACTH,_24 for
the times indicated. As previously reported there was an increase in the Cortisol
output when the cells are treated with ACTH,_24 compared with untreated cells at all
of the time points studied, P<0.05. With a plateau in the Cortisol output occurring at
around 6 hours.
Figure 4.9B illustrates the response by BAC cells incubated in control-conditioned
medium with or without ACTH^-treatment. ACTH1.24-treatment significantly
increased the amount ofCortisol secreted into the medium overlying the BAC cells
compared with untreated cells (P<0.05). The levels ofCortisol secreted into the
medium overlying the cells were higher than those obtained under normal conditions
and no plateau in Cortisol output was found when the data was analysed using the
nonlinear curve equation.
Figure 4.9C illustrates the response by BAC cells incubated in ACTH-conditioned
medium with or without ACTH]_24-treatment. Due to the 24 hour incubation with
ACTH,.24 prior to experimentation there was already an increased amount of Cortisol
in the medium, 7.2 ±0.1nmol/106 cells. When the ACTH,.24-conditioned medium was
placed on BAC cells there was no additional increase in the amount of Cortisol
secreted into the overlying medium. The addition of further ACTH,.24 to the
conditioned medium appeared to produced an increase in the amount of Cortisol
secreted by BAC cells into the surrounding medium; however this trend was found to
be statistically insignificant. The amount ofCortisol secreted into the medium
overlying the cells at 8 and 12 hour was 3.9 ± 0.2 and 4.5 ± 1.2nmol/106 cells
respectively, equivalent to the levels of Cortisol found under normal conditions at 4
and 6 hours.
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Figure 4.9 Effects of conditioned medium BAC cells were treated as A, normal; B,
with control conditioned medium or C, with ACTH).24-conditioned medium. The medium
was then removed at the times indicated and assayed for Cortisol. Results shown are mean ±
SD of three independent cell isolations. Inserts display untreated cell data in more detail.
P<0.05, **P<0.01 comparing ACTH^-treated with untreated cells at each time point
studied. The dotted line indicates the level ofCortisol present in the medium at Oh.
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Figure 4.10 displays the various steroids secreted into the medium overlying the cells
in figure 4.9C As previously determined four steroids are secreted into the medium,
Cortisol, corticosterone, 11 P-hydroxyandrostenedione and cortisone. The Cortisol
values obtained by HPLC were similar to those obtained by the RIA method,
9.0 ± 4.5nmol/106 cells compared with 8.1 ± 1.6nmol/106 cells for the RIA method at
1 hour and 13.6 ± 2.8nmol/106 cells compared with 14.5 ± 3.6nmol/106 cells for RIA,
at 12 hour treatment with ACTH1.24-conditioned medium plus ACTH1.24. As with the
RIA method, HPLC analysis showed no significant difference between ACTH,_24-
conditioned medium and those treated with ACTH^-conditioned medium plus
ACTH,_24 at any of the time points studied.
The amount of corticosterone in the medium after the 24 hour ACTH,_24-treatment
was 0.2 ±0.1nmol/106 cells. When this ACTH-conditioned medium was placed on
BAC cells the corticosterone content of the medium remained constant over the 12
hour period. When ACTH,.24 was added to the ACTH-conditioned medium the
amount of corticosterone secreted into the medium increased over the initial 4 hours,
declining thereafter. No significant difference was found between either treatment at
any of the time points.
The amount of cortisone and 11 P-hydroxyandrostenedione in the medium after the
24 hour ACTH^-treatment was 1.4 +0.3 and 0.5 ±0.1nmol/106 cells respectively.
The levels of both steroids in the medium remained fairly constant when the BAC
cells were incubated with ACTH,.24-conditioned medium. No significant difference
was observed in the cortisone or 11 P-hydroxyandrostenedione levels when further
ACTH,_24 was added to the conditioned medium at any of the time points studied.
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Figure 4.10 HPLC analysis of ACTH1.24-conditioned medium BAC cells were
treated with ACTH^-conditioned medium, with or without ACTH].24. The medium
was then removed at the times indicated and analysed by HPLC. Results shown are
mean ± SD of three independent cell isolations.
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4.3 Discussion
The hypothesis that the plateau seen in Cortisol production over the 12 hour
experimental time period was due to ACTH receptor desensitisation was
investigated. Using BAC cells Kramer et al observed a decline in the Cortisol output
with time. One suggestion for this decline was ACTH receptor down regulation (i.e.
a decrease in receptor number on the cell surface) (Kramer, 1983). To investigate the
continued responsiveness of the cells used in this thesis, BAC cells were treated for
24 hours with ACTH, followed by a second ACTH-treatment for the 12 hour
experimental period. The Cortisol output in response to this second ACTH-treatment
was comparable with the pattern observed in the initial experiments. Indeed the cells
pre-incubated with ACTH for 24 hours produced slightly higher levels of Cortisol
throughout the time course, which was significant at the later time points of 8 and 12
hours. Also the plateau in Cortisol output occurred later than in non pre-treated cells.
The reason for this improved Cortisol response with 24 hours ACTH pre-treatment
was most likely due to the up-regulation in the activity of the steroidogenic enzymes.
A study by Jefcoate et al concluded that the decline in Cortisol response, by BAC
cells, to ACTH treatment was not the result of a loss of sensitivity of the cells to
ACTH, as the 17a-hydroxylase activity increased rapidly between 12 and 24 hours
following ACTH addition (DiBartolomeis, 1984). Another study using cultured
bovine adrenal cells showed that ACTH was one of the few trophic hormones to have
a positive effect on its own receptor and that the binding ofACTH to cells was lower
on day 1 than on day 2 of culture, remaining fairly constant for a further 2 days. This
could be due to a slow recovery of membrane-bound receptors after cell isolation by
enzymatic digestion (Penhoat, 1989). ACTH increased ACTH-receptormRNA, in a
time- and dose-dependent manner, (Penhoat, 1994) and ACTH receptor number
(Penhoat, 1995).
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The continued responsiveness of the ACTH receptor was also demonstrated. BAC
cells were shown to respond to renewed ACTH treatment every 12 hours through 72
hours. The Cortisol output remained reasonably constant throughout the period of
study. These results indicate that in BAC cells the ACTH receptor does not become
desensitised but remains fully functional to long-term ACTH-treatment. The
conundrum concerning an adequate supply of cholesterol is also answered by these
results. For the cells to continue responding to ACTH-treatment for 72 hours there
must be sufficient cholesterol available to sustain steroidogenesis. Rainey et al
measured the total cholesterol content ofBAC cells under lipoprotein-deplete
conditions, treating the cells every 12 hours through 48 hours and found that the total
cholesterol content of the cells decreased by 20% after the first 12 hours of ACTH
treatment with no further decrease thereafter (Rainey, 1986).
This chapter also explored some aspects of the cell culture system. Primary culture is
a foreign environment for BAC cells, lacking the structural morphology and the
biochemical and nervous mechanisms pertaining to the adrenal. The removal from
such a controlled situation may be expected to have some affects on the functional
characteristics of the cells. Nevertheless, the cells respond to ACTH, by producing
Cortisol, suggesting that BAC cells in culture are largely representative of
adrenocortical cells in vivo.
A basic requirement for the well being of cells in culture is the availability of a range
of nutrients. There are various media used to culture BAC cells. Ham's F10 is the
medium used by this laboratory, though another medium of choice by a number of
researchers is DMEM/F12. Both media have a similar amino acid and vitamin
composition but DMEM/F12 contains 3g/l D-glucose, three time the amount found
in Ham's F10. To discover if the glucose concentration had any effect on the Cortisol
response, BAC cells were maintained in both media. The increase in glucose
concentration did not alter the trend in Cortisol output from BAC cells treated with
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ACTH,.24 over a 12 hour period. When the glucose concentration was measured in
the Ham's F10 medium overlying the cells it was found not to have decreased
significantly over the 12 hours. This implies that Ham's F10, as far as glucose
concentration is concerned, was an adequate medium for culturing BAC cells and did
not play a part in the decline in Cortisol output observed.
The stability of ACTH,_24 in the culture system was studied next. In order to resolve
this problem, ACTH1.24 was incubated, in tissue culture dishes, overnight at 37°C
prior to treatment on BAC cells. The response of ACTH,.24 (100 and lOnM) was
comparable to the response seen with freshly prepared ACTH,_24 at these
concentrations, indicating that there was no deterioration in ACTH stability. This
was not the case with lower doses ofACTH,_24. When ACTH,_24 at concentrations of
1 and 0.0InM were incubated overnight at 37°C prior to placing on the cells a
significant decrease in the Cortisol response was seen. These results suggest the
bioactivity of ACTH is affected when utilised in the cell culture system. ACTH in
the medium was measured to investigate what effect, if any, overnight incubation at
37°C was having on its concentration. Because the measurement ofACTH was
carried out using a 2-site immunometric assay (see 2.2.4), it was necessary to use
ACTH,.39 for these experiments. The concentration ofACTH,_39 was found to
decrease at all of the concentrations measured with the largest decrease seen with the
lower concentrations. This decrease in the ACTH,_39 concentration was less marked at
lOnM when BAC cells were present in the tissue culture plates. It is well known that
ACTH and other peptide hormones bind to plastic; however, no reference pertaining
to this phenomenon was found. The results in figure 4.12 support this hypothesis. In
the absence ofBAC cells there was a larger surface of plastic for the ACTH,_39 to
bind; however when cells were present the ACTH,.39 comes into contact with less
area of plastic and therefore binding was reduced.
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The binding ofACTH to the plastic of the tissue culture plates partly explains the
reason for the plateau in Cortisol output by BAC cells. The reduction in bioactivity of
ACTH at lOnM was less marked in the presence ofBAC cells.
An alternative explanation for the plateau in Cortisol output is that some factor(s) was
secreted into the cell culture medium preventing further steroidogenesis. This
element would be removed in vivo via the blood system; however, this would not be
possible within the BAC cell culture situation leading to the accumulation of this
factor(s) and the inhibition of further steroidogenesis. This theory was tested using
'conditioned medium' (section 4.2.6). BAC cells incubated with control-conditioned
medium plus ACTH-treatment displayed a significant increase in Cortisol output
compared with cell incubated in control-conditioned medium alone at each of the
time points studied. The levels of Cortisol produced by cells incubated with control-
conditioned medium, with or without ACTH-treatment, were found to be higher than
those obtained under normal conditions. An interesting observation in the control-
conditioned medium cells treated with ACTH was that no plateau in the Cortisol
output was observed. The presence of some factor secreted by BAC cells into the
control-conditioned medium appears to augment the ACTH-induced response.
After 24 hour ofACTH-treatment Cortisol, cortisone, corticosterone and
11 P-hydroxyandrostenedione were found in the medium overlying BAC cells. When
this medium is placed on cells which had not been treated with ACTH no further
synthesis of steroids was found. This suggests the presence of one or more factors in
the medium preventing further steroidogenesis or as previously shown, the
bioactivity ofACTH was reduced over the 24 hour incubation. Upon the addition of
a second ACTH-treatment there was a statistically insignificant trend for an increase
in Cortisol secretion over the time course. These data suggest the presence of a factor,
possibly Cortisol or another steroid, in the ACTH-conditioned medium which
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attenuate the steroidogenic response by BAC cells, but which may be degraded
overtime.
Glucocorticoids have a diverse array of actions which are mediated by the
glucocorticoid receptor (GR). Among the factors that alter the levels ofGR
expression, glucocorticoids themselves appear to be the most potent regulators and
have been shown to down-regulate the receptor in some cell lines (Burnstein, 1991),
(Burnstein, 1992). It is conceivable, that in BAC cells a local negative feedback loop
exists whereby excess Cortisol causes a down-regulation of GR expression and
thereby preventing further steroidogenesis.
In summary, the decline in Cortisol production was found not to be the result of
ACTH receptor desensitisation. The binding of ACTH to the plastic of the tissue
culture plates has been shown to be a problem, although this was reduced by the
presence of cells. The secretion of a some factor or factors into the medium overlying
the cells may have some effect on the steroidogenic ability of the cells, possibly
acting via the GR. The complex nature of cell culture medium and the components
secreted into it by the cells make this line of investigation difficult.
The results presented in this chapter have provided some possible explanations for
the plateau in Cortisol production found in ACTH-treated BAC cells. Further studies
to investigate the effect of ACTH on other aspects of steroidogenesis, such as StAR
protein, may help provide some answers.
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CHAPTER 5 : EXPRESSION OF STEROIDOGENIC
ACUTE REGULATORY (StAR) mRNA IN CULTURED
BAC CELLS.
5.1 Introduction :
The rate-limiting enzymatic step of steroidogenesis is the conversion of cholesterol
to pregnenolone by CYP11A which is situated on the inner mitochondrial
membrane. However, the acutely regulated step in steroid production is the transfer
of cholesterol from the outer mitochondrial membrane to the inner mitochondrial
membrane (as discussed in chapter 1). In rat adrenal this acute step was shown to
involve the production of a family of 28-to 30kDa proteins (Krueger, 1983). Using
techniques such as [35S] methionine/cysteine-labeling and 2-D gel electrophoresis it
was shown that bovine adrenal glomerulosa and fasciculata cells responded to
steroidogenic stimuli with the rapid appearance of a family of 28- to 30kDa proteins
similar to those described in the rat by Krueger (Elliott, 1993), (Hartigan, 1995). The
family consists of a phosphorylated form found in ACTH-treated cells and an
unphosphorylated form in untreated cells. The 30kDa protein, later named StAR
protein, is synthesised as a larger cytosolic precursor protein of approximately
37kDa. The 37kDa protein is targeted to the mitochondria where it is processed to its
mature 30kDa form (Epstein, 1991b), (Stocco, 1991), (Hartigan, 1995). The 37kDa
protein is rapidly processed proteolytically to the 30kDa protein, which accumulates
in the mitochondria of steroidogenic cells (Hartigan, 1995), (Stocco, 1991).
StAR protein was purified and the cDNA cloned and sequenced in mouse Leydig
tumor MA-10 cells. The bovine StAR cDNA was cloned from differential cDNA
expression studies of corpora lutea cells in the late stages of the estrous cycle. The
bovine cDNA sequence was found to be 84% homologous with the transcripts for the
human and the mouse steroidogenic acute regulatory protein (Hartung, 1995).
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Comparison of bovine tissue showed that the expression of StAR mRNA was
strongest in ovarian corpora lutea and adrenal. All other tissues studied including
heart, lung, pituitary and liver showed no detectable StAR mRNA expression.
Suiprisingly no StAR mRNA expression was found in the testis (Hartung, 1995),
which has been shown to express StAR mRNA in humans (Sugawara, 1995a). A
later study did show the expression of StAR mRNA in bovine fetal and adult testes
(Pilon, 1997), the reason for this discrepancy is unclear. Although StAR protein is
not expressed in human placenta it has been found in the placenta of cow (Pescador,
1996), (Pilon, 1997). Immunohistochemical staining has demonstrated the presence
of StAR protein in the zona glomerulosa, fasciculata and reticularis of the bovine
adrenal (Lo, 1998).
Analysis of the StAR mRNA in the bovine adrenal reveals that there are two specific
transcripts, 3.0 and 1.8 kilobases (kb) (although a minor transcript at 1,6kb is
sometimes seen) (Hartung, 1995). Studies on other species have shown three
transcripts in the mouse (Clark, 1995b); human (Sugawara, 1995a); rat (Lee, 1997)
and pig (Pescador, 1997) and one transcript in sheep (Juengel, 1995). The functional
significance of the different sizes of transcripts is as yet unknown; however, it is
thought that the differences in length maybe due to differences in length of the
3' untranslated regions (Hartung, 1995).
It has been demonstrated that there is a close temporal relationship between steroid
biosynthesis and StAR mRNA and protein synthesis (Clark, 1995b). In mouse
Leydig tumor MA-10 cells StAR mRNA and protein have been shown to be induced
in close coordination via a cAMP-mediated mechanism, within a time frame
concomitant with the acute production of steroid hormones (Clark, 1995b). The
continued translation of StAR protein and steroidogenesis has been shown to be
dependent on the continued transcription of the StAR gene (Clark, 1997).
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The aims of this chapter were to establish the appropriate culture conditions with
which to study the expression of StAR mRNA in BAC cells. The results presented in
this thesis thus far have demonstrated that BAC cells show an enhanced
responsiveness to ACTH-treatment on day 3 of culture. The use of the culture
medium Ham's F10 and serum-free conditions were also shown to be appropriate for
the study of Cortisol secretion in BAC cells. To investigate whether the expression of
StAR mRNA by ACTH-treated BAC cells in culture paralleled the Cortisol response,
experiments similar to those performed for Cortisol production were carried out.
Once the culture conditions were established, the expression of the StAR transcripts
in response to ACTH and other agonists was studied.
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5.2 Results :
5.2.1 Expression of StAR mRNA in ACTH1.24-treated BAC cells with
time in culture.
BAC cells were treated with ACTH,^ (lOnM) on the day of isolation (day 0), and on
consecutive days in culture through day 4. The cells were cultured in 25cm2 tissue
culture flasks with 5x106 cells/flask. The cells on day 0 were treated in sterile 25ml
universals (5xl06 cells/universal). The cells were maintained in Ham's F10
containing 10% CPSR1 throughout the experiment, see 3.2.1 for more details on
experimental protocol. On each day the cells were treated with or without ACTH,_24
(lOnM) for 6 or 24 hours. The time points were chosen as the literature available at
the time showed the expression of StAR mRNA in the MA-10 mouse Leydig tumor
cell line was maximal at 6 hours of dbcAMP-treatment followed by a decline in
levels (Clark, 1995).
The quantification data for StAR mRNA is presented in three ways; 1) StAR mRNA
levels as quantified by the phosphoimaging system, the results are the sum ofboth
the 3.0 and 1.8kb transcripts. This was to take into account any variability between
the two transcripts. 2) The StAR mRNA levels corrected for actin, statistics were
performed on the actin corrected graph only. Actin was used to ensure equal loading
of the RNA onto the agarose gel. Therefore, any change in the StAR transcript levels
was due to the treatment of the cells and not unequal amounts of RNA loaded onto
the gel. 3) Inserts show the appropriate data relative to the untreated levels. This
takes into account any variability in the untreated levels over the experimental time
course.
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Figure 5.1 displays the northern hybridisation of StAR mRNA expression by BAC
cells. Consistent with other studies, two StAR transcripts were found, 3.0 and 1.8kb.
The expression of StAR mRNA, at both the 6 and 24 hour time points, was found to
be highest on the day of isolation (day 0). The expression of the StAR transcripts
was raised in both the untreated and the ACTH^-treated cells on day 0. On day 1 of
culture the expression of the StAR transcripts had fallen. The expression of the
transcripts in the untreated cells was undetected and an induction of the StAR
transcripts in response to ACTH^-treatment was observed at 6 and 24 hours. A
similar pattern was found on day 2 of culture. The StAR mRNA expression by BAC
cells in response to ACTHj.^-treatment for 6 hours was found to be maximal on day
3 of culture. However, the expression of the StAR transcripts, in response to
ACTH,_24-treatment, had fallen to untreated levels by 24 hours on day 3. A similar
pattern was seen on day 4.
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Figure 5.1 Representative northern hybridisation of StAR mRNA expression in
BAC cells treated on separate days of culture. BAC cells were treated with or
without ACTHj.24 as indicated. RNA was extracted from the cells and subjected to
northern hybridisation using a bovine StAR cDNA probe. Two transcripts were
found; 3.0 and 1.8 kb. The membrane was stripped and reprobed for p-actin to
ensure equal loading ofRNA.
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Figure 5.2 displays the quantified levels of the two StAR transcripts. Due to the high
levels of StAR mRNA found on day 0 were there was no significant difference in the
StAR mRNA levels between the untreated cells and the ACTH,_24-treated cells at
either of the time points studied. On each of the other days in culture a significant
increase in the amount of StAR transcript levels in ACTH,.24-treated cells compared
with untreated cells at 6 hours was seen (P<0.05). No significant difference was seen
between untreated and ACTH,_24-treated cells at 24 hours on any of the days studied.
The levels of the StAR transcript was found to be significantly lower, for both
untreated and ACTH^-treated cells, on days 1 and 2 compared with day 0 (P<0.05).
The expression of StAR mRNA in ACTH,.24-treated BAC cells on day 3 is
significantly greater than that found on day 1 (P<0.05). Day 3 of culture also
displays a 9-fold increase in StAR mRNA expression at 6 hours by ACTH,_24-treated
BAC cells when compared with untreated cells, P<0.05. However there is no
significant difference between untreated and treated values at 24 hours. Again on day
4 the trend was for the 6 hour ACTH,_24-treated BAC cells to be increased over
untreated cells, 3-fold increase (P<0.05), with no significant difference found
between the two conditions at 24 hours ACTH,_24-treatment.
It would appear from the northern analysis that the levels of StAR transcripts
decreased at 24 hours on each of the day studied. The quantification of the StAR
transcripts showed that this decrease was found to be significant on day 0 only
(P<0.05). The data normalised to the untreated values (inserts) show significantly
higher values at 6 hour treatments compared with 24 hours on day 1, 2 and 3
(PO.05).
These results indicate that day 3 of culture was the optimum time to study StAR
mRNA expression in BAC cells. This is in keeping with the Cortisol data presented
in chapter 3 and further experiments to study the expression of StAR mRNA were
carried out on day 3.
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Figure 5.2 Quantification of northern hybridisation showing StAR mRNA expression
in BAC cells treated on separate days of culture. A, sum of the two StAR transcripts
shown in figure 5.1; B, days 1 through 4 and C, the sum of the two StAR transcripts
corrected for actin. Mean ± SD from three independent cell isolations. Inserts shown values
normalised to untreated cells. *P<0.05 comparing untreated and ACTHi.24-treated. +P<0.05
comparing 6 and 24 hour ACTH^-treated cells on each of the days studied.
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5.2.2 Effects of serum on StAR mRNA expression
BAC cells were cultured for 2 days in 25cm2 flasks. One set of cells was serum-
deprived overnight in Ham's F10 with 0.2% BSA, the other set of cells remained in
the serum-containing medium. The following day the cells were treated with ACTH,_
24 (lOnM) for various times up to 24 hours.
The results indicate that StAR mRNA expression is not affected by the absence of
serum (figure 5.3), akin to the Cortisol data presented in chapter 3. From the northern
hybridisation the expression of StAR mRNA by BAC cells, in response to ACTH,.24-
treatment, appears to be similar in both serum-free and serum-containing media.
When comparing the data obtained from the phosphoimaging system, the values for
the serum-free group of cells were slightly higher than those of the serum-replete;
however, no significant difference was found between the two conditions at any of
the time points studied. Untreated samples were analysed only at 6 hours; therefore
comparisons between untreated and ACTH,_24-treated were not possible except at 6
hours. In light of these results further experiments were carried out in serum-free
medium.
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Figure 5.3 Effects of serum on StAR mRNA expression in BAC cells. BAC cells
were treated with or without ACTHi_24 (lOnM), in the presence or absence of serum, as
indicated, untreated (UT) sample at 6 hours only. RNA was extracted from the cells and
subjected to northern hybridisation using a bovine StAR cDNA probe. A, representative
northern showing the two StAR transcripts at 3.0 and 1.8 kb. The membrane was stripped
and reprobed for P-actin. B, quantification (sum of the two transcripts) ofnorthern
hybridisation and C, the sum of the two StAR transcripts corrected for actin. Both graphs are
mean ± SD from three independent cell isolations.
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5.2.3 Effect of various doses of ACTH1.24 on the StAR mRNA
expression produced by BAC cells
Figure 5.4A displays a representative northern hybridisations of StAR mRNA from
BAC cells treated with ACTH,.24 over the concentration range, O.OlpM-lOnM, for 6
hours. The expression of the StAR transcripts (1.8 and 3.0kb) were increased over
untreated cells, at the three highest concentrations ofACTH,_24 O.lnM, InM, and
lOnM. There did not appear to be a difference in the intensities of the bands at the
two lower concentrations, 0.0lpM and lpM, when compared with the untreated
bands.
Figure 5.4B&C displays the quantified data. No significant difference was found
between the levels of the StAR transcript in untreated cells and those treated with
ACTH,_24 at O.OlpM and lpM. A 2-fold increase compared with untreated cells was
found at both 0.1 and InM ACTH,_24 and a 3-fold increase over untreated was seen
with lOnM ACTH,_24. A significant difference in treated and untreated values was
found at each of these concentrations, (P<0.01).
The Cortisol response by BAC cells treated with various concentrations of ACTH,_24
is displayed in figure 5.5. As with the StAR transcripts levels there is no significant
increase in the Cortisol output with O.OlpM ACTHj_24; however, there was a
significant increase in the amount ofCortisol secreted into the overlying medium
with lpM ACTH,_24. Again in parallel with the StAR mRNA data, there was a
significant increase in the Cortisol secreted into the medium overlying the cells at
0.1, 1, and lOnM ACTH,.24.
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Figure 5.4 StAR mRNA levels in response to increasing doses of ACTH^.
BAC cells were treated with or without various doses ofACTH(.24 as indicated for
6hours. RNA was extracted from the cells and subjected to northern hybridisation
using a bovine StAR cDNA probe. A, representative northern showing the two StAR
transcripts, 3.0 and 1.8 kb. B, quantification of northern hybridisation shown is the
sum of the two transcripts and C, corrected for [3-actin. Both graphs are mean ± SD
from three independent cell isolations. The inserts display the data normalised to
untreated.
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Figure 5.5 Cortisol response to various doses of ACTH1.24. BAC cells were treated
with or without various doses ofACTH^ as indicated for 6hours. Results shown
are mean ± SD from three independent cell isolations. **P<0.01, ***P<0.001,
comparing ACTHl.24-treated with untreated cells.
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5.2.4 Expression of StAR mRNA in BAC cells in response to
ACTH1.24 at various times over a 12 hour period.
The following three figures (5.6-5.8) display the StAR mRNA expression in BAC
cells treated with 1,10 and lOOnM ACTH].24. The representative northern
hybridisations showed the two StAR transcripts, 3.0 and 1.8 kb, at all three
concentrations.
Figure 5.6 shows an induction in the expression of the StAR transcripts was found
after 1 hour of InM ACTH,_24-treatment. The expression of the StAR transcripts
increased over the initial time points, reaching a peak at between 4+6 hours and
decreasing to almost untreated levels by 12 hours. Quantification of the northern
confirmed these observations (figure 5.6B&C). BAC cells treated with InM
ACTH,_24 showed detectable StAR mRNA levels after 1 hour of treatment, which
was found to be significantly different from the levels of the StAR transcripts found
in untreated cells at 1 hour (P<0.01). There was also a significant increase in StAR
mRNA levels in ACTH,_24-treated cells compared with untreated cells at 2, 4 and 6
hours (P<0.05). StAR transcript levels increased over the time period, peaking at 4
hours ACTH ^-treatment, with a 8-fold increase compared with untreated cells
found, and decreasing thereafter to almost untreated levels at 12 hour.
Figure 5.7 displays the StAR transcript expression by BAC cells treated with lOnM
ACTH,_24. Again expression of the StAR transcripts were detected after 1 hour of
ACTH1.24-treatment, with an increase in expression found at 4, 6 and 8 hours of
ACTH,.24-treatment followed by a decline in the level of the transcripts at 12 hours.
The quantification data (figure 5.7B&C) illustrate a significant increase in the StAR
transcript levels of lOnM ACTH,.24-treated BAC cells at 1, 2, 4 and 6 hours
(P<0.05). The levels of the StAR transcripts increased with time, peaking at 6 hours
followed by a fall in levels at 12 hours.
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The expression of the StAR transcripts by BAC cells in response to lOOnM
ACTH,_24 is shown in figure 5.8. The levels of the transcripts were again detected
after 1 hour of treatment, with a peak around 6 hours and a subsequent decrease in
expression. Quantification of the northern hybridisation showed an increase in StAR
transcript levels at all of the time points studied, with a significant increase compared
with untreated cells found at 1, 2, 6, and 8 hours (P<0.05) (figure 5.8C). The peak in
StAR transcripts was again found at 6 hours ofACTH,_24-treatment with a 21-fold
increase over untreated levels found, the levels declining thereafter.
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Figure 5.6. StAR mRNA expression in BAC cells treated with ACTH1.24 (lnM).
BAC cells were treated with or without ACTH^24 for the times indicated. RNA was
extracted from the cells and subjected to northern hybridisation using a bovine StAR cDNA
probe. A: representative northern showing the two StAR transcripts 3.0 and 1.8kb. the
membrane was stripped and reprobed for P-actin. B: quantification of northern hybridisation
shown is the sum of the two StAR transcripts and C: corrected for P-actin. Both graphs are
mean ± SD from three independent cell isolations. Inserts show ACTH^-treated levels
normalised to untreated levels. *P<0.05 comparing untreated and ACTH^-treated levels.
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Figure 5.7. StAR mRNA expression in BAC cells treated with ACTH^ (lOnM).
BAC cells were treated with or without ACTH,_24 for the times indicated. RNA was extracted
from the cells and subjected to northern hybridisation using a bovine StAR cDNA probe. A:
representative northern showing the two StAR transcripts, 3.0 and 1.8kb. The membrane was
stripped and reprobed for P-actin. B: quantification of northern hybridisation shown is the
sum of the two StAR transcripts and C: corrected for P-actin. Both graphs are mean ± SD
from three independent cell isolations. Inserts show ACTH^-treated levels normalised to
untreated levels. *P<0.05 comparing untreated with ACTHi^-treated levels.
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Figure 5.8. StAR mRNA expression in BAC cells treated with ACTHi.24
(lOOnM). BAC cells were treated with or without ACTH].24 for the times indicated. RNA
was extracted from the cells and subjected to northern hybridisation using a bovine StAR
cDNA probe. A: representative northern showing the two StAR transcripts, 3.0 and 1.8kb.
The membrane was stripped and reprobed for P-actin. B: quantification of northern
hybridisation shown is the sum of the two StAR transcripts and C: corrected for P-actin.
Both graphs are mean ± SD from three independent cell isolations. Inserts show ACTH1.24-
treated levels normalised to untreated levels. *P<0.05 comparing untreated ands ACTH^-
treated levels.
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5.2.5 Effect of ACTH^g on StAR mRNA expression
The StAR transcript expression by BAC cells treated with lOnM ACTHI 39 (figure
5.9) is comparable to that found with lOnM ACTH,.24 (figure 5.7). The northern
hybridisation displayed in the figure 5.9A shows a comparable pattern of expression
of the two transcripts, 3.0 and 1.8kb, as found with lOnM ACTH,_24. Quantification
of the northern (figure 5.9B+C) showed an increase in the StAR mRNA levels at
most of the time points studied. A peak in the StAR transcript levels was found at 4
hours, thereafter the levels of the StAR mRNA decreased to almost untreated levels
by 12 hours of ACTfQjg-treatment. This was reflected in the StAR levels when
presented relative to the control values (inserts). At 6 hours ACTH,_39-treatment BAC
cells gave raise to a 6-fold increase compared with untreated cells. As this result was
in agreement with the response found with ACTH,_24-treated BAC cells and the
Cortisol response in these cells (figure 3.11), the experiment was performed only
once.
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Figure 5.9. StAR mRNA expression in BAC cells treated with ACTH^ (lOnM).
BAC cells were treated with or without ACTH1.39 for the times indicated. RNA was extracted
from the cells and subjected to northern hybridisation using a bovine StAR cDNA probe. A:
representative northern showing the two StAR transcripts, 3.0 and 1.8kb. The membrane was
stripped and reprobed for P-actin. B: quantification ofnorthern hybridisation shown is the
sum of the two StAR transcripts and C: corrected for P-actin. Both graphs are from one cell
isolation. Inserts show ACTHi.39-treated levels normalised to untreated levels.
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5.2.6 StAR mRNA expression in BAC cells cultured in DMEM/F12
BAC cells maintained in DMEM/F12 were shown to produce an equivalent Cortisol
response to lOnM ACTH ^-treatment to those maintained in Ham's F10, the
medium of choice for the work carried out in this thesis (figure 4.3). To ascertain if
the StAR mRNA expression was similar under both conditions BAC cells were
maintained in DMEM/F12 as described in 4.2.3.
The results presented in figure 5.1 OA demonstrates that the StAR mRNA expression
by BAC cells in response to lOnM ACTH,_24- treatment was similar to that produced
by cells maintained in Ham's F10. StAR mRNA (figure 5.7). Correspondingly, StAR
transcripts were detected after 1 hour of ACTH,.24- treatment, with a peak in
expression around 6 hours, followed by a decrease in the levels by 12 hours. An
increase in the levels was found at each of the time points when the northern was
quantified by the BioRad phosphoimaging system. After 6 hours of ACTH,_24-
treatment a 3-fold increase in the StAR transcript levels was found compared with
untreated cells (inserts). As this result was in agreement with the response found
with ACTH1_24-treated BAC cells and the Cortisol response in these cells (figure
3.11), the experiment was performed only once.
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Figure 5.10. StAR mRNA expression in BAC cells maintained in DMEM/F12
BAC cells were treated with or without lOnM ACTH1.24 for the times indicated. RNA was
extracted from the cells and subjected to northern hybridisation using a bovine StAR cDNA
probe. A: representative northern showing the two StAR transcripts, 3.0 and 1.8kb. The
membrane was stripped and reprobed for |3-actin. B: quantification of northern hybridisation
shown is the sum of the two StAR transcripts and C: corrected for |3-actin. Both graphs are
from one independent cell isolation. Inserts show ACTHi.24-treated levels normalised to
untreated levels.
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5.2.7 StAR transcript expression in BAC cells treated with
forskolin, 8Br-cAMP and Angll
The northern hybridisation ofBAC cells treated with forskolin (lOpM) showed that
StAR mRNA was detected in the cells after 1 hour. There was a slight increase in the
StAR transcript expression up to around 6 hours, followed by a slight decrease in
expression through 12 hours (figure 5.11). The quantification of the northerns
showed a significant increase in the amount of StAR expression in the forskolin-
treated cells at 1, 2, 4, 6 and 8 hours compared with the untreated cells (P<0.05),
there was no significant difference found at 12 hours. The peak in StAR transcript in
forskolin-treated BAC cells occurred around 6 hours.
Figure 5.12 displays the expression of StAR mRNA in BAC cells treated with
8Br-cAMP (lOOpM). The northern hybridisation shows the presence of StAR
mRNA in the cells after 1 hour of treatment. The expression of the StAR transcripts
remained constant over the course of the experiment. When the data was quantified
the levels of the StAR transcripts were found to be significantly increased above
untreated levels at 4 hours only. When the data was normalised to the untreated cells
(inserts) a constant level of StAR mRNA expression over the 12 hour time course
was seen.
The StAR mRNA expression in BAC cells treated with Angll (lOnM) is shown in
figure 5.13. StAR mRNA is detected in the cells after 1 hour ofAngll treatment.
There was a significant increase in the StAR transcript levels in Angll-treated cells
compared with untreated cells at 1, 2 and 4 hours (P<0.05). The peak in StAR
transcript levels occurs at 4 hours ofAngll treatment with a fall to untreated levels
by 12 hours.
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Figure 5.11. StAR mRNA expression in BAC cells treated with forskolin (lO^tM)
The cells were treated with or without forskolin for the times indicated. RNA was extracted
from the cells and subjected to northern hybridisation using a bovine StAR cDNA probe.
25|_ig total RNA/lane. A: representative northern analysis showing the 3.0 and 1.8 kb bands.
B: quantification ofnorthern hybridisations, shown is the sum of the two transcripts C:
corrected for P-actin. Results are mean ± SD from three independent cell isolations. Inserts
show valuse normalised to untreated. *P<0.05 comparing untreated and forskolin-treated
levels.
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Figure 5.12. StAR mRNA expression in BAC cells treated with 8Br-cAMP
(lOOfrM). BAC cells were treated with or without 8Br-cAMP for the times indicated.
RNA was extracted from the cells and subjected to northern hybridisation using a
bovine StAR cDNA probe. 25jag total RNA/lane. A: representative northern analysis
showing the 3.0 and 1.8 kb bands. B: quantification of northern hybridisations,
shown is the sum of the two transcripts and C: corrected for actin. Results are mean
± SD from three independent cell isolations. Inserts show values normalised to
untreated. *P<0.05 comparing treated with untreated cells.
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Figure 5.13. StAR mRNA expression in BAC ceils treated with Angll (lOnM).
BAC cells were treated with or without Angll for the times indicated. RNA was extracted
from the cells and subjected to northern hybridisation. A, representative northern analysis
showing the 3.0 and 1.8 kb bands. B: quantification of northern hybridisations, shown is the
sum of the two transcripts and C: corrected for actin. Results are mean ± SD from three
independent cell isolations. Inserts show values normalised to untreated. *P<0.05 comparing
untreated and Angll-treated cells.
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5.3 Discussion :
Northern hybridisation analysis of total BAC cells mRNA, using a [a32P]-labeled
cDNA probe encoding a 5'region of the bovine StAR mRNA (nucleotides 210-608)
revealed two principal hydridising species, 3.0 and 1.8 kb. This is consistent with
other studies using bovine corpora lutea (Pescador, 1996), (Hartung, 1995), bovine
adrenal glomerulosa cells (Brand, 1998), (Cherradi, 1998b) and bovine fasiculata
cells (Le Roy, 2000), (Ivell, 2000). The different transcript sizes found are due to
alternative polyadenylation sites found in the cDNA sequence (Hartung, 1995).
The results presented in chapter 3 concluded that the optimum conditions for the
study of Cortisol release from BAC cells in response to ACTH-treatment was 48
hours after culture, with the cells serum-deprived overnight prior to experimentation.
The results obtained in this chapter confirmed that these conditions were also
optimum for the study of StAR mRNA expression in BAC cells.
StAR mRNA was expressed at high levels in both untreated and ACTH-treated cells
when measured on day 0; however, the Cortisol levels were found to be low. One
explanation could be that the cells are in a state of stress due to the abattoir and the
isolation procedure, with the levels of StAR mRNA increasing to initiate
steroidogenesis to deal with these stresses. On the other hand the cells maybe
incapable of producing Cortisol due to the low number of lipid deposits present
within the cells and damage to the cells' ultrastructure integrity caused by the
isolation procedure (Williams, 1989). The StAR mRNA levels fall dramatically on
day 1 of culture, although an increase in the expression of StAR mRNA is seen with
6 hours of ACTH-treatment. Compatible with the data obtained on the Cortisol
output the optimum expression of StAR mRNA was on day 3 of culture. The
expression of StAR mRNA was found to decrease to almost untreated levels after 24
hours ofACTH-treatment on each of the days studied. A similar pattern of events
was found with StAR protein, high levels were found in freshly isolated cells which
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then decrease with time in culture. ACTH-treatment on days 1-4 in culture increased
StAR protein levels at 6 hours, however after prolonged (24h) ACTH-treatment
StAR protein levels returned to untreated levels (Nicol, 1998). In agreement with the
Cortisol data presented in chapter 3, there was no difference in the expression of the
StAR transcripts by BAC cells treated with or without serum present in the cell
culture medium. Similarly no difference was found in the StAR transcript expression
when cells were cultured in DMEM/F12 compared with Ham's F10.
ACTH-treatment produced an increase in StAR mRNA expression with levels
detected after 1 hour, reaching a maximum at around 4-6 hours and falling to near
untreated levels by 12 hours treatment. A similar pattern of StAR mRNA expression
was found with different concentrations ofACTH,_24 and the native ACTH,_39
peptide. From these results it appears that StAR mRNA levels in BAC cells are
acutely regulated in concert with ACTH-stimulated Cortisol secretion. This is
consistent with studies in MA-10 Leydig tumor cells, where a marked increase in
StAR mRNA was seen within 2 hours of dibutyryl-cAMP (dbcAMP)-treatment, with
peak levels observed at 4-6 hours and levels falling to almost untreated levels by 12
hours (Clark, 1995b).
StAR protein has been shown to be regulated through the cAMP messenger pathway
(Clark, 1995b). As mentioned above dbcAMP-treatment ofMA-10 cells showed a
similar pattern of StAR mRNA expression to that found in ACTH-treated BAC cells.
The progesterone production in the MA-10 cells was also found to reach a maximum
by 6 hours followed by decline in levels thereafter (Clark, 1995b). Treatment of
BAC cells with forskolin and 8Br-cAMP showed no plateau in Cortisol production
(figure 3.12, 3.13), the effect of forskolin and 8Br-cAMP on StAR mRNA
expression in BAC cells was therefore evaluated. StAR mRNA levels in BAC cells
increased in response to forskolin-treatment. As seen in figure 5.9 StAR mRNA
expression was detected at 1 hour, increasing to a maximum at around 6 hours, with
the levels decreasing slightly thereafter. Detectable upregulation of StAR mRNA
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was also seen within 1 hour of 8Br-cAMP treatment, thereafter the levels of StAR
mRNA remained constant over the 12 hour period. 8Br-cAMP was shown to
increase StAR protein levels significantly at 6 hours in BAC cells (Morley, 2000).
The cAMP analogues, dbcAMP, has been shown to stimulate StAR protein in
MA-10 cells (Huang, 1997) and in the human adrenocortical carcinoma cell line,
H259 (Clark, 1995a) in a time dependent manner.
Studies performed in this thesis have also examined the effects of alternate second
messenger pathways on StAR mRNA expression. The results presented in chapter 3
showed that Angll increased Cortisol production in BAC cells; this is consistent with
other studies (Clyne, 1993a), (Bird, 1989), (Walker, 1991b). Angll increased Cortisol
production over the initial 4 hours, with a plateau, similar to that seen with ACTH,
occurring at around 4 hours. In BAC cells the expression of StAR mRNA was found
to be upregulated within 1 hour of Angll-treatment, peaking at around 4 hours and
declining to almost untreated levels by 12 hours. Studies using H295 cells also
demonstrated an induction of StAR protein in response to Angll-treatment in a time-
dependent manner (Clark, 1995a). The data presented in this chapter suggest that
StAR expression is a common mechanism utilised by PKA and PKC second
messenger systems for the acute regulation of steroid biosynthesis.
In summary, the rate-limiting step in steroidogenesis is the delivery of cholesterol
into the mitochondria where it is converted to pregnenolone by CYP11A, which is
dependent on the hormonally-induced StAR protein (Clark, 1994). ACTH-treatment
ofBAC cells gave rise to an increase in StAR mRNA expression, which reached a
peak at around 4-6 hours followed by a decline in expression throughl2 hours. This
pattern of expression parallels the response seen in Cortisol production, which was
found to increase over the initial 4-6 hours ofACTH-treatment after which the
further synthesis in Cortisol was not detectable. The results presented in sections
4.2.1 and 4.2.2 have shown that the BAC cells are still responsive to ACTH-
treatment, therefore, the hypothesis of receptor desensitisation was ruled out. These
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data also demonstrated that the lack of cholesterol was unlikely to be the cause of the
decline in steroidogenesis. The question as to whether this second steroidogenic
response is also mediated via the transcription of StAR requires further investigation.
These data raise the question as to whether the decline in steroidogenesis is a result
of the decline in StAR transcription and if so, what causes this decline in StAR
transcription. One possibility is the presence of a local negative feedback inhibition
mechanism with in the BAC cell culture system. A study in by Morrow et al in 1967
suggested that steroids were capable of inhibiting adrenal steroid production by
inhibition of adrenal protein synthesis (Morrow, 1967). Therefore the possibility that
Cortisol, or one of the other steroids produced by BAC cells, has an inhibitory effect
on StAR transcription was intriguing.
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CHAPTER 6 : FURTHER CHARACTERISATION OF
StAR mRNA EXPRESSION IN BAC CELLS.
6.1 Introduction
Cortisol is produced by the adrenal cortex under the regulatory influence ofACTH.
The latter is produced by corticotrophins of the anterior pituitary, in turn, under the
regulatory influence of hypothalamic CRH (see chapter 1.2). The hypothalamic-
pituitary-adrenal (HPA) axis is kept in balance by the negative feedback effects of
Cortisol on the secretion of ACTH and CRH. ACTH was one of the first hormones
found to stimulate steroidogenesis through a specific cell surface receptor via the
cAMP second messenger pathway (Lefkowitz, 1970). In adrenal cells, the ACTH
receptor exhibits a highly specific affinity for ACTH and l25I-ACTH was not
displaced by other melanocortins such as aMSH or (3MSH. Contrary to most of the
peptide hormone receptors, which are desensitised by their own ligand, the ACTH
receptor is positively regulated by ACTH (Penhoat, 1994). Moreover, studies have
shown that ACTH can regulate Angll receptors in the zona glomerulosa (Andoka,
1984), and that Angll can influence the ACTH receptor in zona fasiculata/reticularis
cells (Le Roy, 2000), (Penhoat, 1995).
Most known effects of glucocorticoids are mediated by a ~94kDa intracellular
protein, the GR (see chapter 1 section 1.4.5). Some studies have indicated that
glucocorticoids may directly affect the function of the adrenal gland. A direct
inhibitory effect of glucocorticoids on its own synthesis at the adrenal level has been
suggested by several researchers (Peron, 1960), (Salmenperae, 1976). An inhibitory
effect of corticosterone on steroidogenesis in the mouse adrenal tumor cell line Y-l
has also been demonstrated. Steroids which do not possess glucocorticoid action did
not inhibit steroidogenesis. (Saito, 1979). The binding of Synacthen (ACTH,_24) to
partially purified bovine adrenocortical plasma membrane receptors was found to be
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inhibited by Cortisol, but not its immediate precursor 11-deoxycortisol. Suggesting
that Cortisol may regulate its own synthesis by inhibiting binding of ACTH to
adrenocortical cells (Latner, 1977).
A number of drugs can be used in the suppression ofACTH-induced steroidogenesis
by interfering with one or more of the enzymatic steps. These compounds are useful
in the characterisation of the processes involved in steroidogenesis and in therapy of
glucocorticoid excess. Ketoconazole and etomidate are members of a class of
imidazole-derived antifungal drugs, which in the early 1980s were found to have
antisteroidogenic actions in humans (Orth, 1992). The effects of these compounds
were first noticed in human testosterone production because the men taking the drug
developed gynaecomastia. Ketoconazole acts in the adrenal by primarily inhibiting
CYP11B1, it can also inhibit CYP11A (Orth, 1992) and CYP17 (Englelhardt, 1991).
Etomidate also inhibits CYP11B1, but at higher doses can also inhibit CPY11A.
Trilostane is an inhibitor of 3P-HSD, but has no effect on lip, 17a or 21-
hydroxylation, and is used in the treatment of breast cancer (Orth, 1992).
The regulation of StAR expression by trophic hormones and other steroidogenic
agents has been extensively studied. In virtually every system studied, agents that
caused an increase in steroid biosynthesis also increase the expression of the StAR
protein. Thus steroid production and StAR expression has been found to be
up-regulated by ACTH (Nishikawa, 1996), (Nicol, 1998); CRH (Huang, 1997);
cAMP analogs (Clark, 1995a), (Huang, 1997), (Balasubramanian, 1997) and Angll
(Clark, 1995a). The StAR gene is also subject to negative regulation and studies have
shown that compounds such as diethylumbelliferyl (Choi, 1995), transforming
growth factor-P, (Brand, 1998), atrial natriuretic peptide (Cherradi, 1998b), tumor
necrosis factor a (Mauduit, 1998); interleukin lp (Ogilvie, 1999); econazole (Walsh,
2000a) and various pesticides (Walsh, 2000d), (Walsh, 2000b), [Walsh, 2000c) cause
disruption of the StAR gene.
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The results presented in section 4.2.1 of this thesis have demonstrated that the ACTH
receptor in BAC cells did not become desensitised after 24 hours ofACTH-
treatment. The response by BAC cells to a second ACTH challenge was equivalent to
that seen in cells without 24 hour pre-treatment with ACTH. One of the aims of this
chapter was to investigate the effect of 24 hour ACTH pre-treatment on the StAR
transcript expression when the cells are re-challenged with ACTH. In addition, the
effect ofAngll on the steroid output and StAR transcript expression was
investigated.
As described above ACTH has been shown to have a positive effect on its own
receptor, and was therefore ruled out as an explanation for the plateau found in
Cortisol secretion by BAC cells. Other studies have also shown a direct inhibitory
effect of glucocorticoids on its own synthesis at the adrenal level. Therefore, the
effect ofCortisol and cortisone, in the culture medium of BAC cells, on steroid
secretion and StAR transcript expression was also investigated in this chapter.
Upregulation of StAR mRNA is implicated in the rapid synthesis and secretion of
steroids by steroidogenic cells in response to trophic hormones. Finally, in this
chapter, inhibitors were used to prevent Cortisol production by inhibiting different
stages of the steroidogenic pathway. The effect of this inhibition on the StAR
transcript expression produced by ACTH-treated BAC cells was investigated.
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6.2 Results
6.2.1 StAR mRNA expression in BAC cells in response to repeat
ACTH1.24-treatment.
BAC cells were treated with or without ACTH,_24 (lOnM) for 24 hours, the medium
was removed and the cells were washed with EBSS. The cells, regardless of 24 hour
pre-treatment, were then treated with ACTH,_24 (lOnM) and samples were taken at
various points over a 12 hour time course.
Figure 6.1 shows the results of two independent cell isolations. The representative
northern hybridisation shows the two StAR transcripts at 3.0 and 1.8kb. The northern
shows that the StAR mRNA expression is similar under both conditions. With the
StAR transcripts being detected after 1 hour under both conditions. An increase in
the transcripts was seen in both conditions, peaking at around 4-6 hours followed by
a decline thereafter. The membrane was stripped and reprobed for the P-actin gene to
ensure there was equal loading and transfer of the RNA samples.
Quantification of the two experiments is displayed in figure 6.1B&C. BAC cells
maintained as normal and treated with ACTH]_24 show the familiar pattern, with a
peak in StAR transcript levels found at 6 hours. The response found in BAC cells
treated with ACTH,_24 for 24 hours prior to the 12 hour ACTH,.24-treatment paralleled
that found under the normal 12 hour ACTH^-treatment. After 1 hour of ACTH,_24-
treatment the StAR transcripts were detectable, with a peak in transcript expression
found between 4 and 6 hours ofACTH,.24-treatment, with a decline in levels
thereafter. This was in keeping with the results obtained for the Cortisol, where no
difference was found between the two conditions (figure 4.1).
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Figure 6.1. StAR mRNA expression in BAC cells re-treated with ACTH^.
BAC cells were treated with or without ACTH^ for 24 hours then recharged with
ACTHi_24 for the times indicated. RNA was extracted from the cells and subjected to
northern hybridisation using a bovine StAR cDNA probe. A, Representative northern
analysis showing the 3.0 and 1.8 kb bands. B, Quantification of northern
hybridisations, results are mean from two independent cell isolations (dots indicating
value for each experiment). Upper panel is the sum of the two transcripts, the lower
panel is corrected for P-actin.
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6.2.2 Effect of repeated 12 hour ACTH.,.24 treatments on StAR
transcript expression.
BAC cells were treated with or without ACTH,_24 for 72 hours, the medium was
changed every 12 hours. Samples for untreated cells were taken at 24, 48 and 72
hours only.
BAC cells harvested after 12 hours ofACTH,_24-treatment show detectable StAR
mRNA levels (figure 6.2) upon northern hybridisation. The expression of the StAR
transcripts appeared to fall at 24 hours of ACTH,_24-treatment and recover slightly
thereafter.
When the StAR transcripts were quantified, the levels of StAR mRNA expressed in
the cells over this time period were found not to be significantly different from the
untreated levels at 24, 48 and 72 hours. There was no significant difference in the
expression of the ACTH,.24-treated StAR transcripts over the course of the
experiment.
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Figure 6.2. StAR mRNA expression in BAC cells treated with ACTHj.24 every
12 hours. BAC cells were treated with or without ACTH1.24 for the times indicated.
RNA was extracted from the cells and subjected to northern hybridisation using a
bovine StAR cDNA probe. A: representative northern analysis showing the 3.0 and
1.8 kb bands. B: quantification of northern hybridisations, shown is the sum of the
two transcripts and C: corrected for P-actin. Results are mean ± SD from three
independent cell isolations.
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6.2.3 The effect of Angll on the ACTH^-induced steroid response.
The Cortisol output by BAC cells in response to treatment with Angll with or without
ACTH|_24 present is displayed in figure 6.3. BAC cells treated with Angll show a
significant increase in the Cortisol secreted into the overlying medium compared with
untreated cells at each of the time points studied (P<0.05). A similar increase in
Cortisol secretion over untreated was also found in the ACTH,_24-treated cells (P<0.01
at all time points), and in cells treated with both Angll and ACTH,_24 (P<0.01).
Fitting a nonlinear curve equation to determine when the Cortisol output reaches a
plateau, it was found that for all three conditions the plateau was reached at around 4
hours of treatment.
ACTH,_24 was found to secrete more Cortisol into the medium overlying the cells than
Angll at all of the time points studied (P<0.05). Thus indicating that ACTFI was a
more potent stimulus in BAC cells compared with Angll. Similarly ACTH,_24/Angll
produced significantly more Cortisol than Angll alone (P<0.05). However, there was
no significant difference found in the amount ofCortisol secreted by BAC cells
treated with ACTH compared with ACTH^/Angll treatment.
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Figure 6.3. Effect ofAngll on the Cortisol output by ACTHj^-treated BAC
cells.
BAC cells were treated as indicated, the medium was removed and assayed for
Cortisol. Results shown are mean ± SD from three independent cell isolations. Insert
shows untreated levels. *P<0.05, **P<0.01 comparing untreated with treated cells at
each time point.
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6.2.4 The effect of Angll on the expression of the StAR transcripts
in ACTH1.24-treated BAC cells.
Figure 6.4A shows a representative northern analysis of BAC cells treated with
Angll, ACTH,_24 and Angll/ ACTH,_24. The response by BAC cells to Angll- and
ACTH1.24-treatement was found to be similar to that already present within this
thesis. With ACTH,_24 there was a significant increase in the expression of the StAR
transcripts within 2 hours (P<0.05), with a peak in expression found between 4 and 6
hours (16-fold compared with untreated at 6 hours). The levels falling to almost
untreated levels by 12 hours (2-fold compared to untreated). Angll-treatment of BAC
cells displayed a significant increase in the StAR transcript levels compared with
untreated cells at 1, 2 and 4 hours (P<0.05). The peak in the expression of the StAR
transcripts by Angll-treated cells occurred around 4 hours (3-fold increase compared
to untreated), with a decline to untreated levels by 12 hours.
The results provided by the representative northern hybridisation suggest that when
ACTH,_24 and Angll were used together to treat BAC cells the increase in StAR
transcript expression is less than that found with ACTFI1.24 alone. The quantification
data showed an increase in the expression of the StAR transcripts compared with
untreated cells, a 7-fold increase compared with untreated at 6 hours, although this
was found to be significant at 2 hours of treatment only (P<0.05). The expression of
the StAR transcript was found to be lower in the cells treated with both agonists than
with ACTH,_24 alone. However, this was not found to be significant (figure 6.5).
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Figure 6.4 Representative northern analysis of StAR mRNA expression in BAC
cells treated with ACTH^ and/or Angll. BAC cells were treated as indicated
above. RNA was extracted from the cells and using 25pg total RNA/lane subjected
to northern hybridisation using a bovine StAR cDNA probe. Two transcripts were
found; 3.0 and 1.8 kb. The membrane was stripped and reprobed for P-actin
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□ Untreated cells ■ Angll
□ ACTH □ ACTH/Angll
Figure 6.5 Quantification of northern hybridisation. StAR mRNA expression in
BAC cells treated with ACTH ^24 and/or Angll. A, Sum of the two StAR transcripts
shown in figure 6.10. B, The sum of the two StAR transcripts corrected for actin.
Mean ± SD from three independent cell isolations. Inserts shown values normalised
to untreated cells.
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6.2.5 Effect of Cortisol on the steroid output in cultured BAC cells
To investigate if Cortisol was having any effect on the Cortisol output a level of
Cortisol corresponding to the maximum amount secreted by the cells at 6 hours was
added to the cell culture medium. BAC cells were treated with or without ACTH,_24
(lOnM) in the presence or absence of 5pM Cortisol.
For the cells treated without added Cortisol the picture was as previously reported
(figure 6.6A). There was a significant increase in the production of Cortisol when
cells are treated with ACTH,_24 compared to untreated cells at all time points studied
(P<0.01). The plateau in Cortisol output occurred after 6 hours of ACTH,_24-
treatment.
With the addition ofCortisol to the medium, the level of Cortisol at the start of the
experiment (Oh) was 5.5 (+ 0.5) nmol/106 cells. This appeared to decrease over the
course of the experiment, with a significant fall in the amount ofCortisol in the
overlying medium seen at 8 and 12 hours compared with the 1 hour levels (P<0.05).
A significant difference in the levels of Cortisol between the untreated cells and
ACTH,.24-treated cells was found at the later time points, (P<0.05).
BAC cells treated with lOnM ACTH,_24 in the presence of 5pM Cortisol displayed an
increase in Cortisol output over and above that found in the medium at 0 hour.
Although this was found to be significant only at 4 and 8 hours.
6.13























:*i n n S [i





Figure 6.6. Cortisol added to the cell culture medium. BAC cells are treated with
or without ACTHi^lOnM) in the A, absence or B, presence of 5pM Cortisol.
Results shown are three independent cell isolations. *P<0.05, **P<0.01 comparing
untreated cells with ACTFh^-treated cells. Insert shows the untreated values in
more detail. +P<0.05 comparing ACTH-treated cells with 0 hour time point. The
broken line indicates the level of Cortisol in the medium at the start (Oh) of the
experiment.
6.14
Further characterisation of StAR mRNA expression in BAC cells Chapter 6
Cortisone and corticosterone were found upon HPLC analysis of the medium
overlying the cells (figure 6.7). Cortisone was seen after 6 hours ofACTH,_24-
treatment and increased slightly to 12 hours. Corticosterone was detected after
I hour ofACTH,_24-treatment. There was significant increase in the amount of
corticosterone found in the ACTH,.24-treated cells over the ensuing hours compared
with the value found at 1 hour (P<0.05). However, there was a plateau in the
corticosterone output at 4 hours of ACTH,_24-treatment.
II P-hydroxyandrostenedione was not detected at any of the time points studied.
Cortisol was detected in the untreated cells, due to the presence of 5pM Cortisol in
the medium, this was found to decrease with time as observed with the RIA data.
Cortisone was also detected in the untreated cells after 4 hours, whereas previously
no steroids were found in the untreated cells (chapter 4). The appearance of cortisone
in the medium overlying the untreated cells corresponds to the decrease in the
Cortisol levels. The level of cortisone detected in the overlying medium after 12
hours ACTH,.24-treatment was found to be half the value obtained for Cortisol,
1.2 ±0.1 and 2.4 ±0.5nmol/106 cells respectively.
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■ Cortisol □ cortisone ■ corticosterone
Figure 6.7 HPLC analysis of medium with Cortisol added. Cells are treated A:
without or B: with ACTH^ (lOnM) in the presence of 5juM Cortisol. Results shown
are mean ±SD of three independent cell isolations. *P<0.05, **P<0.01 comparing
untreated with ACTH].24-treated cells at each time point. XP<0.05 comparing 1 hour
corticosterone values with other time points.
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6.2.6 Effect of cortisone on the steroid output in cultured BAC
cells
The presence of cortisone in the culture medium did not have any effect on the
Cortisol secretion when the cells are treated with or without ACTH,.24 (figure 6.8). A
level of 5p.M was chosen in keeping with Cortisol in the previous experiment. Figure
6.8A illustrates the Cortisol response by BAC cells to ACTH^-treatment under
normal conditions (i.e. no added steroids). A significant increase in the levels of
Cortisol produced by ACTH1.24-treated cells was found compared with untreated cells
in the presence of cortisone (P<0.05). The levels of Cortisol secreted into the
overlying medium of ACTH,.24-treated cells, in the presence of cortisone was found
to be similar to that observed under normal circumstances.
A slight increase in the amount ofCortisol secreted into the overlying medium was
noted at the later time points, 3.7 ±0.5 and 3.1 ±0.9 at 8 and 12 hours respectively in
the presence of cortisone compared with 2.6 ±0.6 and 2.4 ±0.6 at 8 and 12 hours
respectively in the absence of cortisone; however, no significant difference between
the two conditions was seen at any of the time point studied, the plateau in Cortisol
output was found to occur around 6 hours with both conditions.
Analysis of the medium overlying the cells by HPLC revealed the presence of
corticosterone and 11 P-hydroxyandrostenedione in addition to Cortisol and cortisone
in ACTH,_24-treated cells (figure 6.9), this is in keeping with the results presented in
figure 3.7. ACTH,.24-treated BAC cells produced Cortisol and corticosterone in the
presence of cortisone, over the initial 4 hours ofACTH-treatment in equal amounts.
11 P-hydroxyandrostenedione was not detected in the cells until 4 hours and remain
constant through 12 hours. From the data presented in figure 6.9A, the cortisone
levels in untreated cells appear to decreased over the 12 hour period.
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Figure 6.8. Cortisone added to the cell culture medium. BAC cells were treated
with or without ACTH1.24 (lOnM) in the A, absence or B, presence of 5jaM cortisone.
Insert shows basal values in more detail. Results shown are mean ±SD from three
independent cell isolations. *P<0.05, **P<0.01, comparing untreated with ACTHi_24-
treated cells.
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Figure 6.9. HPLC analysis of cortisone added to the cell culture medium. BAC
cells were treated A, without or B, with ACTH^ (lOnM) in the presence of 5pM
cortisone. Results shown are from one cell isolations.
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6.2.7 Effect of Cortisol and cortisone on StAR transcript
expression in cultured BAC cells
The presence of 5pM Cortisol had no effect on the expression of the StAR transcripts
on lOnM ACTH,.24-treated cells. The representative northern hybridisation (figure
6.1OA) displays a similar pattern of expression to that previously described for lOnM
ACTH,.24-treated cells (figure 5.7). With detectable levels of the StAR transcripts
found at 1 hour ACTH,.24-treatment. The levels of the transcripts appear to peak at 4
hours with a decrease to almost untreated levels by 12 hours. Quantification of the
StAR mRNA levels demonstrated an increase over untreated levels at 2 hours (3-fold
compared with untreated cells), with a peak at around 6 hours (4-fold increase) and
decreasing again by 12 hours ofACTH,_24-treatment, however none of these were
found to be significantly different from the untreated levels (figure 6.10).
Figure 6.11A displays a representative northern hybridisation of the StAR transcript
expression in BAC cells treated with lOnM ACTH,_24 in the presence of cortisone.
The levels of the StAR transcripts were detected after 1 hour ofACTHj _24-treatment
and a significant increase (P<0.05) in the transcript levels, compared with untreated
cells, was found at time points thereafter. A peak in expression occurred around 6
hours (4-fold compared with untreated cells), with a decline in the levels of the StAR
transcripts thereafter, but remaining significantly increased over the untreated levels
at 12 hours (P<0.05).
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Figure 6.10 StAR mRNA expression in the presence of 5^M Cortisol. BAC cells
were treated with or without ACTHi_24 (10nM) for the times indicated. RNA was extracted
from the cells and subjected to northern hybridisation using a bovine StAR cDNA probe. A:
representative northern analysis showing the 3.0 and 1.8 kb bands. B: quantification of
northern hybridisations, shown is the sum of the two transcripts and C: corrected for (3-actin.
Results are mean ± SD from three independent cell isolations.
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Figure 6.11 StAR mRNA expression in the presence of 5pM cortisone. BAC cells were
treated with or without ACTHi_24 (lOnM) for the times indicated. RNA was extracted from
the cells and subjected to northern hybridisation using a bovine StAR cDNA probe. A:
representative northern analysis showing the 3.0 and 1.8 kb bands. B: quantification of
northern hybridisations, shown is the sum of the two transcripts and C: corrected for (3-actin.
Results are mean ± SD from three independent cell isolations. *P<0.05 comparing untreated
with ACTHi.24-treated cells.
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6.2.8 Inhibition of steroidogenesis with etomidate, ketoconazole,
trilostane and cycloheximide.
Using a 6 hour incubation the effect of the inhibitors on ACTH,_24 treatment of BAC
cells was studied. The 6 hour time point was chosen in light ofprevious results; both
Cortisol output and StAR mRNA expression are maximal around 6 hours, plus all
four steroids were detectable using HPLC at this time.
Figure 6.12 illustrates the Cortisol response by BAC cells to ACTH,_24 in the presence
of etomidate (l&lOpM), trilostane (5pg/ml), ketoconazole (5pM) and cycloheximide
(lOOpM). As shown in previous experiments, BAC cells treated with ACTH,_24
(lOnM) for 6 hours showed a significant increase in the amount of Cortisol secreted
into the medium overlying the cells when compared with untreated cells (P<0.001).
The presence of etomidate (1 & lOpM), trilostane, ketoconazole and cycloheximide
in the incubation medium significantly reduced the Cortisol output in ACTH,.24-
treated cells (P<0.001) (figure 6.12).
No other UV-absorbing steroids were detected in the overlying medium in the
presence of etomidate (1 & lOpM), trilostane or cycloheximide (figure 6.13). The
peak at around 15 minutes on the etomidate lOpM trace was etomidate itself. There
was some Cortisol and corticosterone detected in the overlying medium in BAC cells
treated with lOnM ACTH,.24 plus ketoconazole, 0.7 ±0.3 and 1.3 ±0.3nmol/106 cells
respectively
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Figure 6.12 Cortisol response by BAC cells treated with ACTHi_24 in the
presence of inhibitors. BAC were treated with ACTH^ (10nM) in the presence of
etomidate (1 & 10pM), trilostane (5pg/ml), ketoconazole (5|liM) and cycloheximide
(lOOpM) for 6 hours. ***P<0.001, comparing ACTH^-treated cells with untreated
cells. xxP<0.01, xxxP<0.001 comparing ACTH].24-treated with ACTH^ &
inhibitors. Result shown are mean ± SD from three independent cell isolations.
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Figure 6.13 Representative HPLC traces of steroids produced by BAC cells treated
with ACTHj.24 in the presence of inhibitors. BAC cells were treated with ACTFE.24
(lOnM) in the presence of A & B, etomidate (1 & 10p.M), C, trilostane (5pg/ml); D,
ketoconazole (5pM), and E, cycloheximide (lOOpM) for 6 hours. Peak 1 is Cortisol; 2
corticosterone and 3 testosterone, the internal standard. The small peak, in trace B, at around
15 minutes is etomidate. Experiments were repeated three times.
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6.2.9 Effects of inhibitors on StAR mRNA expression in BAC cells
Study of the StAR transcript expression by northern hybridisation demonstrated an
increase in the levels of StAR mRNA in cells treated with 1 OnM ACTH,_24 as seen
previously. There also appeared to be an increase in the StAR transcript expression
by BAC cells treated with lOnM ACTH,.24 in the presence of the inhibitors (figure
6.14). The increase in the StAR transcript levels was most pronounced in the
presence ofACTH,_24 and cycloheximide, a small increase in the expression of the
StAR transcripts in untreated cells in the presence of cycloheximide was also
detected.
Quantification of the StAR transcripts showed a significant increase in expression of
cells treated with ACTH,_24 compared with untreated cells (P<0.05). A significant
increase in the StAR transcript expression was also observed in ACTH,.24-treated
cells in the presence of etomidate (1 &10pM), P<0.05 and cycloheximide, P<0.01,
compared with untreated cells. No difference was seen between ACTH,.24-treated and
untreated cells in the presence of trilostane and ketoconazole (figure 6.15). A 3-fold
increase compared with untreated was found in BAC cells treated with 1 OnM
ACTH,_24 and ACTH,_24 in the presence of lpM etomidate and trilostane. A 7-, 8- and
10-fold increase compared with untreated was found with ketoconazole, etomidate
(lOpM) and cycloheximide respectively.
The presence of cycloheximide increased significantly the StAR transcript levels in
ACTH,_24-treated cells compared to ACTH,.24-treatment alone (P<0.05). This was not
found in the presence of the other inhibitors.
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Etom(A):- etomidate (1 piM), Etom(B):- etomidate (10pM)
Figure 6.14 Representative northern analysis of StAR mRNA expression in BAC
cells treated with or without ACTH1.24 (lOnM) in the presence of inhibitors.
BAC cells were treated as indicated above for 6 hours. RNA was extracted from the
cells and using 25pg total RNA/lane subjected to northern hybridisation using a
bovine StAR cDNA probe. Two transcripts were found; 3.0 and 1.8 kb. The
membrane was stripped and reprobed with P-actin.
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Figure 6.15 Quantification of northern hybridisation. StAR mRNA expression in
BAC cells treated with or without lOnM ACTH1.24 in the presence of inhibitors. A,
sum of the two StAR transcripts shown in figure 6.14. B, the sum of the two StAR
transcripts corrected for actin. Mean ± SD from three independent cell isolations.
Inserts shown values normalised to untreated cells. *P<0.05, **P<0.01 comparing
untreated with ACTH-treated. xP<0.05 comparing ACTH^-treated with ACTH].24-
treated plus inhibitors.
Et, etomidate; Tril, trilostane; Keto, ketoconazole; CHX, cycloheximide.
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6.2.10 Effect of etomidate on ACTH1.24-treated BAC cells in the
presence of steroids.
BAC cells were incubated with or without lOnM ACTH1_24 and various combinations
of etomidate (lpM), Cortisol (5pM) and progesterone (10pM) for 6 hours as follows :
1) with or without ACTH,.24 (normal); 2) with or without ACTH,_24 plus etomidate;
3) with or without ACTH,_24 plus progestrone; 4) with or without ACTH,_24 plus
progesterone plus etomidate; 5) with or without ACTIil 24 plus Cortisol; 6) with or
without ACTH,.24 plus Cortisol plus etomidate.
Figure 6.16 displays the Cortisol output by BAC cells under these various conditions.
BAC cells treated with progesterone, with or without etomidate, produced a
significant increase in the amount of Cortisol secreted compared with normal
untreated cells, P<0.01. The presence of etomidate in these cells reduced the Cortisol
production compared with progesterone alone, P<0.01. The addition of Cortisol to the
culture medium obviously increased the levels in untreated cells compared with
normal untreated cells. With the addition of etomidate no decrease in the Cortisol
levels was observed.
Cells treated with ACTH,_24 (normal, Cortisol and progesterone) produced a
significant increase in the levels ofCortisol secreted into the overlying medium
compared with corresponding untreated cells, PO.Ol. When Cortisol or progesterone
was added to the culture medium BAC cells secreted significantly more Cortisol into
the overlying medium when treated with ACTH,_24 compared with ACTH,.24-treated
cell alone, P<0.05. This increase was found to be additive rather than synergistic
compared with the corresponding untreated cells. In the presence of etomidate there
was a significant decrease in the amount ofACTH,.24-induced Cortisol secretion into
the overlying medium in all three conditions, P<0.05.
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□ Untreated ■ ACTH
Figure 6.16 Effect of etomidate (lpM) on the ACTH^-treatment of BAC cells
in the presence of steroids. BAC cells were treated with or without ACTH^ in the
presence or absence of etomidate (lpM), Cortisol (5pM) and progesterone (lOpM) as
indicated. The results are mean ± SD of triplicate wells from one cell isolation.
*P<0.05, **P<0.01 comparing untreated with ACTH-treated for each treatment.
+P<0.05 comparing normal ACTH-treated with other ACTH-treated. ♦ ♦PO.Ol
comparing untreated (normal) with untreated + additions.
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Figure 6.17 displays the northern hybridisation and quantification of the StAR
transcript expression by BAC cells treated as described above, this experiment was
performed once.
The expression of the StAR transcripts in the northern analysis showed that there was
little StAR mRNA expression in untreated cells regardless of the treatment. Upon the
addition of 1 OnM ACTHI_24 there was an increase in the levels of the StAR
transcripts in all the conditions studied.
Quantification of the northern demonstrated, as previously, the addition of etomidate
(lpM) to ACTH,_24-treated BAC cells increased the StAR transcript levels compared
with ACTH,_24-treatment alone. The addition of Cortisol (5pM) to the culture medium
had no effect on the ACTH,_24-induced StAR transcript levels, although the levels
were increased by the addition of etomidate. Progesterone increased the StAR
transcript levels compared with ACTH,.24 alone, with a further increase observed
when etomidate was added to the culture medium. The increase in the StAR
transcript levels in the presence of progesterone, with and without etomidate, was
also found to be greater than that found with ACTH-treatment plus etomidate.
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Figure 6.17 StAR mRNA expression in BAC cells treated with ACTH1.24 in the
presence of etomidate, Cortisol and progesterone. BAC cells were treated with or
without ACTHt.24 (10nM) in the presence or absence of etomidate (lpM), Cortisol
(5|uM) and progesterone (10p,M) as indicated. RNA was extracted from the cells and
subjected to northern hybridisation using a bovine StAR cDNA probe. A: representative
northern analysis showing the 3.0 and 1.8 kb bands. B: quantification of northern
hybridisations, shown is the sum of the two transcripts corrected for p-actin. Results are from
one cell isolations.
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6.3 Discussion
The results presented in chapter 4 demonstrate that when pre-treated with ACTH for
24 hours the Cortisol response by BAC cells was comparable to that found in cells
without ACTH pre-treatment, indicating that the plateau in Cortisol production was
not due to ACTH receptor desenitisation. In fact, BAC cells were able to maintain a
constant level of Cortisol output over a 72 hour treatment period. The results in figure
6.1 show that the response by BAC cells to a second challenge ofACTH is mediated
via the transcription of StAR mRNA in a similar manner to the initial ACTH
response. Both sets of cell, with or without ACTH pre-treatment, displayed an
increase in StAR transcript expression over untreated cells, peaking at around 4-6
hours and declining thereafter to almost untreated levels. This is consistent with in
vivo and in vitro studies which have shown that ACTH increases rather than
decreases the steroidogenic response to further hormonal stimulation (Penhoat,
1989), (Kolanowski, 1977). In BAC cells, ACTH has been demonstrated to increase
the ACTH receptor mRNA after 3 hours of treatment, reaching a maximum by 24
hours (Penhoat, 1995). This would account for the continued response ofBAC cells
to ACTH seen in this thesis, but does not help explain the plateau in Cortisol
secretion found after 6 hours ofACTH-treatment.
When the ACTH challenge is renewed every 12 hours, expression of StAR
transcripts does not increase above untreated levels whereas a steady level ofCortisol
output is observed. On reflection, this result is not unexpected as all the ACTH-
treatments performed in this thesis have shown a decline in the transcripts to almost
untreated levels at 12 hours.
In mammals, ACTH and Angll are the main hormones that regulate steroid secretion
by the adrenal gland. Angll has been shown to stimulate steroidogenesis in BAC
cells and the results displayed in figure 6. 3 are in keeping with these findings.
Although the Cortisol response to Angll by BAC cells is about 3-fold less than the
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response to ACTH, a similar pattern in the Cortisol output is seen i.e. an increase in
Cortisol output followed by a diminish in production around 4- to 6 hours of Angll-
treatment. StAR mRNA expression was found in Angll-treated cells by 1 hour,
peaking at around 4 hours and declining thereafter through 12 hours. A similar result
was found by Le Roy et al, who showed that both StAR mRNA and protein in
response to Angll-treatment ofBAC cells peaked within 2-3 hours followed by a
rapid decline to almost undetectable levels by 36 hours of treatment (Le Roy, 2000).
Thus, indicating that Angll-induced steroidogenesis in BAC cells is also mediated
via the regulation of StAR.
The effect of AngTT on the StAR transcript expression in ACTH-treated BAC cells
was investigated (figure 6.3-5). The Cortisol response by BAC cells treated with
ACTH and Angll together was also found to be equivalent to that of ACTH on its
own. These results indicated that ACTH and Ang II do not act synergistically.
Indeed, there was not even an additive effect on the Cortisol output. The StAR
transcript expression was found to be lower in the cells treated with ACTH and
Angll together than in cells treated with ACTH alone. Penhoat et al demonstrated
that in BAC cells, Angll caused a decrease in ACTH binding sites and steroidogenic
desenitisation (Penhoat, 1995). This would be consistent with the results found in
this thesis. A recent study by Le Roy et al showed an strong inhibitory effect of
Angll on both Cortisol secretion and StAR mRNA expression in BAC cells after 36
hours ofAngll-treatment (Le Roy, 2000). Therefore, the inhibitory effect on ACTH-
induced Cortisol secretion observed in this thesis appears to be StAR-independent, as
StAR mRNA levels were still raised during the period studied.
In vivo, ACTH release is regulated by the negative feedback inhibition by Cortisol
(chapter 1.2). Glucocorticoids, in addition, to their well known effects of inducing a
number of genes may act on so-called negative glucocorticoid response elements
causing inhibition rather than enhancement of transcription (Bamberger, 1996).
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The cell culture system does not posses such a HPA axis. Therefore, to investigate
the possibility of a local negative feedback inhibition on steroidogenesis by adrenal
steroids BAC cells were incubated with high levels of Cortisol or cortisone. The
results presented in this chapter show that in the presence of 5pM Cortisol, BAC cells
were capable of producing Cortisol over and above that already in the culture
medium, in response to ACTH-treatment. Over the time course studied the Cortisol
levels of untreated cells decreased with time. HPLC analysis of the culture medium
revealed the presence of cortisone in the medium after 4hours ACTH-treatment,
previously no steroids were detected in untreated cells. This was probably due to the
activity of the 1 lp-HSD enzyme as a result of the increase levels of Cortisol. The
levels of cortisone detected in the medium overlying the BAC cells treated with
ACTH in the presence of added Cortisol were not increased over those found in
untreated cells; however the levels ofCortisol did not fall to a similar degree found in
the untreated cells. This implies that ACTH-treatment was either; 1) increasing the
production ofCortisol, compensating for the fall found in untreated cells, but not in
any quantity to significantly increase the levels over the amount originally found in
the culture medium or 2) inhibiting the action of 11P-HSD. ACTH has been
demonstrated to lower the capacity of human adrenal slices to convert Cortisol to
cortisone (Mazzocchi, 1998). The presence of increased levels of Cortisol in the
culture medium had no effect on the ACTH-induced StAR mRNA expression.
The presence of 5pM cortisone in the cell culture medium had no effect on the
ACTH-induced steroid production or StAR transcript expression. This can be
explained by the fact that cortisone is an inactive metabolite of Cortisol and therefore
has no glucocorticoid activity. If the mechanism for the local negative feedback
inhibition was via the glucocorticoid receptor then cortisone would have no effect. A
study using the mouse adrenal tumor cell line Y-l demonstrated that corticosterone
inhibited ACTH-induced steroidogenesis, whilst other steroids which did not possess
glucocorticoid action had no effect. The ACTH receptors in these cells were
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unaffected by corticosterone. (Saito, 1979). In rats it was suggested that certain
steroids may inhibit adrenal steroid production and that this effect was mediated by
inhibition of the synthesis of a regulatory adrenal protein (Morrow, 1967), (Ferguson,
1967). This would be consistent with the hypothesis of a local feedback inhibition of
steroidogenesis by adrenal steroids, where the protein inhibited was StAR protein.
Nevertheless this was found not to be the case in BAC cells as the addition ofCortisol
or cortisone to the culture medium had no effect on the ACTH-induced StAR
transcript expression.
Dexamethasone has also been shown to inhibit the ACTH-induced accumulation of
CYP11A and CYP17 mRNAs at a transcriptional levels in BAC cells. Unpublished
observations by this group of researchers have suggested that Cortisol, cortisone and
corticosterone may also have an inhibitory effect on the accumulation ofCYP11A
and CYP17 mRNAs in BAC cells (Trzeciak, 1993).
To investigate further the effects of inhibiting the steroid pathway on the expression
of the StAR transcripts the protein inhibitor, cycloheximide, and various
steroidogenic enzyme inhibitors were used. The effects of cycloheximide on blocking
hormone-sensitive steroidogenesis have been well studied (Ferguson, 1962), (Garren,
1965). The results presented in this thesis show the inhibition of steroidogenesis by
cycloheximide and that StAR mRNA accumulates within the cells suggesting that the
effects of cycloheximide are pre-transcriptional.
The imidazole compounds, etomidate and ketoconazole, were used to inhibit
steroidogenesis enzymes post CYP11A, although etomidate at high concentrations
can inhibit CYP11A. A greater increase in StAR transcript levels was found with the
higher concentration of etomidate. Suggesting that at the lower concentration (lpM)
the inhibition was less potent and that some steroidogenesis was occurring although
no steroids were found upon HPLC analysis. The measurement of pregnenolone in
these samples may have provided useful information. Unfortunately, such an analysis
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was not available. Similarly, the increase in StAR transcript levels in the presence of
trilostane was less than that observed by the other inhibitors, again the measurement
of pregnenolone or 17a-hydroxypregnenolone may have been provide further
information. Another imidazole compounds, econazole, has been shown to reduce
dbcAMP stimulation ofprogesterone production in MA-10 cells. In this study
econazole increased the expression of StAR mRNA, with a reduction in StAR protein
levels observed (Walsh, 2000a). The question as to whether the drugs used in this
thesis have the same effect on BAC cell StAR protein levels as found by Walsh et al
requires further investigation. The mechanism by which these drugs disrupt the
expression of the StAR transcripts remains to be elucidated.
The presence of progesterone in the culture medium produced a significant increase
in Cortisol production by BAC cells in the absence of ACTH-treatment after 6 hours,
with no increase in the expression of StAR transcripts. In the presence ofACTH-
treatment a further increase in Cortisol levels were found, with a concomitant increase
in StAR transcript levels. The increase in StAR mRNA levels was greater than that
found with ACTH-treatment alone. The reason for this is unclear at present, as
progesterone had no stimulatory effect on StAR mRNA levels in untreated cells and
the increase observed in the Cortisol output in ACTH-treated cells was additive rather
than synergistic compared with untreated Cortisol levels. The presence of etomidate
in the cell culture medium of both untreated and ACTH-treated cells produced a
decrease in the Cortisol secreted into the overlying medium, with an increase in the
expression of the StAR transcripts found in the ACTH-treated cells. The addition of
progesterone to the cell culture medium resulted in a greater increase in ACTH-
induced StAR transcript levels, with and without etomidate treatment, than that
found with normal ACTH-treatment and etomidate. The reason for this increase is
uncertain, also these are the results from one experiment and therefore need to be
repeated.
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Also in this experiment the addition of Cortisol to the cell culture medium produced a
significant increase in ACTH-treated cells compared with normal conditions at 6
hours, thus adding to the previous results (section 6.2.5) that Cortisol does not exert a
negative feedback inhibition in BAC cells. The StAR transcript levels in ACTH-
treated cells in the presence of 5pM Cortisol was similar to that found in normal
ACTH-treated cells, as previously found. The addition of etomidate to the culture
medium again decreased the Cortisol output with an increase in the StAR transcript
levels in ACTH-treated cells.
In conclusion, BAC cells respond to ACTH-treatment with an increase in StAR
transcript expression, with a peak in levels found around 6 hours followed by a
decline to almost untreated levels by 12 hours. This pattern was found when the cells
were subjected to a second ACTH-treatment. Further investigation into the decline in
StAR transcript levels and decline in Cortisol were undertaken in this chapter. The
possibility ofCortisol exerting a local negative feedback inhibition was investigated
by the addition of Cortisol to the medium. However, the result suggested that this was
not the case, therefore, cortisone was investigated and was also found not to have any
effect on the steroidogenesis ofBAC cells. Finally, the use of cycloheximide,
trilostane and the imidazole antifungal drugs, etomidate and ketoconazole to help
elucidate the effect of inhibiting the steroid pathway on the expression of the StAR
transcripts showed that the levels of the transcripts increased in the presence of the
inhibitors. Other studies have shown that StAR protein levels are decreased in the
presence of other imidazole drugs (Walsh, 2000a), thus suggesting that the process of
inhibition, for these drug at least, is post-transcriptional.
6.38
Concluding remarks Chapter 7
Chapter 7 Concluding remarks
The aims of this thesis were to 1) investigate the mechanisms leading to the decrease
in the Cortisol secretion rate found in BAC cells treated for 12 hours with ACTH, 2)
to determine what relationship exits between the pattern of Cortisol secretion and the
expression of StAR mRNA and 3) to establish whether or not a local feedback
inhibition was involved in the secretion of Cortisol by cultured BAC cells to account
for these findings.
The adrenal cortex is an architecturally complex tissue, with three distinct zones, the
zona glomerulosa, fasiculata and reticularis. The steroidogenic output is thought to be
dependent on the complex arrangement of the adrenal, determined in part by the flow
of steroid precursors from one zone to another (Vinson, 1992), and the proximity of
intraadrenal regulatory factors (Ehrhart-Bornstein, 1998). It is of course important to
know what products are produced by the whole gland, but it is equally important to
know what the contributions are of the individual cell types. In vitro studies, whilst
not necessarily reflecting the whole physiological situation in vivo, are a useful tool
for obtaining insight into possible in vivo mechanisms. Among studies of adrenal
steroidogenesis in vitro, methods of tissue preparation have varied widely, from
primary cell cultures (DiBartolomeis, 1984), (Walker, 1991), (Williams, 1989) to
intact glands(Hinson, 1985), cellular suspensions (Walker, 1991) and tissue slices
(Englelhardt, 1991). Isolated cell preparations are an invaluable tool in studying many
aspects of cell function and they have been used with great effect in studies to
elucidate the mechanism of action ofACTH on glucocorticoid synthesis. The
advantages of isolated cells for the study of steroidogenesis include readier access of
the trophic hormone to the cell surface receptors and separation of the zones thus
determining the actions of each zone individually (Vinson, 1978).
The day of culture on which BAC cells are used for the study of steroidogenesis in
culture varies from freshly isolated to cells cultured for up to 6 days, depending on
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the researcher (Tachikawa, 1999), (DiBartolomeis, 1984). The first line of
investigation in this thesis was to establish the optimum time in culture to study the
Cortisol response by BAC cells. The results presented here clearly establish that BAC
cells were less responsive to ACTH after isolation but recover with time in culture.
The cells secreted Cortisol in response to ACTH on each of the days studied, but were
less able to maintain the levels of Cortisol output over a 24 hour period in the freshly
isolated cells. Possible reasons may the reduced lipid content or a reduction in the
number of functional ACTH receptors (Williams, 1989), (Penhoat, 1989). The
response by BAC cells to ACTH-treatment was found to be maximal on day 3 of
culture, thus further experiments were carried out at this time.
Previous studies have investigated the short-term (up to 6 hours) effects of ACTH on
the acute steroidogenic mechanisms in adrenocortical cells (e.g. the second messenger
responses) or have investigated the longer-term (48 hours or over) effects, (e.g.
induction of the steroidogenic enzymes) (Clyne, 1993), (Walker, 1991), (DuBois,
1981), (Funkenstein, 1983). The work carried out in this thesis investigates the
responsiveness ofBAC cells to ACTH-treatment at the intermediate time periods.
The Cortisol output by BAC cells treated with ACTH (lOnM) was found to increase
over the initial 6 hours with a decrease in the Cortisol secretion rate between 6 and 12
hours. The protein content of the culture wells was measured to ensure that the
decline in Cortisol secretion was not due to the detachment of cells. This was found to
be constant over the 12 hour time period. Several lines of investigation were
undertaken to investigate the decline in Cortisol secretion observed in BAC cells.
Cholesterol is essential for Cortisol production and is supplied to the steroidogenic
cells either via de novo synthesis or from exogenous sources such as HDL or LDL
(Krieger, 1999). Serum is essential in the initial stages ofprimary culture for effective
plating and maintenance of the cells. However, when studying the steroidogenic
response of BAC cells to various agonists it is advantageous to use a serum-free
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medium, thus ensuring the responses found are due to the agonists used and not as a
result of hormones or other substances found in the serum (Hornsby, 1991). The
results presented in figures 3.3 demonstrate that ACTH produced a comparable
Cortisol responses under both lipid-deplete and lipid-replete conditions. A previous
study also demonstrated that BAC cells grown in the absence of exogenous
cholesterol can produce steroids in response to ACTH by increasing their ability to
synthesise cholesterol de novo (Rainey, 1986). This, argues against the decline in
steroidogenesis seen in the BAC cells as a result of a lack of exogenous cholesterol
supply.
The profile of steroids produced by BAC cells in response to ACTH-treatment was
investigated to determine whether the decline in Cortisol output was due to other
steroids being synthesised in preference to Cortisol (e.g. corticosterone). Another
possibility may be the conversion of Cortisol to its inactive metabolite cortisone, as
I ip-HSD activity has been found in BAC cells (Romero, 2000). Using HPLC, four
principal steroids were detected in the medium overlying BAC cells; Cortisol,
corticosterone, 11 P-hydroxyandrostenedione and cortisone. Over the initial 4 hours
of ACTH-treatment only Cortisol and corticosterone were detected, both being
produced in about equal amounts for the first 2 hours of treatment. Cortisone and
II P-Hydroxyandrostenedione were not detected in the medium overlying the BAC
cells until 6 hours ofACTH-treatment. After the initial 2 hours, Cortisol was found to
be the main steroid (>50%) produced at each of the time points studied. The amount
of cortisone in the medium overlying the BAC cells did not increase significantly
over the time period studied and failed to account for the decrease in Cortisol output.
In fact the total steroid production (figure 3.7/table 3.1) displayed a decrease in
production after 6 hours.
The decline in the rate ofCortisol secretion was also found over a range of ACTH
concentrations, with the plateau most apparent with the lower concentrations of
ACTH used. ACTH InM produced a plateau in Cortisol output between 4 and 6
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hours, whereas with lOOnM ACTH the plateau was found to occur between 8 and 12
hours. ACTH,_24 (synacthen) was used in these experiments, as an alternative to the
native ACTH,_39 peptide. In most species studied the N-terminal 24 amino acids are
identical and this is the part essential for adrenocortical activity. (Schwyzer, 1977).
To determine if the decrease in Cortisol secretion was due to some inherent property
of the truncated analog, BAC cells were treated with the ACTH,_39 peptide. No
difference in the Cortisol response compared with ACTII|.24 was found. These
findings are important in that they demonstrate the particular pattern of secretion in
response to ACTH,_24 is comparable to native ACTH,_24.
In order to determine if this decline in steroidogenesis was confined to ACTH, the
effect of other agonists on Cortisol production over the 12 hour time course was also
studied. The data presented in this thesis demonstrated that 8Br-cAMP and forskolin
increased Cortisol production significantly compared with untreated cells (P<0.05) at
all of the time points studied. An interesting observation was that no plateau in
Cortisol production was observed with forskolin or 8Br-cAMP. HPLC analysis
indicated that the four main steroids were produced by forskolin, in a similar pattern
to that found with ACTH. In response to 8Br-cAMP Cortisol, corticosterone and
cortisone were detected but no 11 (3-hydroxyandrostenedione was found, possibly due
to the lower overall level of steroids produced by the BAC cells treated with 8Br-
cAMP. This suggests that the decline in Cortisol production was possibly specific to
ACTH related to an event pre-cAMP as both forskolin and 8Br-cAMP utilise the
cAMP second messenger system as well as ACTH. Nevertheless, the measurement of
cAMP levels may have provided useful information as it has been shown that ACTH
increases the levels of cAMP in BAC cells (Walker, 1991).
To determine if the decline in Cortisol secretion was found with an alternate second
messenger pathway Angll was used to treat the cells. Angll acutely increases
aldosterone synthesis in bovine glomerulosa cells through the activation of PKC and
calcium second messenger pathways (Kojima, 1985). An increase in Cortisol output
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was found in Angll-treated BAC cells (figure 3.14), results which are consistent with
previous studies (Bird, 1989), (Clyne, 1993), (Le Roy, 2000). The data presented in
this thesis demonstrated that Angll produced a significant increase in Cortisol
production over untreated cells at all of the time points studied, with a plateau in
Cortisol production at 4 hours of treatment.
The decline in steroidogenesis was therefore not limited to ACTH-treatment ofBAC
cells. Since the actions of both ACTH and Angll are mediated through cell surface
receptors (whereas forskolin and 8Br-cAMP are not). A further possibility is that the
decline in Cortisol output seen in BAC cells could be through receptor desensitisation.
The initial phase of receptor occupancy and target cell activation is frequently
followed by a period of diminished responsiveness. This may be due to the presence
of residual hormone on the receptor site (Catt, 1979).
BAC cells treated for 24 hours with ACTH (lOnM) and then re-challenged with
ACTH (lOnM) for the 12 hour time course showed a comparable response to those
treated with ACTH without pre-treatment. It therefore appears that the BAC cells did
not become desensitised to ACTH with continued exposure to ACTH-treatment.
Indeed, the cells pre-treated with ACTH for 24 hours, showed an increase in the
amount of Cortisol secreted compared with those without pre-treatment, (significant at
8 and 12 hours, P<0.05). This might be explained as the result of the up-regulation of
various steroidogenic enzymes with the 24 hour ACTH-pre-treatment (Simpson,
1988), or due to an increase in the number ofACTH receptors. Various studies on the
ACTH receptor have shown that ACTH has a positive effect on its own receptor,
(Penhoat, 1995), (Penhoat, 1994), (Liakos, 1998). In BAC cells, lOnM ACTH-
treatment was found to maximally increase the ACTH receptor mRNA after 24 hours.
This stimulatory effect ofACTH on the ACTH-R mRNA was associated with an
increase in receptor numbers (Penhoat, 1995).
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Studies performed in this thesis also demonstrated that BAC cells could maintain a
level ofCortisol output over a 72 hour time period. BAC cells treated with ACTH
which was renewed every 12 hours throughout 72 hours displayed a consistent
repetitive pattern ofCortisol output. Further experiments to investigate whether the
Cortisol response over each of the 12 hour challenges (1-12 hour treatments) was
similar to that seen originally may have been more informative. Overall these results
corroborate the earlier studies on the use of serum-free medium for the experiments.
Thus, BAC cells were able to maintain a steroidogenic output after 24 hours ACTH
treatment or up to 72 hours ACTH treatment in serum-free medium, implying that the
cells have an adequate supple of cholesterol, possibly from de novo synthesis
(Rainey, 1986).
The stability of the ACTH also investigated. ACTH,.24 alone was incubated overnight
at 37°C and the following morning placed on BAC cells. The Cortisol output was
compared with that found for ACTH prepared freshly on the day of the experiment.
At the lower concentrations used (0.01 and InM) there was a significantly reduced
response in Cortisol production compared with ACTH prepared on the day of the
experiment. The two higher concentrations (10 and lOOnM) showed no difference. In
order to investigate of the stability ofACTH, the concentration in the cell culture
medium was measured. ACTH,_39 was used in these experiments due to the
immunometric assay used. ACTH1.39 was incubated overnight at 37°C in tissue culture
plates without BAC cells present. The concentration of InM ACTH was reduced to
O.lnM, whereas lOnM and lOOnM were reduced to 2.7 and 61nM respectively (figure
4.4). These results show that although 10 and lOOnM ACTH are reduced significantly
in concentration the final concentration is still sufficient to elicit a Cortisol response.
When the ACTH was incubated overnight in the presence ofBAC cells, the fall in
concentration ofACTH (lOnM) was less dramatic compared with the ACTH
incubated in the absence ofBAC cells (figure 4.7). These finding provide only a
partial explanation for the decline in the Cortisol output observed in BAC cells, since
the studies presented here were carried out using lOnM ACTH. The decrease in the
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immunoactivity ofACTH especially at the lower concentrations, contributes to the
decline in Cortisol secretion. The reason for the observed decline in all of the ACTH
concentrations in the absence of cells is unclear, though the hypothesis that ACTH
binds to plastic may provide an answer. This may also help explain the plateau
observed with Angll-treatment, although this line of investigation was not followed
in this thesis.
The next approach was to look at the expression of StAR mRNA to determine if there
was a relationship between Cortisol secretion and StAR mRNA expression. StAR
protein mediates the delivery of cholesterol into the mitochondria where it is
converted to pregnenolone by CYP11A (Orth, 1992). StAR mRNA is regulated by
trophic hormone in a time frame concomitant the acute production of steroid
hormones (Stocco, 1991), (Clark, 1994). The initial experiments performed in the
thesis were to characterise the expression of StAR mRNA in BAC cell culture. On
northern hybridisation of the StAR mRNA two transcripts were found, 3.0 and 1.8kb,
consistent with other studies (Ivell, 2000), (Le Roy, 2000). The first step in the study
of StAR mRNA expression in BAC cells was to measure the response on day 3 since
previous experiments had shown an enhanced Cortisol response on this day. Both
Cortisol output and StAR mRNA expression in response to ACTH-treatment were
found to be maximal on day 3 of culture.
The StAR mRNA expression in BAC cells over a 12 hour period followed a similar
pattern to Cortisol. There was an increase in expression over the initial 4-6 hours,
peaking at around 4 or 6 hours, followed by a decrease in StAR transcript levels to
almost untreated levels by 12 hours of ACTH-treatment. This pattern was seen with
various concentrations ofACTH. At lpM ACTH the Cortisol response and the levels
of StAR mRNA did not correlate. A significant increase in Cortisol was seen over the
6 hour treatment but no increase in StAR mRNA levels was detectable (figures
5.4&5.5). A previous study has demonstrated that Cortisol secretion and StAR protein
expression differ in response to high (lOnM) versus low (lpM) ACTH-treatment in
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BAC cells (Wang, 1999), with a strong correlation between Cortisol secretion and
StAR protein induction at the higher but not at the lower ACTH concentrations.
Increasing evidence has suggested that arachidonic acid metabolites may be important
second messengers for ACTH stimulation (Yamazaki, 1996), (Finkielstein, 1998). A
study by Wang et al has demonstrated that in BAC cells, ACTH-treatment at low
concentrations is mediated via arachidonic acid metabolites involving a StAR-
independent mechanism (Wang, 2000).
Forskolin and 8Br-cAMP also increased the expression of StAR mRNA. In response
to forskolin a peak in StAR mRNA levels at around 4 hours were observed; however
the levels did not fall to near untreated levels by 12 hours but remained elevated
above untreated values, (P<0.05 at 8 hours). No peak in StAR mRNA levels was
found with 8 Br-cAMP. Instead a constant level of expression, above that found in
untreated cells, was seen over the 12 hour time period. This was inconsistent with
other studies. In MA-10 cells Clark et al demonstrated that the levels of StAR mRNA
in response to dbcAMP peaked at around 6 hours of treatment followed by a decrease
in levels by 12 hours (Clark, 1995). The reason for this discrepancy is unclear at
present. Both the Cortisol output and the StAR mRNA expression in BAC cells
treated with forskolin and 8Br-cAMP remain elevated over the 12 hour time period.
This also accords with the ongoing Cortisol response, as distinct from the decline in
secretion rate observed with ACTH-treatment.
After treatment ofBAC cells with Angll there was an increase in the relative amounts
of the two StAR transcripts. The increase was already detectable after 1 hour of
treatment, by comparison with the untreated levels, and reached a maximum at about
4 hours. As with ACTH-treatment there was a rapid decline in transcript levels
thereafter. Angll has also been shown to acutely stimulate StAR protein in bovine
zona glomerulosa cells (Brand, 1998), (Elliott, 1993). Thus, the induction of StAR
mRNA in response to ACTH, forskolin, 8Br-cAMP and Angll argue that cAMP- or
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protein kinase C-dependent processes may be key regulators of StAR mRNA
expression.
As discussed earlier, BAC cells pre-treated for 24 hours with ACTH prior to a second
12 hour ACTH-treatment showed a repeat of the pattern of secretion seen without
pre-treatment. The next step was to detennine if this second increase in the Cortisol
response was mediated via an second increase in StAR transcription. BAC cells
treated for 24 hours with ACTH (lOnM) and then re-challenged with ACTH for the
12 hour time course showed a comparable StAR mRNA response to those treated
with ACTH and no pre-treatment. Therefore the second ACTH-treatment was also
mediated via the up-regulation of StAR transcription, suggesting the start of a new
cycle of steroid production rather than a continuation of the first one.
Previous studies have provided some evidence that certain steroids may inhibit
adrenal steroid production and that this may be mediated by the inhibition of adrenal
protein synthesis (Morrow, 1967), (Ferguson, 1967). Therefore, an obvious candidate
for this inhibitory factor in the medium could be Cortisol itself. In vivo, Cortisol is
produced by the adrenal cortex under the regulatory influence ofACTH, which in
turn is under the influence ofCRH (see sectionl .2). The HPA axis is kept in balance
by the negative feedback effects of Cortisol on the secretion ofACTH and CRH
(Aron, 2000). At the cellular level, the effects ofCortisol are mediated via the
glucocorticoid receptor (GR) (Bamberger, 1996). Hormone binding to the GR
activates the receptor causing it to bind to GREs in the regulatory region of target
genes (see section 1.4.5). This interaction causes either stimulation or, less frequently,
inhibition of transcription (Bamberger, 1996). One important example of negative
regulation by the GR is the feedback inhibition mechanism of the HPA axis
(Reichardt, 1998). Glucocorticoids themselves appear to be potent regulators of
glucocorticoid receptor expression and have been shown to cause down-regulation of
the receptor in many cell lines and in tissues or cells from intact animals and healthy
human subjects (Burnstein, 1992).
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To test the hypothesis that Cortisol was exerting a local negative feedback inhibition
within the BAC cell culture, Cortisol (5pM) was added to the culture medium.
At 0 hour the level of Cortisol in the cell culture medium was measured as
5.5 ±0.5nmol/106 cells. The addition of ACTH to the cells resulted in an increase in
the Cortisol levels, although this was found to be significant only at 4 and 8 hours.
The expression of the StAR transcripts in the presence of increased Cortisol levels
was found to be comparable with that found under normal conditions. These
experiments do not support the hypothesis that increased Cortisol levels in the
medium exert any major negative feedback effect on the steroidogenic capability of
BAC cells.
Although cortisone is metabolically inactive and the levels of cortisone did not
exceed those ofCortisol, the possibility this steroid was exerting a negative effect on
the steroidogenic capability of the cells was also investigated. The cortisone levels in
the untreated cells were found to decrease with time. The reason for this is unclear
since the metabolism of cortisone normally occurs in the liver (Orth, 1992). When
BAC cells were treated with ACTH in the presence of increased levels of cortisone a
significant increase in Cortisol output was found at each of the time points studied.
Moreover, the presence of cortisone appeared to have a slight enhancing effect on the
Cortisol output of the BAC cells, although no effect on the ACTH-induced StAR
mRNA expression was found. ACTH has been shown to lower the conversion of
Cortisol to cortisone in human adrenal slices (Mazzocchi, 1998). One explanation for
the enhanced Cortisol secretion could be that due to the raised levels of cortisone this
conversion is depressed further with less newly synthesised Cortisol converted to
cortisone.
The decrease in Cortisol output observed in cultured BAC cells was not due to the
presence of cortisone accumulation in the medium and was unlikely to be due to the
increasing levels of Cortisol. Further studies on different steroids, e.g. corticosterone,
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in the cell culture medium may have been informative. The preffered diversion of
pregnenolone into the synthesis of the cardiotonic steroid ouabain may provide a
further possibility. Ouabain is a plant derived cardiac glycoside with Na+-K+-ATPase
inhibitory properties (Doris, 1994). Ouabain or a 'ouabain-like compound' (OLC) has
been detected in rat, bovine (Doris, 1989) and human (Hamlyn, 1991) adrenal gland
and in the culture medium ofbovine adrenocortical cells (Laredo, 1995), (Perrin,
1997). The biosynthetic pathway of this compound in mammals and specifically in
adrenocortical tissue is unclear. Cardiac glycosides possess a basic steroid skeleton
and in plants it has been shown that cholesterol, pregnenolone and progesterone are
metabolic precursors (Doris, 1994). The presence of cholesterol from endogenous or
exogenous sources, and of pregnenolone and progesterone as intermediates suggests a
possible biosynthetic pathway in the adrenal. Incubation of BAC cells with excess
pregnenolone or progesterone increased the production of OLC (Perrin, 1997). One
possibility could be that at the later time points (6-12hours) the BAC cells were
producing OLC in preference to Cortisol. The measurement of OLC in the culture
medium overlying the BAC cells used in this thesis may have shed light on this.
However, there have been discrepancies in the measurement of ouabain, by either
HPLC or RIA, with some researchers unable to detect OLC (Doris, 1994). This line
of investigation was not followed; nevertheless, it is interesting that both ACTH and
Angll have been shown to stimulate the secretion of OLC by BAC cells (Laredo,
1995).
The use ofACTH-conditioned-medium on the BAC cells suggested that one or more
factors were secreted into the medium overlying the cells which might inhibit further
steroidogenesis. BAC cells treated with ACTH-conditioned medium (figure 4.9)
showed no significant increase in Cortisol output above that already found in the
ACTH-conditioned medium alone. The ACTH already in the conditioned medium did
not stimulate the untreated, set B cells. When further ACTH was added to the
medium there appeared to be some increase over the ACTH-conditioned medium
alone; however this trend was found to statistically insignificant from the Oh level.
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These results suggest that there may be one or more factors secreted into medium that
attenuate the ACTH-induced Cortisol production in BAC cell culture but may be
degraded over time, thus leading to the statistically insignificant trend in Cortisol. The
expression of StAR transcripts in the conditioned medium conditions would have
been of potential interest and might help to resolve the question as to whether
steroidogenesis was actually inhibited under these conditions or not. These
experiments were not done due to a lack of time.
It is generally accepted that glucocorticoids act indirectly on the adrenal cortex by
inhibiting the HPA axis (Aron, 2000). The existence of a direct inhibitory effect of
glucocorticoids on the adrenocortical cells is more controversial. Some in vivo studies
(Hill, 1968), (Black, 1961) and in vitro (Salmenpera, 1976), (Morrow, 1967) have
suggested a suppressive effect by glucocorticoids on adrenal steroidogenesis. In this
connection, evidence has been obtained that adrenocortical cells possess
glucocorticoid receptors (GR) (Loose, 1980) and that glucocorticoids themselves
appear to be potent regulators of these receptors (Burnstein, 1991). It is possible that
the negative effect of glucocorticoids on GR expression represents a feedback
inhibition mechanism. This mechanism may be important in vivo for protecting the
adrenal from excessive glucocorticoid levels in states of hypercorticoidism.
In conclusion, the main steroid produced by BAC cells in response to ACTH-
treatment was Cortisol. The response by BAC cells to ACTH-treatment was an
increase in Cortisol output over the first 6 hours followed by a plateau in Cortisol
output thereafter. The output in Cortisol was mirrored by an increase in StAR mRNA
expression, with a peak in StAR mRNA expression at 6 hours followed by a decline
thereafter. Thus showing a temporal relationship between steroid production and
StAR mRNA expression in BAC cells. A series of experiments to investigate the
cause of this decline in steroidogenesis were undertaken. Various aspects of the cell
culture system, such as serum, were looked at and found not to influence either
steroid output or StAR mRNA expression. The concentration ofACTH and the
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peptide length were found not to be a factor. The decline in StAR mRNA and Cortisol
production was found with various ACTH concentrations and with both ACTH|.24 and
ACTH,.39. The bioactivity ofACTH was reduced after 24 hours in the cell culture
system at the lower concentrations ofACTH. The binding of ACTH to the plastic of
the cell culture plates was a possibility; this could be investigated further by using
radiolabeled ACTH. Desensitisation of the ACTH receptor was investigated by
retreating the BAC cells with ACTH after 24 hours. The steroid output and StAR
mRNA expression in BAC cells treated with ACTH for a second time was similar to
that seem with the first ACTH treatment. This suggests that the ACTH receptor was
fully functional.
The use of conditioned medium suggested the presence of a factor(s) within the cell
culture system that could be having an inhibitory effect on steroidogenesis. One
possibility was that the high level of Cortisol secreted into the medium was exerting
negative feedback inhibition. However this was found not to be the case when Cortisol
added to the cell culture medium had no effect on either the steroid output or the
StAR mRNA expression in ACTH-treated BAC cells. Further studies into the
identification of the proposed inhibitory factor would be interesting. However, this
may prove to be a laborious task as many factors are secreted into the cell culture
medium. The decline in steroidogenesis may also be the result of the "static" nature
of the cell culture system. Further experiments using a superfusion system whereby
the medium bathing the cells is continually moving, therefore more akin to the
situation in vivo, would be of interest.
Another possibility is that glucocorticoids may act negatively to regulate gene
expression of the steroidogenic enzymes, although this was not investigated in this
thesis. It has been shown that the glucocorticoid dexamethasone can suppress the
ACTH-induced accumulation ofCYP11A and CYP17 mRNAs with a concomitant
fall in Cortisol secretion (Trzaciak 1993). Measurement of the mRNA levels for the
various steroidogenic enzymes throughout the ACTH treatment period would be of
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interest. This could be done using northern analysis or real-time RT-PCR.
Developments in DNA microarray technology, which allows patterns of gene
expression of several steroidogenic enzymes to be analysed at once, would be
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ABSTRACT
StAR protein may facilitate rapid transfer of cholesterol from the outer to the inner
mitochondrial membrane, the site at which cholesterol is converted to pregnenolone by
the cholesterol side chain cleavage complex. We have studied the effect of ACTH
treatment on StAR mRNA and protein levels in bovine adrenocortical cells in primary
culture. Ceils were initially cultured for 3 days after isolation, and then treated with
ACTH (lO^M) for various times up to 24 hours. Northern analysis of total BAC mRNA,
using a [a32P]-labelled cDNA probe encoding a 5' region of bovine StAR mRNA,
revealed two principal hybridising species of 1,6 and 3.0 kb. Western immunoblot
analysis revealed a principal band at 30 kDa. Levels of both StAR mRNA and protein'
showed an increase at 1 hour, reached a maximum at around 6 hours and declined to
basal levels at 24 hours. Cortisol secretion (measured by RIA) showed a similar change
over the same period. From these results it appears that StAR mRNA and protein levels
in BAC are acutely regulated in concert with ACTH-stimulated Cortisol secretion.
INTRODUCTION
The first enzymatic step in steroidogenesis is the conversion of cholesterol to
pregnenolone ,catalysed by the cytochrome P450 side chain cleavage (P450s£c) enzyme
which resides on the inner mitochondrial membrane. The rate-limiting -step in this
process is the translocation of cholesterol from the outer to the inner mitochondrial
membrane, which requires a rapidly synthesised regulatory protein. StAR protein was
initially described in rat and bovine adrenal cells by using two-dimensional gel
565
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electrophoresis to identify a family of mitochondrial proteins synthesised in response to
ACTH-stimulation. StAR protein has also been found in other steroidogenic tissues (1,2)
and StAR cDNA was first cloned and sequenced from mouse MA-10 Leydig tumour
cells (3). MA-10 and COS-1 cells transfection with StAR cDNA, in conjunction with the
P450scc system, resulted in steroidogenesis in the absence of trophic hormone
stimulation (4,5). Demonstration that the inherited defect, lipoid congenital adrenal
hyperplasia, is due to mutations in the StAR gene further emphasises the its role in
steroidogenesis (6).-StAR cDNAs have now been cloned from a variety of tissues and
species including bovine luteal cells where the corresponding mRNA was found to be
transcribed as 3 kb and 1.6 kb transcripts (7). In this study, we have examined the
regulation of StAR mRNA and protein levels in bovine adrenocortical (BAC) cells in
response to trophic hormone treatment.
METHODS
BAC ceils were isolated and cultured as previously described (8). Cells were plated
at a density of 5 x 106 per 25 cm2 flask for mRNA studies and 1.5 x 106 per well of a 6-
well plate for protein studies. Total RNA (25 (ig) was analysed by northern blot and
StAR mRNA was detected using a [a32P]-labelled cDNA probe encoding a 5' region of
the bovine StAR (GenBank acc.# S79908, position 210-608). Total cellular protein (25
fig) was analysed by western blot using a primary polyclonal sheep antiserum raised
against a peptide fragment (amino acids 82-107) of the bovine StAR protein and a
donkey anti-sheep second antibody coupled to a HRP-conjugate (The Binding Site,
Birmingham, UK). The final signal was detected by chemiluminescence (SuperSignal
ULTRA kit. Pierce, Rockford, USA). Cortisol contents ofmedia were quantified using a
double antibody radioimmumoassay.
RESULTS AND DISCUSSION
This study demonstrates the presence, in BAC cells, of two principal StAR mRNA
transcripts of 1.6 and 3.0 kb and principal and minor protein species of 30 and 40 kDa^
similar to other studies on StAR mRNA (9) and protein (10) in BAC cells. Distinctly in
the present study, western blot analysis shows that freshly isolated BAC cells contain:
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FIGURE 1
BAC cells isolated at time 0 were cultured for 24, 48, 72 or 96 hours and then treated
with/without ACTH (10"* M) for a further 6 and 24 hours. Quantification ofWestern blot
analysis (30 kDa band) was made using an image analyser.
high levels of StAR protein, while these levels decrease over 3 days of culture. ACTH
treatment for 6 hours following 24, 48, 72 or 96 hours of culture increases the StAR
protein levels; however, when ACTH treatment is prolonged for 24 hours, the StAR
protein levels return to untreated levels (Figure 1). Western blotting and northern
analysis show that StAR gene expression appears to be most responsive to ACTH
stimulation following 48 and 72 hours of culture (Figures 1 and 2). We therefore chose
to use cells cultured for 72 hours for subsequent experiments.
Following ACTH treatment StAR mRNA levels and Cortisol secretion were increased
after I hour (Figures 2B and 3), whereas StAR protein levels were not increasecLabove
that in untreated cells until 6 hours of treatment (Figure 2A). This suggests that the
initial steroidogenic response is not primarily dependent on the presence of high levels of
newly synthesised StAR protein, although participation of a small sub-pool of new
protein cannot be excluded. Instead, mechanisms, such as post-translational modification
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FIGURE 2
BAC cells were cultured for 72 hours after isolation, then incubated with/without ACTH
(10"* M) for 1, 2, 4, 6, and 24 hours. (A) Quantification ofWestern blot analysis (30 kDa
band) and (B) Quantification of northern blot analysis (3 kb band) was made using an
image analyser.
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FIGURE 3
Effect of time of ACTH treatment on the rate of Cortisol secretion into media overlying
BAC cells (nmol/hour)
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response, while newly synthesised StAR is needed to maintain steroidogenesis over a
period of hours. Consistent with this hypothesis, the decreased rate'of Cortisol secretion
observed after prolonged (24 hour) ACTH treatment is associated with decreased StAR
mRNA and protein levels (Figure 3). The discordance between StAR protein and
mRNA levels, and the production of Cortisol at the early time-points merits further
investigation.
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ABSTRACT
Up regulation of the steroidogenic acute regulatory
protein (StAR) is implicated in the rapid synthesis
and secretion of steroidogenic cells to produce
steroids in response to stimulation by trophic
hormones of the gonadal and stress axes. In the
present study, we have assessed the kinetics of both
StAR gene transcription and protein biosynthesis in
primary cell cultures of bovine adrenocortical and
ovarian theca cells, under conditions of acute
stimulation by corticotrophin (ACTH) and luteiniz¬
ing hormone (LH), respectively. In both cell
systems, detectable upregulation of StAR gene
transcription occurred within 1—2 h, reaching
maxima at 4 h (theca cells) or 6 h (adrenocortical
cells). mRNA levels returned rapidly to baseline, by
12 h or 24 h, respectively. Specific StAR protein
levels were assessed by western blotting using a
novel antibody raised against a bovine StAR
peptide, and showed a similar fast upregulation,
albeit delayed by 1—2 h compared with the mRNA.
The response of the cultured theca cells was more
acute than that of the adrenocortical cells, possibly
reflecting the propensity of the LH receptor to
desensitize rapidly, unlike the ACTH receptor. The
primary bovine theca cell cultures were also used for
fully homologous transfection studies using various
deletion promoter—reporter constructs of the bovine
StAR gene. Kinetic analysis of the results indicated
that the acute transcriptional response resides
within the proximal ( — 315 bp) promoter region,
which includes two putative responsive elements for
the steroidogenic factor-1. More distal promoter
regions may be involved in modulating the
specificity of expression by combining enhancer and
inhibitory functions.
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INTRODUCTION
In steroidogenic tissues, the rate-limiting step in the
acute hormone-dependent upregulation of steroid
biosynthesis is considered to be the transport of the
cholesterol substrate to the inner mitochondrial
membrane, where it is converted to pregnenolone
by the cytochrome P450 cholesterol side-chain
cleavage complex (reviewed in Thomson 1998).
This rate-limiting mitochondrial transport is depen¬
dent upon the de novo biosynthesis of new protein
(reviewed in Stocco & Clark 1996). An important
candidate for this role is the recently cloned
steroidogenic acute regulatory protein (StAR; Clark
et al. 1994), which is rapidly and highly upregulated
after a steroidogenic stimulus, and becomes associ¬
ated with mitochondria (Stocco & Clark 1996).
Furthermore, the apparently indispensible nature
of StAR is revealed by the severe impairment of
steroidogenesis after inactivation of the StAR
gene in mice by homologous recombination (Caron
et al. 19976), or in the naturally occurring human
deficiency disease, congenital lipoid adrenal
hyperplasia (Miller 1997).
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The cDNA and gene sequence encoding the
StAR protein have been elaborated, initially for the
mouse (Clark et al. 1994), and subsequently for
other species, including the bovine (Hartung et al.
1995). Initial experiments investigated the basal
levels of StAR mRNA in different tissues in vivo, or
in tumour cell lines, and the levels attained after
long-term stimulation. Although several studies
have looked at factors regulating the StAR gene
promoter (reviewed in Reinhardt et al. 19996), most
of these used a prolonged (>12 h) stimulation
protocol, and so the molecular mechanisms respon¬
sible for the acute (<4 h) cAMP-dependent upregu-
lation of StAR gene transcription remain unclear.
In order to investigate this in a homologous system,
we have exploited the ability of bovine ovarian theca
cells and bovine adrenocortical cells to produce
large amounts of steroids in response to acute
stimulation by the natural adenylate cyclase-linked
secretagogues, luteinizing hormone (LH) and
adrenocorticotrophic hormone (ACTH), respect¬
ively. Using northern and western blotting for
StAR mRNA and protein, we first characterized the
time-course of the acute specific stimulation of
StAR gene transcription in these cell types by
their natural effectors. Subsequently, we used
transfection of previously characterized promoter—
deletion-reporter constructs derived from the
bovine StAR gene (Rust et al. 1998) into cultured
bovine primary ovarian theca cells to provide a
completely homologous system in which to de¬
lineate elements of the StAR promoter that are
required for the rapid LH-dependent increase in
transcription. These results show that the time- and
hormone-specificity of StAR gene transcription
reside within the proximal promoter region,
between — 315 and the transcriptional start site.
MATERIALS AND METHODS
Cell culture
Bovine theca interna cells were prepared from large
antral follicles (10—25 mm diameter) of ovaries
collected from mid- to late-cycle cows at the local
abbatoir. Cell preparation and primary culture
conditions were exactly as described by Bathgate
et al. (1999). After Percoll purification, cells were
resuspended in 1 : 1 Dulbeccos's minimal essential
medium and Ham's F-12 medium, supplemented
with 2 mM l-glutamine, 100 IU/ml penicillin,
lOOpg/ml streptomycin, 01% BSA, 5 pg/ml trans¬
ferrin, and 5 ng/ml sodium selinite. For mRNA and
protein preparation, approximately 106 cells were
seeded into vitrogen-coated six-well plates and
cultured at 37 °C under 95% air—5% C02 for 6 days
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(with medium changed every 2 days), attaining in
that time approximately 80% confluence. Foi
measurements of endogenous mRNA and protein
production, after the medium change on day 6, cells
were supplemented in addition with 100 ng/ml
bovine insulin with or without 10 ng/rnl bovine
luteinizing hormone (bLH; a kind gift of NIADDK
and the National Hormone and Pituitary Program,
NIH, Bethesda, MD, USA), and culture continued
for the times indicated. Primary zona fasciculata/
reticularis (ZFR) cells were isolated from sliced
bovine adrenocortical tissue as previously described
(Williams et al. 1989, Nicol et al. 1998) and were
plated at a density of 15 x 106 per well of a six-well
plate for both mRNA and protein studies. After
plating, cells were maintained for 48 h in Ham's
F-10 medium containing 10% v/v controlled pro¬
cessed serum replacement-1 (Sigma, Poole, Dorset,
UK), 100 IU penicillin, lOOpg/ml streptomycin
and 5 pg/ml amphotericin B at 37 °C under 95%
air—5% C02, with one medium change after 24 h,
and then for a further 16 h in Ham's F-10 medium
containing 0-2% BSA and antibiotics as above,
before hormone treatment using 10 nM Synacthen
(synthetic ACTH(1—24) peptide, Novartis Pharma¬
ceuticals, Camberley, Surrey, UK) in the same
medium.
Northern hybridization
For the ovarian theca cells, total RNA was extracted
using the peqGOLD RNA-Pure (peqLab,
Erlangen, Germany) reagent and pooled from two
wells per experiment for each data point. Two
micrograms total RNA per slot were subjected to
northern hybridization using 13% agarose—2 2 M
formaldehyde gels in morpholinopropanesulphonic
acid running buffer (Sambrook et al. 1989). RNA
was transferred to a nylon membrane (Nytran;
Schleicher & Schtill, Dassell, Germany) by over¬
night capillary transfer and fixed by u.v. crosslink-
ing. Hybridization with a 750 bp gene-specific
probe from the 5' region of the bovine StAR cDNA
was exactly as previously described (Hartung et al.
1995). To control for even loading and transfer of
the RNA, blots were rehybridized using a radio-
labelled probe specific for the bovine SI5 ribosomal
protein (Bathgate et al. 1999). For the ZFR cells,
total RNA was isolated using the RNAzol B reagent
(Biogenesis, Poole, Dorset, UK), and 20 pg RNA
per slot was denatured with glyoxal (Thomas 1983),
resolved on a 12% agarose gel in 10 mM sodium
phosphate pH 7 0 buffer, capillary-transferred to
positively charged nylon membranes (Stratagene)
and fixed by u.v. crosslinking. Hybridization for
StAR mRNA was as above, but using a somewhat
www.endocrinology.org
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shorter 5' cDNA probe (accession number S79908,
nucleotides 210-608). Even loading and transfer
were confirmed by rehybridization using a (3-actin
probe. All northern and western (see below)
blotting experiments were repeated at least twice for
fully independent batches of cells, and gave fully
reproducible results.
Antibody production and western blotting
Total cellular protein (ZFR cells 25 pg, theca cells
15 pg per sample), was prepared by homogenization
in PBS containing 0-1% SDS and 1% sodium
deoxycholate, resolved on a 12% acrylamide gel,
and electroblotted onto Immobilon-P membrane
(Sigma). Western analysis was carried out using, as
primary antibody, a polyclonal sheep antiserum
raised against a peptide fragment (AMQRALGIL
KDQEGWKKESRQANGDE; amino acids 82-
107; Hartung et al. 1995) from the predicted bovine
StAR protein sequence attached to a lysine-web-
based eight-branched antigen scaffold (The Binding
Site, Birmingham, UK), and a donkey anti-sheep
horseradish peroxidase-conjugated second antibody.
After preliminary optimization (data not shown),
primary and secondary antibodies were used
respectively at 1 : 10 000 and 1 : 25 000 dilutions
in PBS containing 10% blocking buffer (Pierce,
Rockford, 1L, Staffs, USA) and 2% w/v non-fat
milk (Marvel Original; Premier Beverages, Stafford,
UK) for immunodetection of adrenocortical pro¬
teins, and at 1 : 7500 and 1 : 10 000 dilutions,
respectively, in PBS containing 10% blocking buffer
(Pierce) and 1% non-fat milk for theca cell proteins.
The final signal was visualized by chemilumi-
nescence (SuperSignal ULTRA kit; Pierce). The
specificity of the antibbdy was demonstrated first by
its ability to detect a protein in adrenocortical
protein extracts at the anticipated size of approxi¬
mately 30 kDa, the pattern of expression of which
followed closely behind that of the StAR mRNA
(see later), and, secondly, by the complete elimi¬
nation of the specific 30 kDa band as a result of the
addition of an excess (>3 ng/ml) of the peptide used
to generate the antibody (not shown).
Cell transfection and analysis
All bovine StAR promoter-reporter DNA con¬
structs, in addition to control vectors, were exactly
as previously described (Rust et al. 1998). DNA was
purified using the EndoFree Plasmid Maxi Kit
(Qiagen, Hilden, Germany) as described by the
manufacturer. For transfection experiments, 10f'
bovine theca cells per well, prepared as above, were
seeded into 12-well plates, and cultured as above
in the presence of 100 ng/ml insulin for 2 days.
Cells were then washed briefly in PBS before
the addition of OPTI-MEM (Gibco-BRL,
Deisenhofen, Germany) transfection medium.
Transfection was carried out by adding 5 |ag per
well LipofectAMINE (Gibco-BRL) at a ratio of
2: 1 with the DNA to be transfected, and
incubating for 5 h. Medium was then replaced by
the standard culture medium and incubation
continued for a further 3 days, before treatment
or not with 10 ng/ml bLH, for the times as
indicated. Cells were then washed rapidly in
PBS and immediately extracted into 40 pi reporter
lysis buffer (Luciferase Assay System; Promega,
Madison, WI, USA) before luciferase activity was
measured using the same kit. As cotransfected
control, a (3-galactosidase reporter gene driven from
the cytomegalovirus (CMV) promoter was used,
measuring the resulting acLivity using the Galacto-
Light kit (Tropix, Bedford, MA, USA). All
transfections were performed in triplicate for any
batch of primary cells. All experiments were
repeated at least twice using independent batches of
cells, with fully reproducible results.
RESULTS
Expression of endogenous StAR mRNA and
protein in primary cultures of bovine ovarian
theca and adrenocortical (ZFR) cells
The endogenous StAR mRNA in bovine ovarian
theca and adrenocortical (ZFR) cells was expressed
as transcripts of three different sizes (Figs 1, 2), as
shown previously also for bovine corpus luteum
(Hartung et al. 1995, Pescador et al. 1996) and
predicted from the positions of alternative poly-
adenylation sites within the 3' UTR of the cloned
bovine cDNA (Hartung et al. 1995). These
migrated as two major bands at approximately
3 0 kb and 18 kb, and a minor band at 1-6 kb,
evident only in the theca cells. Levels in untreated
cells were very low for both cell types (Figs IB, 2B).
After treatment of theca cells with bLH or
adrenocortical cells with ACTH, there was a similar
rapid increase in the relative amounts of the two
major StAR transcripts in both cell systems. This
increase was already detectable after 1 h of
stimulation, by comparison with the untreated
controls, and reached a maximum at about 4 h
(theca cells, Fig. 1A) and 6 h (adrenocortical cells,
Fig. 2A) of treatment. At the time of maximal
induction of StAR mRNA, the shorter 16 kb
transcript became readily detectable in the theca
cell cultures (Fig. 1A). Also of significance was the
rapid decline in transcript levels at subsequent
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FIGURE 1. Northern hybridization of StAR mRNA in extracts of bovine theca
cells cultured for the time indicated in the presence (A) or absence (B) of
10 ng/ml LH. As control for even loading and transfer, blots were
rehybridized against a probe for the bovine ribosomal protein, SI5. The blots
in (A) and (B) are from parallel experiments using (he same batch of cells
Duplicate lanes represent RNA from independent parallel cell cultures from
within the same experiment, to indicate the extent of within-batch variation
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figure 2. Northern hybridization of StAR mRNA in
extracts of bovine adrenocortical (zonae fascicularis and
reticularis) cells cultured for the times indicated in the
presence (A) or absence (B) of 10 nM ACTH. As
control for even loading and transfer, blots were
rehybridized against a probe for (5-actin. The blots in
(A) and (B) are from parallel experiments using the
same batch of cells, with all operations being performed
in parallel.
time-points, such that, at 12 h (theca cells) or 24 h
(adrenocortical cells), StAR mRNA had returned to
basal (unstimulated) levels. The apparent and slight
long-term increase in StAR mRNA in the absence
of bLH (Fig. IB) probably reflected the differen¬
tiation of these cells in culture under the influence
of insulin only (Bathgate et al. 1999).
Total cellular protein was also prepared from
similar cultures of stimulated and unstimulated cells
and subjected to western blotting using a newly
developed anti-StAR polyclonal antibody. This
antibody was raised against a 26-mer sequence from
the predicted external surface of the bovine StAR
protein (Hartung et al. 1995) and specifically
recognized a 30 kDa protein (Fig. 3). Protein bands
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of similar size were detected in adrenocortical and
luteal protein extracts using another polyclonal
antibody raised against mouse recombinant StAR
protein (Pescador et al. 1996, Ronen-Fuhrmann
et al. 1998, and data not shown). The time-course of
changes in StAR protein levels in the two cell types
was similar (Figs 3, 4), with a first detectable
increase at 2 h and maximum levels being main¬
tained through to 6 h (theca cells) or somewhat
longer (adrenocortical cells), but with a return to
near basal values by 12-24 h. Thus StAR protein
production was marginally delayed, both in appear¬
ance and disappearance, with respect to the changes
in levels of the specific mRNA. Absolute levels of
StAR protein, both basal and stimulated, appear to
be much greater in the adrenocortical cells than in
the bovine theca cells, as indicated by the control
lanes (1 and 2) in Fig. 3, in which the same amount
of total protein as in the other lanes had been
loaded.
Acute regulation of the bovine StAR gene
promoter in homologous cell culture
In a previous study (Rust et al. 1998), we have been
able to characterize the role of certain cis elements
within the upstream promoter region of the bovine
StAR gene responsible for expression in a heterolo¬
gous cell system cotransfected or not with the
transcription factor, steroidogenic factor-1 (SF-1;
Ad4 BP; Fig. 5). In this system, deletion promoter-
reporter constructs had been transfected into
non-steroidogenic cells together with appropriate
expression vectors. In order to determine whether
the SF-l-responsive elements are also involved in
endogenous StAR gene expression in primary
cultures of bovine steroidogenic cells (i.e. in a
homologous system as close to the in vivo situation
as possible), and are sufficient to account for the
acute up- and downregulation of the StAR gene, a
time-course for activation of defined promoter-
reporter constructs was determined under acute
bLH stimulation after transfection into primary
ovarian theca cells (Fig. 6). The results show that
there was consistently detectable upregulation
in response to bLH by 3 h of stimulation. The
maximum level of luciferase activity accumulated in
the cells was reached by 4—6 h, and was not further
increased at later times. A comparable time-course
was obtained irrespective of the use of a long
promoter fragment (— 1245 bp; Fig. 6A), or a
shorter fragment ( — 315 bp; Fig. 6B) attached to the
luciferase reporter gene. However, it should be
noted that, in repeated experiments, the response to
LH appeared generally to be more robust, consist¬
ent, and somewhat earlier in these primary cell
Journal of Molecular Endocrinology (2000) 24, 109—118
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figure 3. Western blot of immunoreactive StAR protein in extracts of bovine adrenocortical cells cultured as
indicated for increasing times in the absence or presence (+) of lOnM ACTH. The upper, more slowly migrating
band appears to be non-specific and its intensity does not alter with time or incubation conditions. The specific,
approximately 30 kDa StAR protein appears as a doublet with a more rapidly moving isoform increasing in
intensity, in parallel with the principal StAR protein band. In all lanes, 25 pg protein were loaded.
cultures, for the shorter -315 bp construct (cf.
Fig. 7).
Experiments using different promoter—deletion
constructs transfected into theca cells optimally
stimulated by bLH for 4 h indicated that the acute
stimulation of the bovine StAR gene requires only
the minimal promoter up to -315 bp (Fig. 7), which
includes the first two proximal SF-1 binding motifs
(Rust et al. 1998). Indeed, even shorter constructs
comprising only one (—203) or none (— 101) of the
proximal SF-1 sites, also appear to be responsive to
LH. Longer promoter constructs, however, do not
increase the level of luciferase activity obtained. As
already indicated in Fig. 7, these appear to have
reduced activity by comparison with the shorter
constructs. This would suggest that the region
upstream of the -315 construct may include a
negative factor that could modulate the activity of
the proximal promoter.
DISCUSSION
The acute response of steroidogenic cells to the
anterior pituitary hormones, LH or ACTH, is an
essential part of the regulatory mechanisms promot¬
ing steroid biosynthesis. Both peptide hormones are
released in short pulses or trains of pulses, and elicit
both immediate and sustained effects. Amongst the
immediate effects are those influencing steroid
secretion (reviewed in Thomson 1998). In addition
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to such very acute events, there is also an effect a
the transcriptional level. This effect was quite rapid
newly transcribed StAR mRNA being detectabh
in both adrenocortical and ovarian thecal cells aftei
about 1 h of stimulation. Equally important
however, is the observation, also for both cell types
that levels ofmRNA peaked at about 4—6 h. and ther
declined to basal values by, maximally, 12-24h
This shows that the stimulatory effect upor
transcription is short-lived, and that mechanism:
are present in these steroidogenic cells for the rapic
degradation of the newly synthesized StAR mRNA
It is important to note that the primary cell culture:
were exposed continuously, through the treatmen1
period, to the effectors LH or ACTH. It is knowr
that the LH receptor is rapidly downregulatec
(desensitized, internalized) within the first fev
minutes of hormone exposure (e.g. for bovine lutea
cells; Budnik & Mukhopadhyay 1987), thus al
subsequent LH-dependent events will be receptor-
independent consequences of this initial stimu¬
lation. For the effect of ACTH on adrenocortica
cells, the situation appears to be different. Instead o:
being desensitized, the cognate receptor appear:
rather to be upregulated (Penhoat et al. 1989). Thi:
could explain the more sustained transcriptiona
response of the StAR gene to ACTH treatmeni
evident in the adrenocortical cell cultures.
By transfecting different promoter—reporter con¬
structs into ovarian theca cells, under a treatmen
paradigm similar to that above in which we have
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figure 4. Western blot of immunoreactive StAR protein in extracts of bovine theca cells cultured as indicated for
increasing times in the absence or presence (+) of 10 ng/ml bovine LH. It should be noted that the absolute levels of
the StAR protein are considerably less than in the adrenocortical cells (lanes 1 and 2), and there is thus an increased
non-specific background. As for the adrenocortical cells, the StAR protein appears to be represented as a doublet. In
all lanes, 15 pg protein were loaded.
shown acute upregulation of the endogenous StAR
gene, we were also able to show that luciferase
activity (i.e. expression of active protein) follows the
same time-course of induction as the native StAR
protein. Increased luciferase activity was evident
first at 2—3 h, just like the endogenous StAR protein
seen in the western blots, suggesting that both StAR
and luciferase mRNAs are translated in a compar¬
able manner. The induction of reporter activity
was, as expected, slightly delayed by comparison
with the induction of transcription. The disappear¬













figure 5. Schematic representation of the bovine StAR gene and its
promoter, indicating putative transcription factor binding elements.
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figure 6. Primary cultures of bovine theca cells
transfected with luciferase reporter constructs linked
with either the — 1245 (full-length, A) or the
—315 (short, B) bovine StAR gene promoters. Three
days after the transient transfection, cells were
stimulated or not as indicated by addition of 10 ng/ml
bovine LH. The amount of luciferase protein
synthesized is estimated from its enzymatic activity
expressed in relative light units (RLU; relative to the
cotransfected CMV-P-galactosidase constitutive
construct) as a percentage of the level attained with the
strong constitutive promoter of the pGL3-C construct
(C2) in the absence of LH. CI, luciferase activity of the
empty reporter vector, pGL3-B. Data are expressed as
means ± s.e.m from parallel triplicate experiments using
the same batch of primary cells.
time-course different from that for the endogenous
protein, as this will depend on the function of
substrate-specific proteases. Nevertheless, it is
evident that there is a plateau in luciferase
expression at 4—6 h, with no further increase after
this, reflecting precisely the short phase of tran¬
scriptional induction. This experiment showed that
the promoter information required for this acute
cm - lh
mm-* lh
pGL3-B pGL3-C -101 -203 -315 -1009 -1245
figure 7. Primary cultures of bovine theca cells
transfected with luciferase reporter constructs linked
with different deletion fragments of the bovine StAR
gene promoters. The promoter fragments correspond tc
DNA sequences extending upstream from the
transcription start site to the restriction sites for BanI
(-101), Hpall (- 203), PstI (-315), Kpnl ( - 1009)
and BamHI ( — 1245), respectively. Results are
expressed in relative light units (RLU) as a percentage
of the luciferase activity obtained using the strong
constitutive promoter construct, pGL3-C, in the
absence of LH.
upregulation of transcription resides within the fir:
1200 bp upstream of the transcription start site, an
probably within the first 315 bp of this. Use c
promoter-deletion constructs confirmed what w
have previously shown for this gene using
heterologous transfection system (Rust et al. 1998
namely that LH-induced, cAMP-dependent gen
activation is maximal where the first two SF-1
responsive elements, which reside within tb
—315 bp immediate upstream region of the pre
moter, are present. It should be noted, though, th:
a marked LH-dependent stimulation was als
evident for the very short —101 construct (Fig. 7
which does not include an SF-1 binding elemen
suggesting that SF-1 may not be absolute!
required to mediate the stimulatory effect of LP
Other genes have also been described in the same c
related cell types, for example, P450scc in lute;
cells (Liu & Simpson 1997) or oxytocin in granulos
cells (Wehrenberg et al. 1994), which also depen
upon SF-1 interaction, and respond to LI
stimulation. These responses, however, have a quit
different time kinetic and cell specificity. Tht
other factors must act in conjunction with SF-1 t
encode the cellular and temporal specificity ob
served for the StAR gene. One candidate in tb
case of the mouse StAR gene is the transcriptio
factor, CCAATT/enhanced binding protein
(C/EBPP) (Reinhardt et al. 1999a, Silverma
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et al. 1999). Support for this view is provided by
a comparison of the present transfection results,
using cells endogenously expressing the StAR
gene, with the heterologous system used previously.
In the previous study, the transcriptional activity
induced by SF-1 attained maximally only 2% of the
level reached by the same constitutively active
control plasmid (pGL3-C) as that used here; this
compares with greater than 50% in the present
homologous system. Similarly, a constitutively
active protein kinase A subunit was able to increase
the SF-1-dependent transcriptional activation by
only about 50% in the previous study whereas,
in the homologous system, LH induced up to a
10-fold increase in reporter gene activity. The
molecular mechanisms by which SF-1 could be
involved in cAMP-dependent signal transduction
are not yet understood. In a recent study, a
potential serine acceptor site for protein kinase A
(PKA) phosphorylation, and the C-terminal acti¬
vation domain were both implicated in the transcrip¬
tional upregulation of the high-density lipoprotein
receptor gene in rat luteal cells via SF-1 (Lopez et al.
1999). Also, possible mitogen-activated protein
kinase phosphorylation of SF-1 has been suggested
in the context of cofactor recruitment (Hammer et al.
1999).
The requirement for other factors to act with SF-1
in mediating cAMP-regulated signal transduction
would also offer an explanation for the anomalous
findings regarding specific nuclear protein-binding
to the bovine StAR promoter (Rust et al. 1998). Of
the three putative SF-1 binding motifs evident in the
bovine StAR promoter (Fig. 5), only the distal
element bound purified SF-1 with high affinity. The
second proximal element bound SF-1 only weakly,
and the most proximal element failed to show any
binding activity (Rust et al. 1998). Yet it is the
proximal promoter containing the first SF-1 motifs
which, in this and other studies, appeared to mediate
SF-l-dependent activation of the StAR gene by
adenylate cyclase in (for example) humans
(Sugawara et al. 1996), mouse (Caron et al. 1997a),
rat (SandhofF et al. 1998) and pig (LaVoie et al.
1999). Findings of a recent study using the mouse
StAR gene promoter even suggested that an inter¬
action of SF-1 in the proximal promoter may not
be essential, and that adenylate cyclase-induced acti¬
vation can be mediated by a combination of the
transcription factors C/EBPp and GATA-4 only
(Silverman et al. 1999). This opinion is supported by
findings of the present study, in which the -101
construct of the bovine StAR gene was able to
transduce LH-stimulation to the reporter gene. This
fragment does include an inverse GATA motif at
position-65 (Rust et al. 1998).
www.endocrinology.org
Other regions of the promoter may be involved in
the definition of expression specificity. There is
evidence, from the transfection studies, for a mildly
inhibitory element in the region upstream of
nucleotide -315. There is also, in this region,
marked nuclear protein binding unrelated to SF-1
(Rust et al. 1998). Furthermore, although not
apparently contributing to gene activation, a very
good binding site for SF-1 exists in the upstream
region of the promoter at -1100 (Rust et al.
1998). Concerning the rapid switching off of the
StAR gene, this might involve the activation of the
negative transcription factor, DAX-1, which has
been shown to interact with the mouse StAR
gene promoter, possibly interfering directly with
SF-1 binding in the proximal promoter region
(Zazopoulos et at. 1997, Reinhardt et al. 1999b,
Sandhoff & McLean 1999).
ACKNOWLEDGEMENTS
This research was generously supported by the
Deutsche Forschungsgemeinschaft (grant Iv7/1—4),
the endowment fund of the Department of Clinical
Biochemistry, Royal Infirmary, Edinburgh, and the
award of a University of Edinburgh Faculty of
Medicine Gunning Research Scholarship (no.
E06004) and also an Overseas Research Student
Award from the UK Committee of Vice-
Chancellors and Principals to H W. We are also
grateful to Dr Alistair Smith, Head of Diagnostic
Medicine, Royal Infirmary NHS Trust, University
of Edinburgh and Dr Brent Williams, Department
of Medical Sciences, Western General Hospital,
University of Edinburgh, for advice and helpful
discussions.
REFERENCES
Bathgate R, Moniac N, Bartlick B, Schumacher M, Fields M &
Ivell R 1999 Expression and regulation of relaxin-like factor
gene transcripts in the bovine ovary: differentiation-
dependent expression in theca cell cultures. Biology of
Reproduction 61 1090—1098.
Budnik LT & Mukhopadhyay AK 1987 Desensitization of
LH-stimulated cyclic AMP accumulation in isolated bovine
luteal cells - effect of phorbol ester. Molecular and Cellular
Endocrinology 54 51—61.
Caron KM, Ikeda Y, Soo SC, Stocco DM, Parker KL & Clark
BJ 1997a Characterization of the promoter region of the
mouse gene encoding the steroidogenic acute regulatory
protein. Molecular Endocrinology 11 138—147.
Caron KM, Soo SC, Wetsel WC, Stocco DM, Clark BJ &
Parker KL 19976 Targeted disruption of the mouse gene
encoding steroidogenic acute regulatory protein provides
insights into congenital lipoid adrenal hyperplasia.
Proceedings of the National Academy of Sciences of the USA
94 11540-11545.
Journal of Molecular Endocrinology (2000) 24, 109—118
kp.-.- >• :
* iFx?: :>••'■ ■ •.
118 r ivell and others • Acute regulation of StAR gene
Clark BJ, Wells J, King SR & Stocco DM 1994 The
purification, cloning and expression of a novel luteinizing
hormone-induced mitochondrial protein in MA-10 mouse
Leydig tumor cells. Characterization of the steroidogenic
acute regulatory protein (StAR). Journal of Biological
Chemistry 269 28314-28322.
Hammer GD, Krylova I, Zhang Y, Darimont BD, Simpson K,
Weigel NL & Ingraham HA 1999 Phosphorylation of the
nuclear receptor SF-1 modulates cofactor recruitment:
integration of hormone signaling in reproduction and stress.
Molecule and Cell 3 521—526.
Hartung S, Rust W, Balvers M & Ivell R 1995 Molecular
cloning and in vivo expression of the bovine steroidogenic
acute regulatory protein. Biochemical and Biophysical
Research Communications 215 646—653.
LaVoie HA, Garmey JC & Veldhuis JD 1999 Mechanisms of
insulin-like growth factor 1 augmentation of follicle-
stimulating hormone-induced porcine steroidogenic acute
regulatory protein gene promoter activity in granulosa cells.
Endocrinology 140 146—153.
Liu Z & Simpson ER 1997 Steroidogenic factor 1 (SF-1) and
SP1 are required for regulation of bovine CYP11A gene
expression in bovine luteal cells and adrenal Y1 cells.
Molecular Endocrinology 11 127—137.
Lopez D, Sandhoff TW & McLean MP 1999 Steroidogenic
factor-1 mediates cyclic 3',5'-adenosine monophosphate
regulation of the high density lipoprotein receptor.
Endocrinology 140 3034—3044.
Miller WL 1997 Congenital lipoid adrenal hyperplasia: the
human gene knockout for the steroidogenic acute regulatory
protein. Journal ofMolecular Endocrinology 19 227—240.
Nicol MR, Wang H, Ivell R, Morley SD, Walker SW &
Mason JI 1998 The expression of steroidogenic acute
regulatory protein (StAR) in bovine adrenocortical cells.
Endocrine Research 24 565—569.
Penhoat A, Jaillard C & Saez JM 1989 Corticotropin positively
regulates its own receptor and cAMP response in cultured
bovine adrenal cells. Proceedings of the National Academy of
Sciences of the USA 86 4978-4981.
Pescador N, Soumano K, Stocco DM, Price CA & Murphy
BD 1996 Steroidogenic acute regulatory protein in bovine
corpora lutea. Biology of Reproduction 55 485—491.
Reinhardt AJ, Williams SC, Clark BJ & Stocco DM 1999a
SF-1 (steroidogenic factor-1) and C/EBPP
(CCAATT/enhancer binding protein p) cooperate to regulate
the murine StAR (steroidogenic acute regulatory protein)
promoter. Molecular Endocrinology 13 729—741.
Reinhardt AJ, Williams SC & Stocco DM 19996 Transcriptional
regulation of the StAR gene. Molecular and Cellular
Endocrinology 151 161—169.
Ronen-Fuhrmann T, Timberg R, King SR, Hales KH, Stocco
DM & Orly J 1998 Spatio-temporal expression patterns of
steroidogenic acute regulatory protein (StAR) during
follicular development in the rat ovary. Endocrinology 139
303-315.
Rust W, Stedronsky K, Tillmann G, Morley S, Waltzher N &
Ivell R 1998 The role of SF-1/Ad4 BP in the control of th
bovine gene for the steroidogenic acute regulatory (StAR)
protein. Journal of Molecular Endocrinology 21 189^—200.
Sambrook J, Frisch E & Maniatis T 1989 Molecular Cloning,
A Laboratory Manual. New York: Cold Spring Harbor
Laboratory Press.
Sandhoff TW & McLean MP 1999 Repression of the rat
steroidogenic acute regulatory (StAR) protein gene by
PGF2a is modulated by the negative transcription factor
DAX-1. Endocrine 10 83-91.
Sandhoff TW, Hales DB, Hales KH & McLean MP 1998
Transcriptional regulation of the rat steroidogenic acute
regulatory protein gene by steroidogenic factor 1.
Endocrinology 139 4820—4831.
Silverman E, Eimerl S & Orly J 1999 CCAAT enhancer-
binding protein p and GATA-4 binding regions within the
promoter of the steroidogenic acute regulatory protein
(StAR) gene are required for transcription in rat ovarian
cells. Journal of Biological Chemistry 274 17987—17996.
Stocco DM & Clark BJ 1996 Regulation of the acute
production of steroids in steroidogenic cells. Endocrine
Reviews 17 221-244.
Sugawara T, Holt JA, Kiriakidou M & Strauss JF 1 996
Steroidogenic factor 1-dependent promoter activity of the
human steroidogenic acute regulatory protein (StAR) gene.
Biochemistry 35 9052-9059.
Thomas PS 1983 Hybridization of denatured RNA transferre
or dotted onto nitrocellulose paper. Methods in Erzzymology
100 255-266.
Thomson M 1998 Molecular and cellular mechanisms used ir
the acute phase of stimulated steroidogenesis. Hormones am
Metabolism Research 30 16—28.
Wehrenberg U, Ivell R, Jansen M, Von Goedecke S & Walth
N 1994 Two orphan receptors binding to a common site ar
involved in the regulation of the oxytocin gene in the bovir
ovary. Proceedings of the National Academy of Sciences of th
USA 91 1440-1444.
Williams BC, Lightly ERT, Ross AP, Bird IM & Walker SW
1989 Characterization of the steroidogenic responsiveness
and ultrastructure of purified zona fasciculata/reticularis ce!
from bovine adrenal cortex before and after primary cultur
Journal of Endocrinology 121 317—324.
Zazopoulos E, Lalli E, Stocco DM 8c Sassone-Corsi P 1997
DNA binding and transcriptional repression by DAX-1
blocks steroidogenesis. Nature 390 311—315.
revised manuscript received 31 August 1999
Journal of Molecular Endocrinology (2000) 24, 109—118 www. endocrinology, c
